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Abstract
The impedance of biological material changes with frequency, a phenomenon that has
been discovered more than 100 years ago. It is due to the fact that the cell membrane acts
as a capacitor which filters out currents at low frequency and lets them pass at high fre-
quency. This fundamental knowledge about biological dielectrics has incompletely been
exploited to detect and distinguish toxicity eﬀects on cell cultures, although impedance
measurements have been used for long in this field. In this thesis, it was found that low
frequency impedance signals are linked to initial stress responses of cells within cell pop-
ulations when exposed to a toxin whereas high frequency measurements inform about
major cell damage as is indicated by intracellular conductivity changes. In addition,
when cells gain resistance to a toxin, they experience a higher cell stiﬀness which is ex-
pressed by an increased low frequency impedance. The study of impedance changes as
a function of frequency and drug concentrations lead to the creation of an impedimetric
concentration-response map which distinguishes cell responses within four concentration
ranges without the use of any label. Although being inherently non-specific, this measure-
ment method was shown to report on distinct toxicity eﬀects, an important prerequisite
when studying drug action on cancer cells where stimulating and lethal eﬀects need to
be distinguished rigorously.
This thesis further encompasses the subject of three-dimensional impedance measure-
ments, i.e. the screening of the entire depth of a three-dimensional tissue culture. Given
the success of impedance measurements on cell monolayers, one would expect this de-
velopment to continue with 3D cultures since the complex structure of in vivo tissues is
mimicked more closely and, above all, since rapid and inexpensive techniques which are
able to probe thick tissue samples are currently inexistent. Nevertheless, few studies have
been carried out in this field. Here, the requirements of three-dimensional impedance sen-
sors are discussed and challenged by the fabrication of a corresponding device, involving
the development of so-called gel electrodes through a novel 2-step-soft-lithography pro-
cess. Their specific design allows for the decrease of leak currents, a common problem
when performing three-dimensional impedance measurements.
The simultaneous measurement of multiple samples in parallel is an an essential condi-
tion when performing high throughput drug toxicity screening. Electrode switch systems
are necessary which ultimately lead to setup complexity and signal noises. In this thesis,
a method is introduced, enabling the simultaneous implementation of impedance mea-
surements of multiple tissue samples with one electrode pair only. This is simply achieved
by exploiting the frequency domain and finally contributed to reducing setup complexity.
Keywords: impedance, toxicity, tissue, cells, frequency, beta-dispersion, 3D, drug resis-
tance, gel electrodes, cell stress
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Zusammenfassung
Die Impedanz von biologischem Material ändert sich mit der Frequenz. Dieses Phänomen
wurde vor mehr als 100 Jahren entdeckt und ist auf die Zellmembran zurückzuführen,
welche elektrische Ströme bei niedrigen Frequenzen filtert und bei höheren passieren lässt.
Obwohl Impedanzmessungen schon seit Langem eine wichtige Rolle bei Toxizitätsstudien
spielen, konnte dieses fundamentale Wissen über biologische Dielektrika nur geringfügig
genutzt werden um toxische Eﬀekte auf Zellen zu messen und zu unterscheiden. In dieser
Arbeit wurden Niedrigfrequenzimpedanzen mit anfänglichen Stresssignalen von Zellen
als Folge der Behandlung mit toxischen Substanzen korreliert. Hochfrequenzimpedanzen
hingegen wurden mit intrazellulären Leitfähigkeitsänderungen in Verbindung gebracht
und informieren dadurch über den Zelltod. Darüberhinaus konnte festgestellt werden,
dass Medikamentenresistenzen von Zellen eine verstärkte Starrheit verspüren und diese
mittels Niedrigfrequenzsignale detektiert werden können. Die Studie von Impedanzän-
derungen in Abhängigkeit von Frequenz und Wirkstoﬀkonzentration führte zu der Er-
stellung einer impedimetrischen Konzentrations-Antwort Karte, welche Zellantworten in-
nerhalb von vier Konzentrationsbereichen ohne zusätzliche Zellmarkierung unterscheidet.
Obwohl die Impedanztechnologie eine inhärent unspezifische Messmethode ist, wurde in
der Arbeit gezeigt, dass mit dieser Technologie verschiedene Toxizitätseﬀekte detektiert
werden können. Damit erfüllt diese Methode z.B. wichtige Anforderungen an Tests von
Krebsmitteln, bei denen zelltödliche von zellstimulierenden Eﬀekten konsequent unter-
schieden werden muss.
Diese Arbeit befasst sich weiterhin mit drei-dimensionalen Impedanztests von in vitro
Zellkulturen, bei welchen die gesamte Tiefe eines Gewebes zur Messung beiträgt. An-
gesichts des Erfolges der Impedanzmethode von 2D Zelleinzelschichten, sollte davon aus-
gegangen werden, dass diese Entwicklung mit 3D Zellkulturen fortgesetzt wird. Dies
wäre nicht nur auf den vermehrten Einsatz von 3D Zellkulturen in der in vitro Zellkultur
zurückzuführen, sondern vor allem auf die Tatsache, dass aktuell keine andere Methode
zur kostengünstigen und schnellen Analyse von Geweben verfügbar ist. Nichtsdestotrotz
hat es zu diesem Thema relativ wenige Studien gegeben. In dieser Arbeit wurden An-
forderungen an drei-dimensionale Impedanzmessungen diskutiert und ein entsprechender
Sensor entwickelt, welcher durch einen 2-Etappen-Soft-Lithographieprozess hergestell-
ten sogenannten Gel-elektroden ausgestattet ist. Das besondere Design dieses Sys-
tems verhindert elektrische Leckstellen, ein verbreitetes Problem bei drei-dimensionalen
Impedanzmessungen.
Das simultane und parallele Testen von mehreren Proben stellt eine essenzielle Bedin-
gung für Hochdurchsatz Medikamentenuntersuchungen dar. Allerdings involviert eine
solche Untersuchung komplizierte Umschaltsysteme, welche auch zu Signalstörungen
führen. In dieser Arbeit wurde eine Methode entwickelt, die es unter Zuhilfenahme
v
der Frequenzdimension erlaubt, die Impedanz von mehreren Proben gleichzeitig mit nur
einem Elektrodenpaar zu messen. Dadurch kann das Messsystem nicht nur vereinfacht
sondern auch verkleinert werden.
Schlüsselwörter: Impedanz, Toxizität, Gewebe, Zellen, Frequenz, beta-Dispersion, 3D,
Medikamentenresistenz, Gel-elektrode, Zellstress
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1. Introduction
A cell is the simplest viable matter that exists within the hierarchy of biological organ-
isation and represents the basic element of all living organisms. The human body is a
community of numerous diﬀerently specialized cells, which mostly would not be able to
survive in isolation. Even if cells ally to higher organizational levels such as tissues and
organs, all activities of a living organism remain and take place at the level of a cell, e.g.
muscle contraction through myocytes and signal transmission through nerve cells.
To understand the functionality and structure of cells, cell biologists require instru-
ments that are at the same scale, i.e. between 1-100 µm. Although initially being devel-
oped for the electronics industry, microtechnology has opened doors to the fabrication
of miniature structures that allow manipulating cells precisely. Just as microtechnolgy
has enaled the semiconductor industry to be more accurate, eﬃcient and cost-eﬀective,
these very same microfabrication techniques can be exploited to render cell analysis more
accessible, reliable and high through-put.
Although the domain of bio-microelectromechanical systems (Bio-MEMS) has attracted
significant attention in the last years already, this was mostly limited to research purposes
whereas the industrialization of such micro-devices is still in the oﬃng.
1.1. Scope
This thesis contributes to the understanding of electrical properties of in vitro cell cul-
tures, with a particular view to toxicological studies. Thereby, this work represents an
attempt to rendering toxicological laboratory tests more reliable, and by consequence to
help decreasing the high number of sacrificed animals in risk assessment of commercial-
ized chemicals. The great potential of impedance spectroscopy for toxicity probing lies in
its devoid of sample interfering manipulations (e.g. antibodies), enabling continuous and
resource saving implementation of “invisible” toxicity tests. Motivated by the elegance
of this technique, the present thesis discusses the implications of toxicity-induced cel-
lular changes and evolutionary adaptation of a cell population on frequency-dependent
impedance measurements. It is further described how in vivo drug delivery may be mim-
icked in vitro and how impedance screening of three-dimensional cultures is achieved.
The design and fabrication of the used micro-devices is therefore presented. A fourth
part of this thesis pertains a method that allows multiplexing impedance measurements
without using switches.
Finally, an in vitro model for the study of disease propagation in Alzheimer’s disease
was developed as well as a review on microfluidic techniques to study Alzheimer’s disease
was carried out, however this exceeds the scope of the main text and hence has been
included in annex to this thesis.
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1.2. Background
1.2.1. Toxicity testing for human safety
Toxicity is generally referred to as the ability of a substance to damage an exposed living
organism. One can distinguish between the eﬀect on a whole organism and the eﬀect on
a sub-structure of the organism, such as a cell (cytotoxicity) or an organ such as the liver
(hepatotoxicity).
Toxicity testing plays an important role in health and environmental fields and is an
indispensable tool for risk assessment of products on the market such as drugs, cosmetics,
pesticides, food additives or their chemical ingredients. These tests are essential to
characterize toxic eﬀects with respect to target organs, dose dependence, relationship
to exposure and, when appropriate, potential reversibility . Safety assessment is not a
choice but has become an obligation instructed by a wide number of general and specific
regulations in several industry domains (European Medicines Agency, 2009). One of the
most well-known is REACH (Registration, Evaluation, Authorisation and Restriction of
CHemicals), a European Union Regulation that entered into force in June 2007 (European
Commission, 2006) and has been described as the most important EU legislation for 20
years (BBC, 2005). REACH aims at making registration mandatory for the currently
some 80,000 produced chemicals commercialized worldwide for which toxicity data have
partially never been registered as well as for future chemicals (Abbott, 2005).
1.2.2. Cell-based toxicity testing
In pharmaceutical industry clinical trials are required prior to marketing as part of the
development process to determine if new drugs are safe and eﬀective in humans. Non-
clinical studies are preceding these tests in humans in order to select the best lead chem-
ical and to estimate an initial safe starting dose and dose range (European Medicines
Agency, 2009). Non-clinical trials comprehend a wide range of measurement methods
whereas tests on animals seem to be both the most important and the most controversial
ones. In fact, around one million animals are used every year in Europe in toxicology
tests (Abbott, 2005) representing ethical problems as well as enormous costs. More-
over, in a large number of cases, animal studies have been proven inadequate for human
safety assessment due to species diﬀerences (Olson et al., 2000). For example, while all
mammals use cytochrome P4501 (CYP450) to detoxify and eliminate toxic compounds,
specific CYP distribution, pathways and rates of reactions vary significantly between
rodents and humans (Smith, 1991; Astashkina et al., 2012). Nevertheless, inputs to the
risk assessment have traditionally been generated in animal tests as they stand for the
closest whole organism alternative to tests in humans, and therefore are required by in-
ternational regulations (European Medicines Agency, 2009; Opp et al., 2009). All these
facts indicate that preclinical evaluation of new drugs is a very important but still con-
troversial task (European Medecines Agency, 2008) that may require rethinking in terms
of the significance of animal testing and potential alternatives.
1 Cytochrome P450 is a family of enzymes which facilitates the oxidation of organic substances.
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Cell-based assays to predict human toxicity endpoints, may be a key technology towards
diminished animal testing in the future. Although the identity, behavior, and survival
of a cell depend not only on neighboring cells, but on many molecular pathways and
biological processes occurring within the entire organism, it is precisely this complexity
of the whole organism as well as the need to use animal models which are problematic
when it comes to understanding human and mechanistic toxicity responses (Ward, 2008).
Furthermore, based on the assumption that a majority of cancer has environmental causes
and that there are more than 80,000 commercialized chemicals, there is neither enough
time nor resources for long-lasting whole organism tests. The use of cells for toxicity
testing proves promising since, finally, it has a higher physiological relevance with the
ability to obtain data directly from cells at various ages and detailed dose-response data
directly from human models instead of animals. Moreover, the screening eﬃciency for
potential toxicants may be increased since screens for remediators and for toxicity of
mixtures can be easily carried out and sensitive endpoints are conserved across species.
Also, through the use of primary cells or stem cell-derived cells, a better translation of
findings for comparing studies and thus benchmark criteria for linking in vitro to in vivo
studies are within reach (Liu et al., 2013).
Cell-based toxicity testing already plays an important role thanks to the ease of culture
of numerous cell lines, however, it might experience a break-trough in near the future
owing to the recent availability of diﬀerentiated cells from induced pluripotent stem cells
(iPS) (Takahashi and Yamanaka, 2006; Meissner et al., 2007; Okita et al., 2007). The
iPS technology enables the unlimited supply and reconstruction of genetically identical
tissues, a major advantage over cell lines that possess a rather poor relevance to human
biology. Consequently, doors are about to be opened to long term in vitro toxicity test-
ing provided that suitable measurement techniques that fulfill requirements such as high
throughput, simplicity and cost-eﬀectiveness, but also reliability and repeatability are
developed, validated and accepted by industry standards. Therefore, a major diﬃculty
still consists in refining such techniques and more importantly in determining satisfac-
tory morphological or biochemical criteria that characterize early toxicity in culture.
Such standards are necessary given the large number of currently employed laboratory
techniques, in particular regarding the data acquired through non-invasive and label-free
detection of cell toxicity. This is crucial since toxicity testing is an area where a false
positive could be accepted but never a false negative.
1.2.3. Impedance monitoring of cells and tissues
The measurement of the electrical properties of biological tissue and cells has attracted
significant attention over the last century due to three striking advantages over the major-
ity of conventional techniques: electrical impedance screening is (1) a label-free technique
which does not require the use of expensive markers, (2) it is non-destructive meaning
that the detection method does not interfere with the cells enabling continuous measure-
ments and (3) it is fully automatable rendering data acquisition and analysis free from
human error and thus highly objective. Up-to-date a large number of laboratory devices
with focus on impedance measurements have been developed to exploit these advantages
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and to study the impedimetric properties of single cells and cell populations in vitro;
however, as will be shown below, this process has taken more than 100 years and still
substantial work is necessary to make this technique exploitable by diverse laboratories
as well as by the industry.
It was Rudolf Hoeber in 1911 who first discovered that cells have frequency-dependent
electrical properties and that cell membranes may play a big part in that (Höber, 1910).
More, rather theoretical work was carried out where this frequency-dependence for cell
suspensions and tissues was described (Cole, 1940; Debye, 1929; Fricke, 1924; Cole, 1928).
It was further Schwan who founded biomedical engineering as a new discipline by applying
the previous technical advances to biological material amongst others to count cells,
to measure the electric properties of muscle tissue (Schwan, 1954) and to carry out
micro-impedance tomography (Schwan, 1999). He also described that when measuring
the dielectric properties of biological material changes with frequency occur in three
distinct major steps termed ↵,   and  / 2 dispersion3 where the changes originating in
the frequency-dependence of the cell membrane ( -dispersion) are most often the ones
of interest (figure 1.1) (Schwan, 1994). This fundamental knowledge about biological
dielectrics has almost not been exploited to monitor, detect and analyze toxicity eﬀects
on cell populations since its discovery.
α
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Dipolar relaxation effects
Counterion relaxation near cell surface
β-dispersion spectroscopy
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Figure 1.1.: Frequency-dependence of biological tissue. Three distinct dispersions are observed. The
term relaxation refers to a decrease in polarization with increasing frequency.
1.2.3.1. In vitro monolayer impedance monitoring
First electrical measurements on in vitro cell cultures were carried out using the trans-
epithelial electric resistance (TEER) technique developed by Ussing and Zerahn (1951).
2 The   and  -dispersion concern dipolar relaxation eﬀects of free, unbound water and of protein-bound
water respectively. The  -dispersion occuring at higher frequencies than the  -dispersion will be
ignored hereafter since it is the  -dispersion which is of interest in this thesis.
3 Dispersion denotes the frequency-dependence according to the relaxation theory where polarization of
charges will decrease with increasing frequency because the direction of the applied electric field varies
more quickly than the displacement and accumulation of charges (Grimnes and Martinsen, 2008, p.89).
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This method exploits the fact that epithelial cells form tight monolayers through inter-
cellular junctions (tight and adhesive junctions). The aptitude of a drug to interrupt the
permeability of this cell layer is characterized by measuring the trans-epithelial resistance
across the cells growing on a permeable filter as depicted in figure 1.2a.
A simplified setup that circumvents the use of a membrane was invented by Giaever and
Keese (1984) who cultured cells in a petri dish which was patterned with micro-electrodes
(figure 1.2b). It was found that cell attachment and spreading on the electrode results
in a strong eﬀect on the measured impedance and that cell movement leads to signal
fluctuations. In fact, cells reach the substrate with an almost spherical morphology.
The area of closest contact between the basal membrane and the surface is therefore
rather small but increases continuously while the cells spread as illustrated in figure 1.2c
(Wegener et al., 2000). Interestingly it has been shown that diﬀerent spreading behaviors
(kinetics and amplitude) can be obtained by using diﬀerent protein coatings. The method
was termed electrical cell-substrate sensing (ECIS) and resulted in a considerable amount
of studies. Cell motility for example, a common process of mammalian cells within a
cell population that normally is observed in tissue culture by time lapse microscopy
where resolution is limited by the wavelength of light, has been detected on the scale
of nanometers using ECIS (Lo et al., 1993; Giaever and Keese, 1991). Furthermore,
cell detachment from the electrode surface has been studied as a parameter for cell
toxicity where the temporal evolution of the impedance gives indications about the half-
inhibition concentration in response to diﬀerent toxin concentrations and exposure times
(Jahnke et al., 2009; Krinke et al., 2010). Also muscle contraction (Haas et al., 2010),
cell migration (Linderholm et al., 2006) and stem cell diﬀerentiation (Bagnaninchi and
Drummond, 2011) were detected using ECIS, which underlines the impact patterned
micro-electrodes already had on cell monitoring and characterization.
(a)
(b)
(c)
Figure 1.2.: Monolayer impedance monitoring. a) The trans epithelial resistance setup developed by
Ussing and Zerahn (1951). b) The ECIS setup developed by Giaever and Keese (1984). c)
Time course of cell spreading on a substrate and simultaneous increase of adhesion area
Nevertheless, most of the cell-based impedance studies that have been carried out
previously followed-up the impedance magnitude over time at one frequency where the
diﬀerence between the impedance magnitude profile in the presence and that in the
absence of cells is largest. The corresponding impedance magnitude is often referred
to as cell index in literature (CI) (Otero-González et al., 2012). In fact, a literature
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survey in pubmed with the keywords “impedance, cells, toxicity” (20th of January 2013)
revealed that 48 out of the most recent 50 publications used single frequency analysis
(figure 1.3). Only 2 articles used multi-frequency analysis and both of them were carried
out with equivalent circuit fitting, a debatable method as will be discussed more in detail
in section 3.6.2. These facts indicate that frequency dependence of biological tissue is
a well-known phenomenon; however this has almost not been exploited and rather been
neglected when studying toxicity eﬀects on cells.
0 5 10 15 20 25 30 
Spectrum analysis 
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Cell index (26) 
(22) 
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Figure 1.3.: Impedance data analysis methods when studying cell toxicity. The 50 most recent publica-
tions (20th of January 2013) from the search engine pubmed with the keywords “impedance,
toxicity, cells” have been examined.
As already addressed in figure 1.1 and considering a single cell as a shell-covered sphere
(Pauly and Schwan, 1959; Gawad, 2004) it is necessary to distinguish cellular events
within frequency ranges. At lower frequencies, cells act as insulators due to the capaci-
tive nature of the cell membrane. At higher frequencies, the cell membrane capacitor is
short-circuited and intracellular matter has an eﬀect on the impedance. Hence, frequency
dependent impedance screening oﬀers plethora of information on intra- and extracellu-
lar properties. To date there are no reports on distinguishing toxicity eﬀects on cell
populations using frequency-dependent impedance measurements.
1.2.3.2. In vitro three-dimensional impedance monitoring
In vivo tissues have a very complex but well-organized three-dimensional structure. In
contrast to traditional 2D culture, culturing cells in 3D provides another dimension for
external mechanical inputs and for cell adhesion, which aﬀects integrin ligation, cell con-
traction and associated intracellular signaling (Griﬃth and Swartz, 2006; Knight et al.,
2000; Roskelley, 1994). Moreover, the diﬀusion of soluble factors changes dramatically
compared to 2D cultures. Hence, investigating cells in a 3D environment seems highly
promising since the eﬀect of mechanical and chemical stimuli on 3D cultures are mimicked
more closely to the ones in the human body.
Several techniques to assess 3D cell cultures exist, however these technologies suﬀer
from either low throughput, low penetration depth, require labeling or are very costly
(confocal microscopy, coherence tomography, magnetic resonance imaging). Impedance
screening, on the other hand, seems to be an ideal technology owing to its large penetra-
tion depth into tissues and its cost-eﬀectiveness. Nevertheless, only few studies have been
reported. One of them was presented by Linderholm (2006) who developed a technique
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(a) (b)
Figure 1.4.: Device for tissue thickness measurements. a) The sensor consists of 16 linear electrodes
integrated in a culture dish; b) The device consisted of a glass chip with platinum electrodes
bonded to a small circuit board onto which a culture dish was glued. Taken from Linderholm
(2006)
for continuous monitoring of the thickness of tissue cultures ranging from 10 to 80mm
(figure 1.4a). This was achieved by using multiple electrode pairs at diﬀerent distances
to probe diﬀerent depths of the overlayed tissue sample (figure 1.4b).
Multicellular spheroids4 are probably the most classical approach for 3D culture (figure
1.5a) (Friedrich et al., 2009). Dielectric measurements of multicellular aggregates have
been conducted previously (Thielecke et al., 2001; Kloss et al., 2008) where a micro-device
was adapted to spheroidal shapes (figure 1.5b). An array of 100mm deep square micro-
cavities was used for the entrapment of pre-cultured spheroids between gold electrodes. A
drawback of this technique remains the imprecise match of spheroid- and micro-cavity size
leading to current shunting between the spheroid and the cavity wall and thus lowering
the signal sensitivity. Furthermore, single frequency analysis was carried out with no
profound information on the relationship between tissue structure or condition and the
measured impedance.
While spheroids show several advantages as 3D models such as their well-defined geom-
etry which allows correlating structure with function in a reproducible way, they represent
a very dense and low extra-cellular matrix environment. In order to mimic tissues with
lower cell density, hydrogels have been employed as a mechanical support for cells, pro-
viding 3D architecture (figure 1.5c). Impedimetric characterization of such cultures has
been revealed challenging since lower cell densities result in impedances that are barely
detectable, above all due to the inverse relationship between intercellular space and resis-
tance (R ⇡ 1/A). Therefore, few experiments have been reported and these were limited
to cell growth measurements (Frampton and al., 2007; Lin et al., 2009).
4 Spheroids are large aggregates of cells within the range of several hundreds of micrometers. The
mutual contacts between cells and the specific micro-environment allows them to express a tissue-like
phenotype.
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(a)
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Spheroid)
Microcavity) Insulator)
(b)
(c)
Figure 1.5.: Impedance monitoring of three-dimensional cell cultures. a) Cellular spheroids. Cells aggre-
gate into large (several hundreds of micrometers) spheroids and re-establish mutual contacts
and specific microenvironments that allow them to express a tissue-like phenotype (Pam-
paloni et al., 2007). b) Microcavity chip for capturing and impedance recording multicellular
spheroids according to Kloss et al. (2008). c) Hydrogels composed of polymers (orange mesh)
provide a 3D environment for culturing cells.
Based on the success of impedance monitoring of monolayers, it seems reasonable
to assume that impedance monitoring of three-dimensional cell culture would provide
valuable information regarding in vitro drug toxicology, however this requires bearing
some technological challenges.
1.2.3.3. High accuracy impedance measurements with microfluidic chips
An important technological challenge involves the maintenance of cell viability within a
3D cell culture (in the absence of drug) where some cells are not in direct contact with the
nutrient source. To account for cell viability in a complex environment, the human body
has capillaries where gasses, nutrients and wastes are continuously exchanged between
the blood and tissues by diﬀusion. Microfluidic chips have been designed previously to
mimic such flow conditions in vitro where external pumps are connected to the chip
by tubes to guarantee a perfusion flow with a specific flow rate. Cells inside the chip
are exposed to the flow (figure 1.6a) (Leclerc, 2004) or may be protected from shear
stress either by micro-porous microfluidic barriers (figure 1.6b) (Xia et al., 2009; Toh
et al., 2007; Zhang et al., 2008) or by culturing the cells within or behind a hydrogel
wall (figure 1.6c) (Haessler et al., 2009; Shin et al., 2012). Culturing cells in a hydrogel
separated from the perfusion flow represents a configuration close to body tissues given
the three-dimensionality and the almost exclusive diﬀusional transport of nutrients and
waste within the cell area. In addition, hydrogels are more compatible with electrodes
owing to their electric conductance in contrast to high resistance microfluidic barriers.
However, their fabrication combined with impedance sensing is not trivial if mechanical
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(a) (b) (c)
Figure 1.6.: In vitro nutrient and waste exchange between cells and a perfusion flow. a) Perfusion flow
is in direct contact with the cells and may therefore exert shear stress. b) and c) are
configurations where cells are protected from the convective flow: b) Cells are separated
from the perfusion flow by microfluidic barriers which have a high fluidic resistance and
therefore favor diﬀusion but hinder convective flow through them. c) Cells are cultured
within or behind a hydrogel wall that represents a micro-porous matrix, readily allowing
diﬀusion.
stability and the absence of potential leak currents are to be guaranteed.
In contrast to macro-scale impedance measurements such as tomography, where elec-
trode position, sample geometry and movement artifacts due to breathing greatly degrade
signal quality, micro-fabricated systems allow a highly controlled environment. Both the
electrode geometry and cell positioning can then be precisely determined, resulting in
higher accuracy (Linderholm, 2006). In fact, the electric field lines are required to run
in parallel to ensure an equal sensitivity contribution from each part of the tissue to the
total impedance. This presupposes parallel electrodes, which are complicated to fabri-
cate. Planar electrodes can be used instead, however, they need to be placed at a certain
distance from the tissue sample to damp the non-uniformity of the electric field.
To date there is no device that integrates the impedimetric screening of an entire three-
dimensional cell population with continuous perfusion. Such a system is a prerequisite
for reliably studying the eﬀect of low doses of drugs on tissue samples, an experimental
design that, although it has never been conducted before, would be a highly valuable asset
in estimating the relationship between frequency as well as concentrations and enhanced
drug responsiveness.
1.3. Research strategy
1.3.1. Problem definition
Given the high costs and time necessary for bringing lead compounds to the market as
well as for the matter of human safety, it is of high importance to identify drug-induced
toxicity at an early phase. Hence, there is a pressing demand towards the development
of rapid and simple laboratory techniques for the investigation of hazardous drug eﬀects.
Such in vitro techniques are required to mimic the in vivo conditions closely in order to
provide meaningful results. Furthermore, simple toxicity detection is a prerequisite for
achieving high testing throughput.
Currently, several impedimetric screening platforms have been developed, but none of
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them enables the screening of three-dimensional cell cultures reliably and under contin-
uous perfusion. Furthermore, the pioneering work of Höber, Cole, Schwan and others
that described the frequency-dependence of biological material has remained unexploited
when studying drug-induced toxicity on tissues. Although being inherently non-specific,
however, impedance spectroscopy allows distinguishing biological eﬀects provided the
relationship between impedance measurements and biological phenomena are more com-
prehensively understood.
1.3.2. Research objective
The objective of this thesis is to contribute to the knowledge of how cellular toxicity and
acquired drug resistance can be measured and interpreted based on electrical impedance
spectroscopy. More precisely, it investigates whether early drug-induced toxicity can
be singled-out from major, irreversible cell injury and thus if impedance screening, a
naturally non-specific technique, may be rendered more specific. Also, the impedimetric
screening of three-dimensional cell cultures was technologically challenged in terms of
design and fabrication of suitable screening platforms.
1.3.3. Thesis structure
This thesis encompasses one theoretical and four experimental chapters. Chapter 2
comprises a discussion on the theory of impedance measurements of single cells as well as
of tissues, together with a description of non-cell-related impedance parameters. General
recommendations on the design of planar impedance sensors are provided.
Experimental techniques and methods are partly recurrent throughout the thesis and
therefore were summarized in chapter 3. A discussion on the analysis of cell-related
impedance data is included. Furthermore, the procedural method of all performed nu-
merical simulations is explained.
Impedance measurements on hepatocytes are presented in chapter 4 and reveal the
possibility to distinguish minor toxic eﬀects on cells from major cell injury by choosing
diﬀerent but specific measurement frequencies. It is further discussed how such toxicity
distinction is dependent on the cell density.
The acquired resistance of cells to drugs is impedimetrically studied in chapter 5.
Drug-resistant breast cancer cells were compared with their parental cells regarding their
response to doxorubicin, an anti-cancer drug. Distinct impedance changes within four
distinct concentration ranges are discussed.
Chapter 6 describes the design and fabrication of a cell culture platform that allows
measuring the impedance of the entire thickness of a 3D cell culture (instead of cell-
substrate attachment only). The device is partly made of hydrogel that accounts for
gentle drug delivery and that acts as virtual “gel electrodes”.
A method for screening simultaneously multiple samples with only one electrode pair
is presented in chapter 7. Instructions for designing such a frequency-multiplexing
impedance sensor are provided.
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The thesis concludes with a discussion on the significance of impedance technology
for toxicology in chapter 8. All information that has not been considered vital for the
comprehension of the presented results has been placed in the appendix. Moreover, a
model, using similar microfluidic technology as was presented in the main part of this
thesis, was developed for the study of disease propagation in Alzheimer’s disease and is
described in appendix E, together with a review of currently available microfluidic-based
Alzheimer studies.
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2. Bio-impedance theory
Impedance is defined as the opposition of a sample to the flow of an alternating current.
The resulting dielectric response of a material to an external electric field is due to the
polarization of localized (electronic and atomic polarization) as well as of mobile charges
(electronic, atomic, orientational, counter-ion and interfacial polarization) and can be
expressed by its permittivity " and by its conductivity  . For impedance measurements,
a constant current I is applied and the voltage drop4V through the sample is measured.
The relation of potential drop to the owing current is defined as impedance Z.
Z =
4V
I
(2.1)
Frequency-dependent impedance changes are based on the fact that permittivity contri-
butions of certain relaxation processes1 that follow the external field at lower frequencies
disperse at higher ones. This leads to the conclusion that non-homogeneous samples
show characteristic impedance spectra which can consequently be modeled and analyzed
as equivalent electric circuits. By this means, biologic material does not represent a
perfect dielectric insulator because ion movement outside the biological cell acts as a
parallel current path which discharges the ideal cell membrane capacitor. This non-ideal
behavior is represented by Z which is a unified term for capacitive and resistive behavior.
Z = R+ jX = Re+ jIm (2.2)
R represents the resistive part (real, Re) and X the capacitive part2 (imaginary, Im)
of the biological sample. j is the imaginary number.
2.1. Cell-related impedance parameters and their biological
meaning
2.1.1. Single cell impedance
The electric properties of a cell can be described by an equivalent circuit composed of
a membrane capacitor Cmem with a series intracellular resistance Rintra and a parallel
extracellular resistance Rextra (Isambert, 1998) (figure 2.1a). Accordingly, the current
passes around the cell at low frequency (LF) due to the insulating nature of the cell
membrane. The value of the corresponding extracellular resistor is characterized by the
1 With increasing frequency, polarization of charges and permittivity will decrease because the direction
of the applied electric field varies more quickly than the displacement and accumulation of charges.
2 Inductive elements do not play a role when measuring the impedance of biological material.
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  κ
  κσ
  κσ
  κ   κ
  κσ
(a)
 = 1
 =  ∙  + 
 =   = 1
 = 1
∆ log
(b)
Figure 2.1.: Impedance of a single cell. a) Equivalent circuit model. ext, int and m are cell constants
and represent the volume along the potential gradient that is available to conduct the current
outside and inside the cell as well as through the cell membrane respectively. These cell
constants consequently depend on cell size, -shape, -orientation, -attachment and on the
electrode configuration. The thicker line weight indicates the most often dominating current
path within a frequency range of 40Hz-30MHz b) Bode plot of the presented equivalent
circuit in a) (weigthed line). f0 and f1 are the cut-oﬀ frequencies where the cell membrane
reactance Xmem equals the zero and infinite frequency resistance R0 and R1 respectively.
conductivity of the extracellular medium as well as by the volume dimensions along the
potential gradient that is available to conduct the current (indirectly indicates cell size
and cell-substrate binding). By increasing the frequency, the cell membrane capacitor
is short-circuited and current passes through the cell. Hence, the high frequency (HF)
impedance is determined by the intracellular resistance whereas intermediate frequencies
provide information about the membrane capacitor. The value of Cmem is determined by
the surface area of the cell membrane and scales with the cell size. The thickness of the
cell membrane, on the other hand, was described to be constant (5  7nm) and is there-
fore ignored when studying relative diﬀerences of Cmem. The value of the intracellular
resistance is a function of the intracellular conductivity as well as of the space available
for conducting the current (cell size, number of organelles). The resistor originating from
ion channels within the cell membrane Rmem is ignored since its resistance is in the M⌦
range and related relative changes are negligible compared to the ones caused by Rextra
(Borkholder, 1998). In addition, the intra- and extracellular solution may act as a ca-
pacitor (Cextra and Cintra) at very high frequency, however this exceeds the frequency
measurement range that was used in this study. Therefore the capacitive properties of
conductive solutions are ignored. The corresponding impedance spectrum of the above
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described electrical circuit is shown in figure 2.1b.
2.1.2. Cell population impedance
When measuring the impedance of multiple cells within a tissue (figure 2.2a), the impedance
spectrum diﬀers from the one hypothesized for a single cell and displays a cell membrane
relaxation slope of less than 1 over certain frequency ranges (figure 2.2b-2.2d) (Cole,
1932, see paper V on page 183). This is due to the fact that a tissue is composed of
y
x
z
Tissue sample
(a)
 extra  intra  mem
(b) (c) (d)
Figure 2.2.: Tissue impedance. a) Simplified equivalent tissue circuit; b), c) and d) show the impedance
modulus with a distribution of svd = 0.8 for a) Rextra, b) Rintra and c) Cmem. The resulting
curves are compared with the non-distributed curves (dashed line). The distribution curves
on the x-axis represent the distribution of cut-oﬀ frequencies (f0, f1).
thousands to millions of cells with every single cell being characterized by its specific
properties and those of its micro-environment (e.g. distance to neighboring cells, cell size
and amount of intracellular organelles). The multitude of cells within a tissue results in
a distribution of these properties within a certain range of values, thus ultimately also
leading to a distribution of the values of the individual electrical elements of a single cell
circuit (Rextra, Cmem, Rintra).
The diﬀerent elements of a single cell circuit impact distinct parts of the impedance
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spectrum. The eﬀect of their distribution within the complex tissue circuit is depicted
in figure 2.2b-d. It is noted that each cell in the circuit has two cut-oﬀ frequencies
(f0 = 1⁄(2pR0Cmem) and f1 = 1⁄((2pR1Cmem)) where the part of the spectrum at
which the impedance is dominated by the membrane capacitance is separated from the
parts at which the impedance is dominated by the resistance at zero frequency R0 (f0)
and by the resistance at infinite frequency R1 (f1) (these frequencies are precisely
defined by the phase being equal to 45°). When all three elements are the same in every
cell of the whole tissue circuit, they also have the same cut-oﬀ frequencies resulting in an
impedance behavior that is equivalent to the one of a single cell circuit (dotted line in
figure 2.2b-2.2d). On the contrary, when Rextra, Rintra and Cmem are distributed, this
also aﬀects the distribution of f0 and f1, albeit to a diﬀerent extent: a deviation from the
single cell spectrum occurs around f0 when Rextra is distributed (figure 2.2b), around
f1 when Rintra is distributed (figure 2.2c) and around both cut-oﬀ frequencies when
Cmem is distributed (figure 2.2d). In all cases, the transition from resistive to capacitive
regime and vice versa is shifted between the single cell circuits. As a consequence, the
slope of the impedance modulus |Z| is becoming smaller at these frequencies. Regarding
a distribution of Cmem, both cut-oﬀ frequency distributions overlap if they are wide
enough and almost no part of the impedance modulus has a slope of one anymore (figure
2.2d). In a tissue, all three elements are distributed, which leads to a combination of
their eﬀects on the impedance spectrum.
Although an element named constant phase element3 (CPE, equation 2.3) was sug-
gested by Cole (1940);
ZCPE =
1
 (j!)↵
(2.3)
where   is the CPE magnitude, ! is the circular frequency (! = 2⇡f) and ↵ is the
CPE frequency exponent4; and used instead of a capacitance for almost a century to
describe the particular dispersion behavior of cells in tissues (Halter et al., 2007; Kerner
et al., 2002; Meissner et al., 2011), the physical meaning of its parameters (CPEc ex-
ponent ac and magnitude bc) has been controversial and for this reason the parameters
themselves have been rarely used (Cole and Cole, 1941; Grimnes and Martinsen, 2005;
McAdams and Jossinet, 1995). Several studies tried to interpret the ac as an indicator
of tissue heterogeneity in cell sizes and shapes (Ackmann and Seitz, 1984) as well as
of heterogeneity in the extracellular space (Ivorra et al., 2005), but no precise explana-
tion has been provided. In fact, the CPEc assumes a constant phase (of less than 90°)
over frequency, which is not correct. In contrast, the distribution of all three circuit
elements can be diﬀerent leading to a frequency-dependent ↵c. Therefore, we introduced
a general element termed dispersion element (DE, see paper V on page 183) that within
the tissue circuit (figure 2.3) perfectly describes the dispersion behavior of every tissue
3 An index “c” is used for “cells” to distinguish the cellular CPE from the electrode/electrolyte CPE
indexed by an “el” which will be introduced in section 2.2.1 on page 20.
4 ↵ and   from the CPE are not to be mixed up with the ↵- and the  -dispersion. There is no link
between the symbols.
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as illustrated in figure 2.2a owing to the frequency-dependence of its parameters (equa-
tion 2.4). However, this element is theoretical since its parameters cannot be found for
CPEel
Cp
Rintra
Rextra
CPEm
0RRext =
∞
∞
−
= RR
RRR
0
0
intm
C
DE
∞
∞
− RR
RR
0
0
0R
Figure 2.3.: General equivalent tissue circuit that models the complex tissue circuit from figure 2.2a
experimental measurements (see paper V on page 183).
ZDE =
1
 (f) · (j!)↵(f) (2.4)
Diﬀerent more or less simplified cases of the DE have been considered in the past. Both
the capacitance and the CPE are dispersion elements that possess a constant ac and thus
a constant phase over frequency. A new, specific case of the DE was suggested and was
termed logarithmic phase element (LPE). It is a more sophisticated element that takes
into account (and thus informs about) the distribution weighting of the single cell circuit
elements. However, the LPE is not subject of this dissertation and it is referred to paper
V on page 183 for more information. Here, the cell membrane relaxation is approximated
as a CPE to illustrate the non-linear relaxation behavior of cells within tissues.
Considering an isolated tissue, R0 from figure 2.3 entirely depends on the tissue struc-
ture. However, when the tissue is sourrounded by a conductive solution (e.g. ex vivo
and in vitro tissue culture, liquid layer on isolated organs) a shunting para-tissue cur-
rent path is created that decreases the sensitivity of the impedance measurement for
the trans-tissue impedance (figure 2.4). Therefore, it seems desirable to increase the
Rpara
Rext
RintCPEc
Figure 2.4.: Current paths of a tissue with surrounding solution. Low frequency current flows through
the extracellular environment of the tissue (Iext) and through the medium outside the tissue
(Ipara). The para-tissue current decreases the measurement sensitivity for the trans-tissue
impedance. The high frequency current (IHF ) passes through the cells. The corresponding
equivalent circuit is shown.
para-tissue resistance Rpara. Although the measurement in air is feasible for most plant
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tissues that possess evaporation protecting outer skins, this is hardly possible for cell
aggregates and ex vivo tissues that undergo drying-out. Alternatively, the geometry
of the measurement system can be adapted such that the space available for current
shunting around the tissue becomes small. This strategy will be employed in chapter 6.
Altogether, parameters that are related to the tissue structure itself (e.g. Rext, CPEc,
Rint5) are distinguished from parameters that concern the measurement system (Rpara).
Uniquely tissue-characterizing parameters such as Rext, Rint and 4 logR (figure 2.1b)
therefore need to be examined with care since R0 is a function of Rext and Rpara6.
2.2. Non-biological measurement parameters
When measuring the impedance of a biological sample, other eﬀects than the ones from
the tissue may contribute to the measured total impedance (Ztissue 6= Zmeasured). These
additional eﬀects originate from the measurement system and can be represented as elec-
trical components that add up in series or in parallel to the tissue impedance depending
on their nature (figure 2.5).
ZW
RCT Rspread
CsolCPEel
Electrode/Solution interface Solution
Cpar
Parasitic elements
Rlead
Rbulk
Rsol
Constriction zone 
Constriction zone 
Quasi-segmental zone
Rspread
Rbulk
Rspread
Figure 2.5.: Equivalent electrical circuit of non-biological measurement elements that contribute to the
total impedance. Rlead is the resistance of the conductor used for wiring, Cpar is the ca-
pacitance between the wiring traces where other traces are grounded for for AC signals,
CPEel is the constant phase element (non-ideal capacitor) of the electrical double layer at
the electrode/electrolyte interface, RCT is the charge transfer resistance, ZW is the War-
burg impedance, Rsol is the ionic solution resistance (composed of the spreading resistance
Rspread and the bulk resistance Rbulk) and Csol is the solution capacitance.
These additional elements are undesirable since they lead to a decreased measurement
sensitivity for bio-impedance changes. In theory, the impact of their impedance can
be minimized by tuning the multitude of parameters they are dependent on (ionic con-
centration, type of ions, temperature, geometry of the measurement system, electrode
potential, material properties, electrode roughness, impurity adsorption etc.). For biolog-
ical applications however, most of these parameters are inherently determined by the cell
5 The elements of a tissue circuit are denoted by an abbreviated index (Rext, Rint, Cm) in contrast to
the ones of a single cell circuit (Rextra, Rintra, Cmem).
6 Please note that in contrast to a tissue measurement, R0 = Rextra = Rpara for a single cell measure-
ment and therefore R0 is determined by the cell and the measurement system simultaneously.
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culture medium (specific pH and chemical composition), by the electrode material (noble
metals such as platinum and gold are used owing to their high bio-compatibility (Itakura
et al., 1989; Linderholm, 2006)) and by the cells themselves that require an incubation
temperature of 37°C (for all human and most mammalian cells). Therefore, the mea-
surement system geometry with its corresponding current path and energy dissipation
pattern represents the major parameter that may be optimized (figure 2.6).
welsel
lel
Figure 2.6.: Impression of a planar, rectangular electrode pair showing the electrode width wel, electrode
length lel and the inter-electrode space sel. The electrode geometry is the major parameter
that may be modified such that the impedance originating from non-cell related system
elements (figure 2.5) is minimized.
Table 2.1 overviews the model parameters from figure 2.5 and their dependance on
frequency and geometry. A more detailed discussion on how electrode geometry influences
the impedance measurement depth and sensitivity of planar electrodes is provided in
section 2.3.
Circuit model component Impedance scaling with frequency and geometry
CPEel magnitude  el |Z| / 1/Atruef
CPEel exponent ↵el |Z| / fAtrue/Ageometric
RCT |Z| / 1/Atrue
ZW |Z| / 1/Atruepf
Rspread |Z| / 1/
p
Ageometric
p
f
Rbulk |Z| / sel/Across
Csol |Z| / 1/Ageometricf
Cpar |Z| / 1/Atracef
Rlead |Z| / ltrace/Atrace
Table 2.1.: Scaling of theoretically derived model parameters with frequency and surface area (adapted
from Kovacs (1994)). Atrue is the true surface area of a surface including pores. Ageometric
is the apparent surface area excluding pores (= wel · lel). Across is the cross-sectional area
in the direction of the electric field and Atrace is the surface area of the electrode traces and
wiring. ltrace is the length of the wires and electrode traces.
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2.2.1. Electrode interface
When a metal is immersed into an ionic solution, a space charge layer builds up at the
electrode/electrolyte interface (Kovacs, 1994). This layer is due to chemical reactions
where metal atoms go into the solution to form ions and to charge the metal surface.
This process reaches an equilibrium with a constant flow of charge across the interface
and a net flow of zero. The resulting space charge layer separates the charged electrode
from the charged ions and can be distinguished into three separate layers: (1) a hy-
dration sheath of water molecules (inner Helmholtz plane), (2) hydrated cations (outer
Helmholtz plane) and (3) a diﬀuse layer with a decreasing gradient of hydrated cations
(figure 2.7a, top). The first two layers have been described by the Helmholtz-Perrin
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surface area)
Non−porous surface
Porous surface
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Figure 2.7.: Complex interface capacitance. a) The presence of pores on the metal surface leads to
an impedance magnitude slope of less than 45° in contrast to ideally non-porous surfaces.
While the true surface area of an electrode takes into account the surface from the pores, the
geometric surface is referred to the apparent area (without pores). When kept constant, both
cases (similar geometric and similar true surface area) have the same slope, nonetheless their
capacitance and bulk resistance values diﬀer. b) Top: Illustration of a space charge layer at
the electrode/electrolyte interface that is composed of a layer of oriented water molecules,
a layer of fixed hydrated cations and a diﬀuse layer of free hydrated cations (Kovacs, 1994).
Those layers together define the interface capacitance CI . Adsorbed species are not taken
into consideration here. Bottom: The equivalent electrical interface circuit is complex and
distributed due to surface roughness with fractal porous structures. In addition, the complex
circuit is frequency-dependent since the current flows only through the outer areas of the
pore when the frequency is increased (Ivorra et al., 2005).
model where the voltage decreases linearly and the resulting Helmholtz capacitance CH
is voltage-independent. The third layer was described by the Gouy-Chapman model
where a diﬀuse capacitance CGC was considered voltage-dependent. Both layers alone
do not fully match with experimental results, but their combination represents a good
approximation (Stern model) and gives rise to the interface capacitance CI according to
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equation 2.5. Nevertheless, CH becomes more important for higher solute concentration
and higher applied voltage.
1
CI
=
1
CH
+
1
CGC
(2.5)
Furthermore, experimental measurements have revealed that the impedance magnitude
caused by CI has a slope of less than 1 in the frequency domain (figure 2.7b). This
phenomenon has been explained by the imperfect nature of the metal where surface
roughness (De Levie, 1965) and protein deposition (Stieglitz, 2004) lead to a more fractal
nature with a distribution of capacitive and resistive properties (figure 2.7a, bottom).
Additionally, as frequency increases, the current flows through the outer areas of the
pore and that reduces the eﬀective capacitance and resistance resulting in an electrode
pore impedance that is frequency-dependent (Ivorra et al., 2005). For these reasons, the
complex nature of the electrode/electrolyte interface is best approximated by a constant
phase element (CPEel), a circuit element that represents a capacitance with resistive
properties.
As was mentioned above, the net flow of the charge through the interface reaches an
equilibrium in the absence of an applied voltage V (direct current, DC). By increasing the
voltage, the total potential across the interface is pushed away from from its equilibrium
value V0. This potential diﬀerence V  V0 is termed overpotential µ and is responsible for
the net flow of charge. It gives consequently rise to a charge transfer resistance RCT that
adds up in parallel to the interface capacitance. The overpotential is thought to be the
sum of diﬀerent overpotentials (µt: charge transfer through the double layer, µd: diﬀusion
of reactants to and from electrode, µr :due to chemical reactions at the electrode, µc: due
to exchange of metal atoms with corresponding ions). For low magnitudes of the applied
voltage, the electrode will not be greatly perturbed from equilibrium (linear behavior).
At high magnitudes however, the charge transfer resistance decreases exponentially with
applied potential (non-linear behavior). Under alternating current (AC) conditions, an
additional diﬀusion impedance termed “Warburg” impedance ZW adds up in series to
the charge transfer resistance (Kovacs, 1994). It represents the frequency-dependence of
the diﬀusion eﬀects. Ions cannot follow when the direction of the electric field changes
too quickly, resulting in ZW approaching to zero. Both, RCT and ZW , are relevant
elements that need to be considered when high voltages are applied to the system and
when measurements are carried out at low frequencies. In this work however, low voltage
was applied (10mV , no DC bias) resulting in non-measurable eﬀects of these elements
within the screened frequency range (40Hz  30MHz) (see figures 4.5a on page 43, 6.6b
on page 70, 7.7 on page 81). Therefore, both circuit components were neglected for
equivalent circuit fitting in this thesis.
2.2.2. Electrolyte impedance
When the frequency of the alternating current is increased, the interface capacitance is
short-circuited and the sample between the electrodes is probed. The solution conducts
the current in the presence of ionic charge carriers and its resistance consequently de-
21
2. Bio-impedance theory
pends on the ionic concentration, type of ions, temperature, and the geometry of the area
in which current is carried. The major problem in calculating Rsol is due to the deter-
mination of the current flow path since this one is non-uniform in most cases (figure 2.8)
(Davey, 1993). The geometrical factor or cell constant  which accounts for such non-
Ideal parallel
electrodes
Non-ideal parallel
electrodes
Planar electrodes
κ =  κ = λ  κ = 1 2 ∙   1 − 
Figure 2.8.: Electric field distribution for parallel and planar electrodes. In the ideal case, current-lines
are uniformly distributed. In reality, however, spreading of the current lines occurs. A factor
  is introduced to correct the fringing eﬀect. The field distribution of coplanar electrodes is
non-uniform and an analytical solution for the cell constant  is obtained through conformal
transformation (Jacobs et al., 1995). K(x) is the complete elliptic integral of the first kind
and k its modulus. An analytical solution of k is given in table 2.2.
uniformity and for the geometry of the electrolyte is determined experimentally for every
measurement system (equation 2.6) and an analytical solution may be found through
computation using conformal mapping. Table 2.2 provides a summary of equations for
several configurations of planar, bipolar electrodes.
Electrode configuration Cell constant  Sub-equation Ref.
h > 1.25 · sel sel ⇡ wel
coplanar  = 1lel
2K(k)
K
⇣p
1 k2
⌘ k = selsel+2wel [1]
IDE  = 1lel(n 1)
2K(k)
K
⇣p
1 k2
⌘ k = sin⇣⇡2 selsel+2wel ⌘ [2]
sel   wel coplanar  = 2 ln(4lel/wel)⇡lel n/a [3]
h < 1.25 · sel sel ⇡ wel coplanar  =
1
lel
4K(k2)
K
⇣p
1 k2
⌘ k =Eq. 3.48 and 3.41
in [4]
[5]
sel   wel coplanar  = 1wch
⇣
sel
h +
4ln(2)
⇡
⌘
n/a [6]
Table 2.2.: Cell constants of various planar, bipolar electrode configurations. h is the distance between
the planar electrodes and a top insulating wall. An h of more than 1.25 · sel corresponds to
the case where there is no insulating top wall (Linderholm, 2006, p.72). wch is the width
between two insulating walls in longitudinal direction (along sel) and may equal lel if the
electrode reaches over the whole micro-channel; (IDE - interdigitated electrodes); References:
[1]: Olthuis et al. (1995); [2]: Van Gerwen et al. (1998); Olthuis et al. (1995); [3]: Kovacs
(1994); [4]: Linderholm (2006); [5]: Linderholm (2006, p. 73-78); [6]: appendix B on page 97
The solution resistance is generally composed of a spreading resistance Rspread and a
series bulk resistance Rbulk (figure 2.9). In fact, when the electrode surface area is small
compared to the inter-electrode distance (sel), most of the electric energy is dissipated
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very close to the electrodes within a zone that is called spreading or constriction zone
of the current path. The spreading of the current from the small electrode into a larger
electrolyte volume results in a spreading resistance that is determined by the geometrical
surface area of the electrode (Franks et al., 2005). The current constriction diminishes
from a certain distance of the electrode and the current lines are more uniform. This
zone is termed segmental zone and defines the bulk resistance.
0 10 20-10-20
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20
(a)
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20
30
0
0 10 20 30-10-20-30
(b)
Figure 2.9.: Inhomogeneous solution resistance distribution over distance from planar electrodes. a) Sim-
ulated equipotential lines indicate stronger potential drop close to the electrode compared
to deeper in the sample. Thus, the solution resistance is distinguished into spreading resis-
tance Rspread and bulk resistance Rbulk. b) Simulated electric field indicates that energy
disspiation is constricted to a zone close to the electrodes.
Although an ionic solution acts as a resistor over a wide frequency range it behaves
like a capacitor at very high frequency where the ionic charge carriers cannot follow the
direction change of the electric field. Similarly to Rsol, the solution capacitance Csol is
related to  (equation 2.6).
 =  solRsol =
Rsol
⇢sol
=
"0"sol
Csol
(2.6)
where  sol is the conductivity of the solution, "0 is the dielectric constant of free space
and "sol is the relative dielectric constant of the solution.
2.2.3. Parasitic elements
Parasitic elements that contribute to the total impedance in this work are those of the
wiring resistance Rlead and of the parasitic capacitance Cpar such as the stray capacitance
to adjacent signal lines (other capacitances through the substrate and passivation layers
may be considered where applicable). Although parasitic elements can be eliminated
with apparatus calibration (artificial oﬀset), this does not compensate for the sensitivity
loss that is caused by those elements. Therefore, it is recommended to use short and
shielded wires and to short-circuit current injection and voltage measurement electrodes
as close as possible to the biological sample.
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2.3. Geometrical factors of coplanar electrodes
Although planar electrodes display a less uniform electric field distribution compared
to parallel electrodes and thus a position-dependent sensitivity pattern, they are widely
used in micro-technological devices due to their ease of fabrication and thereby associ-
ated low costs. Moreover, the localization of a measurement can be chosen by varying the
electrode size, e.g. the detection of single cells requires electrodes of similar sizes. There-
fore, planar electrodes assure sensitive and repeatable measurements thanks to simple,
standard microfabrication methods.
In this work, coplanar bipolar electrodes have been used to measure the impedance of
cell populations. This section discusses how the depth and the sensitivity of an impedance
measurement depend on the electrode geometry and how to optimize them by carefully
choosing the geometric parameters.
2.3.1. Measurement penetration depth
The impedance measurement depth is defined according to the local energy distribution
within the sample and corresponds to the depth below which half of the electric energy
is dissipated (Linderholm, 2006). The measurement depth z1/2 is given by
1¨
0
z1/2ˆ
0
E2(x, y, z)dxdydz =
1
2
1˚
0
E2(x, y, z)dxdydz (2.7)
where E is the local electric field. This equation was solved numerically for diﬀerent
electrode spacing sel and widths wel while keeping the electrode length lel constant (fig-
ure 2.10a). The penetration depth non-linearly increases for larger values of sel and wel.
When normalizing the penetration depth against the sensor size (wel+ sel), it was found
that the measurement depth is small for thin electrodes since the spreading resistance
dominates the measurement and most of the energy will be dissipated close to the elec-
trodes (figure 2.10b). When wel is larger than sel, the measurement depth will also be
small since most of the current passes between the inner edges of the electrodes. A pen-
etration depth within 10% of the maximum depth regarding the sensor size is therefore
obtained when wel ⇡ 0.5...3⇥ sel.
In a next step, the measurement depth was numerically solved for diﬀerent electrode
lengths (figure 2.11a). The measurement depth is small for short electrodes since most of
the current passes between the bottom and top (longitudinal) edges of the two electrodes.
This edge eﬀect becomes negligible when the electrodes are longer, hence the penetration
depth saturates. It was found that z1/2 was maximal when lel ' 9 · sel (figure 2.11b).
However, larger than this value does not result in a larger measurement depth.
2.3.2. Measurement sensitivity
Although the maximal  -dispersion bandwidth is fundamentally defined by the tissue
itself according to log ("↵/" ) (where "↵ and "  are the dielectric constants of the ↵-
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Figure 2.10.: Optimization of fractional sensor width for maximal penetration depth using numerical sim-
ulation. a) Penetration depth as a function of wel and sel with lel =1. b) Size-normalized
penetration depth points out an optimal compromise between spreading resistance and edge
eﬀects at wel = sel. The dashed zone illustrates the wel/(wel + sel)-range where the depth
is within 10% of the maximum penetration depth. The irregularities are due to numerical
errors. Details about the numerical simulation are provided in section 3.8 on page 35.
and  -dispersion respectively), in reality this bandwidth is often smaller. The measured
impedance may increase at lower frequencies and decrease at higher ones due to the
double layer capacitance at the electrode surface and to the stray capacitance between
measurement cables respectively. Both add a frequency-dependent error to the mea-
sured solution resistance and lead to a decreased  -dispersion bandwidth as depicted in
figure 2.12a. To reduce this error, it is necessary to maximize the corresponding band-
width within which the tissue measurement sensitivity is always above 0.707 (equals a
phase angle of -45°). This optimization requires all three components of the  -dispersion
bandwidth to be maximized: 1) the Rext-bandwidth is maximized according to
f0
fel
=
Cel
C 
/  · Ael (2.8)
where fel = 1/2⇡R0Cel and C  = Cm.
2) The Xm-bandwidth calculates as follows
f1
f0
=
 1
 ext
(2.9)
where  ext is the extracellular conductivity of a tissue and  1 is the infinite frequency
conductivity of the  -dispersion7.
This bandwidth is normally defined by the tissue sample and should therefore not be
aﬀected by a measurement system optimization. However, as was shown in figure 2.4,
para-tissue currents can create a leak that results in a decreased 4 logR.
7 f1/f0 = 4 logR for non-distributed tissues (entirely homogeneous, ↵c = 1), otherwise f1/f0 >
4 logR with ↵C = 4 logR/(f1/f0)
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Figure 2.11.: Optimization of fractional sensor length for maximal penetration depth using numerical
simulation. a) Penetration depth as a function of lel and sel with wel = 200µm. b)
sel-normalized penetration depth illustrates a maximum depth at a lel/sel ' 9 (circles:
wel = 200µm, sel = 10µm; squares: wel = 200µm, sel = 50µm; triangles: wel = 10µm,
sel = 50µm). The dashed zone illustrates the length-spacing-ratio range where the depth
is within 10% of the maximum penetration depth. The irregularities are due to numerical
errors. Details about the numerical simulation are provided in 3.8 on page 35.
3) The R1-bandwidth is maximized according to
fpar
f1
=
C 
Cpar
/ dwires
 · Awires (2.10)
Finally, it is recommended to first minimize the eﬀect of the stray capacitance Cpar /
Awires/dwires where dwires is the distance between signal current paths (cables) and
Awires is the surface area of these wires. An elimination of capacitive stray eﬀects can
be achieved (1) by employing coaxial cables (shielding) to generally reduce the eﬀect of
Cpar (reduced Awires), (2) by placing the conductors such that the distance between both
signal current paths (dwires) is maximal and (3) by compensating for the fixtures with
an open calibration. It is noted that the R1-bandwidth is maximized up to a certain
limit that is defined by the ratio of the  - and  -dispersion capacitances and thus by
" /"  (figure 2.12a). This first optimization mostly diminishes the impact of a large
cell constant8 on the R1-bandwidth that in turn is needed for a maximization of the
Rext-bandwidth. The product of equation 2.8 corresponds to a minimization of fel since
f0 =  ext/2⇡"  only depends on inherent tissue properties. This requires wel and sel to
be as large as possible. Taking into account the total sensor size (wel + sel), a relation
of wel = 1...9 ⇥ sel was found to be advantageous (figure 2.12b). When wel is even
larger, most of the current passes at the inner edge of the electrodes, thus decreasing the
apparent electrode width and resulting in a higher fel. In addition, the minimization of
fel does not depend on lel as long as sel t wel (table 2.2).
8 The cell constant is constant for all cut-oﬀ frequencies as long as the tissue and the electrode dimensions
(wel, sel, lel) are much larger than the size of the single cells that compose the tissue. The tissue is
then considered as homogeneous.
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Figure 2.12.: Optimization of measurement bandwidth. a) The maximum  -dispersion bandwidth is
defined by the ↵ and  -dispersions. This maximal bandwidth is decreased by the electrode
interface capacitance CI and the stray capacitance Cpar between the signal cables (practical
 -dispersion bandwidth). This scheme assumes a large tissue and electrode compared to
the size of a single cell and thus a constant cell constant  for all cut-oﬀ frequencies. b) fel
is plotted against the sensor size normalized electrode width. The dashed area indicates
the wel/sel+sel-range where fel is within 10% of the minimum value. The irregularities are
due to numerical errors. Details about the numerical simulation are provided in section 3.8
on page 35.
2.4. Summary
Cell impedance is not constant with frequency due to the capacitive behavior of the cell
membrane. Current flows outside the cell at lower frequencies and through the cell at
higher ones. Such frequency-dependence can be exploited to extract information about
cell-cell contacts and the cytosol for example. However, the bandwidth within which
the tissue impedance is measured sensitively may be decreased by the electrode inter-
face capacitance at lower frequencies and by parasitic stray capacitances at higher ones.
Therefore, it is important to optimize the electrode geometry such that the bandwidth
is increased. Two general rules should be considered when designing impedance sensors:
(1) The total sensor size needs to be identified first (wel + sel and lel). This size may
be determined by space restrictions (e.g. within a micro-channel or on an implanting
probe) or by the tissue sample itself. In fact, if the electrode is larger than the biological
sample, this leads to a decreased Xm-bandwidth and thus to a decreased sensitivity. If
the electrode is smaller than the tissue sample, on the other hand, this leads to an in-
creased spreading resistance and again to a decreased sensitivity. Therefore, the sensor
is ideally within the size range of the biological sample volume which is measured (e.g.
lel ⇡ sel t 10   20µm for single cells or sel = 100µm for brain slices). (2) Once the
maximum sensor size has been determined (Ael and wel + sel) the planar bipolar sensor
dimensions should be chosen such that wel = 1...2 ⇥ sel and lel   9 ⇥ sel in order to
harmonize a maximal penetration depth with a maximum  -dispersion bandwidth.
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3. Methods
3.1. Microfabrication
3.1.1. Microfluidic chips
Microfluidic chips were made of polydimethylsiloxane (PDMS) and fabricated by soft-
lithography. The fabrication of the mold was carried out using two diﬀerent methods
depending on the critical dimensions. For structures larger than 100µm, a cutter plotter
(Robopro CE5000-40-CRP, Graphtec) was used to cut and structure a 120mm thick
tape that was adhered onto a transparent foil. For structures smaller than 100µm, a
silicon wafer with oxidized surface (1mm) was structured by photolithography (coating
and development: EVG150; exposure: Süss MA6) and deep reactive ion etching (Alcatel
AMS 200 DSE). The obtained tape or silicon master were then used to mold the PDMS.
For this, Silicone elastomer was mixed with curing agent (Sylgard 184, Dow Corning)
at a ratio of 10 : 1, degassed for 30min in a desiccator and cured at 80 C for at least
1h. Holes punched through the PDMS served as injection reservoirs. The PDMS block
is further placed on top of a glass slide with micro-fabricated electrodes.
3.1.2. Electrode chips
Platinum was used as electrode material since it is bio-compatible (Itakura et al., 1989)
and highly polarizable, thus minimizing faradaic currents and reducing the risk of gen-
eration of cytotoxic compounds (Linderholm, 2006). A 20nm thick titanium adhesion
layer and a 200nm thick platinum layer were evaporated in that order and structured on
a 4-inch glass substrate using standard photo-lithographic lift-oﬀ technique. Electrode
edges were rounded up to reduce fringing eﬀects and local current concentration (Kasi
et al., 2011).
3.2. Cell culture
HepG2/C3A and MCF-7 cells (wild-type (WT) and resistant to 1µg/ml doxorubicin
(DOX)) were kindly provided by Prof. Beatrice Desvergne (University of Lausanne) and
by Prof. Kapil Mehta (The University of Texas M. D. Anderson Cancer Center, Houston)
respectively. All cell lines were maintained at 37 C and 5% CO2 and cultured in 75cm2
flasks. MCF-7 cells were incubated in Roswell Park Memorial Institute medium (RPMI)
1640 (Sigma-Aldrich, Switzerland) supplemented with 10% fetal calf serum (Invitrogen,
Switzerland), 2mM glutamine and antibiotics (100 U/ml penicillin and 100µg/ml strep-
tomycin) (Invitrogen, Switzerland). MCF-7 DOX cells were additionally cultured in
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Figure 3.1.: Experimental setup
the presence of 1µg/ml doxorubicin (LC Laboratories, USA) in order to maintain the
drug-resistance phenotype. HepG2 cells were incubated in Dulbecco’s Modified Eagle’s
Medium (DMEM) (Invitrogen, Switzerland), containing 10% fetal calf serum (Invitrogen,
Switzerland). Medium was changed every three days. Once cell confluency was reached,
cells were detached with 0.25% trypsin/EDTA (Invitrogen, Switzerland), counted with
a hemacytometer (Sigma-Aldrich, Switzerland) and loaded into the microfluidic chips.
For the microfluidic cell culture, all materials were autoclaved before use except for
poly-(methyl-methacrylate) (PMMA) parts that were disinfected with 70% ethanol be-
fore use. The glass chip with electrodes and the PDMS chip were surface treated (50W ,
0.6min, 0.6bar) using oxygen plasma (Femto SLS, Diener electronic, Germany). The
assembled PDMS and electrode chip were connected to a printed circuit board (PCB)
for electrical measurements.
3.3. Experimental setup
The devices were placed into the CO2 - incubator on top of a microscope with a humidity-
protected objective (Precise Eye, Navitar, USA) connected to a C-mount camera (uEye,
IDS Imaging, Germany) and an optical light fiber that was attached to a light source
outside the incubator. The objective inside the incubator allowed visual follow-up of
the microfluidic culture. Tubing was used to connect the inlet of the PDMS chip to the
medium reservoir. The tube from the outlet reservoir of the PDMS chip was connected
to a syringe pump (NE-300, TSE-Systems, USA). Coaxial cables were used to connect
the device to an impedance analyzer (Agilent 4294A, Agilent technologies, USA). A
small hole at the back of the incubator connects the inside equipment with the humidity
sensitive outside equipment. The impedance analyzer was connected to a PC via a GPIB
controller (Universal Serial Bus (USB)-GPIB-HS, National Instruments, USA).
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3.4. Immunocytochemistry
For immunocytochemical staining, cultures were fixed with 4% paraformaldehyde in phos-
phate buﬀered saline (PBS) (Invitrogen, Switzerland) for 25min. After washing, cells
were dried and stored at  20 C until use. After thawing, HepG2/C3A and MCF-7 cells
were treated with 3% bovine serum albumin (BSA)/0.1% Triton X-100 (both Sigma-
Aldrich, Switzerland) for 45min. For tight junction staining, cells were first incubated
with the primary antibody monoclonal rabbit-anti-occludin (1:200, Invitrogen, Switzer-
land) for 90min and subsequently with the Cy-2 coupled secondary antibody (1:150, Di-
anova GmbH, Germany) for 2h. For actin staining, cells were incubated with fluorescein
isothiocyanate (FITC) coupled phalloidin (Sigma-Aldrich, Switzerland) for 2h. Subse-
quently, samples were incubated with 0.1mg/ml 4’,6-diamidino-2-phenylindole (DAPI) in
PBS (Sigma-Aldrich, Switzerland) for 30min. After repeated washing, cells were ob-
served with a confocal laser scanning microscope (LSM 700 inverted, Zeiss, Germany).
3D Images were obtained from z-stack acquisition mode by using the 3D image processor
Imaris (Switzerland).
For live/dead staining, cells were washed with PBS and incubated with staining solu-
tion of fluorescein-diacetate and propidium iodide (1:1000, Sigma-Aldrich, Switzerland)
for 10 min. Samples were examined with a fluorescence microscope (LSM 700 inverted,
Zeiss, Germany).
3.5. Cell viability assay
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) stock solution was
prepared by dissolving 2.5mg MTT/ml in PBS without Ca/Mg. Cells were seeded into
a 96-well plate and incubated for 2 days. Cell medium was removed and cells were
incubated in 200µl AP solution (20mM) at diﬀerent times (2h, 6h, 8h, 24h). After
drug exposure, cytotoxicity was determined by removing the drug solution and adding
200ml of fresh medium + 50µl of MTT stock solution. Following 3 h incubation at 37°C,
MTT-DMEM medium solution was removed and 150µl of Dimethyl sulfoxide (DMSO)
was added. After shaking well for 30min, absorbance was analyzed at 590nm using a
micro-plate reader.
3.6. Impedance spectroscopy
3.6.1. Measurement technique
Impedance spectra were recorded from minimum 40Hz to maximum 30MHz (10mV
amplitude, 0mV bias, 100 points per sweep) using the computer-controlled (Matlab,
Mathworks) impedance analyzer (Agilent 4294A, Agilent technologies, USA). The soft-
ware was programmed to carry out a given number of measurements at a given interval.
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3.6.2. Impedance data analysis
Three diﬀerent analysis methods to evaluate recorded impedance data have been used in
this work.
1. Equivalent circuit fitting. The impedance spectra have been fitted to the
equivalent circuit model from figure 2.5 (without cells; strong line) and figure 2.2a (with
cells; with the DE represented by a CPE). Accordingly, cell-dependent circuit components
such as Rext, Rint and CPEc (ac and bc) were obtained. First, the impedance spectra
of the medium without cells were fitted and ↵el,  el and Cpar were extracted. By fixing
these three system components, the impedance spectra with cells were fitted and Rext,
Rint  c and ↵c were determined. Equivalent circuit fitting is convenient since it allows
attributing values to all elements of a specific circuit model. However, this method carries
several drawbacks. There may be diﬀerent circuit models that result in low fitting error
indicating that the extracted values depend on the chosen circuit and therefore are prone
to misinterpretation. Furthermore, the used fitting algorithm may also find several non-
relevant solutions for the same circuit model. This is especially true for cell cultures at low
density where the impedance curves with and without cells are not diﬀerent enough and
the number of fitting cycles is limited. Overall, fitting of impedance data to an equivalent
circuit is very useful when characterizing cell cultures at high density (exerting high Rext)
since circuit elements can be compared between cell models for example.
2. Maximum cell index. The impedance is followed-up over time at one frequency
where the contribution of cells to the magnitude is at its maximum, i.e. where the dif-
ference between the impedance magnitude profile in the presence of cells and that in the
absence of cells is largest. This frequency corresponds to the one with the highest sensi-
tivity to cellular changes and is determined by finding the maximum relative impedance
value according to equation 3.1. The corresponding impedance magnitude is referred to
as cell index in literature (Otero-González et al., 2012).
CI = maxi=1,...,n
 |Z|cells (fi)  |Z|medium (fi)
|Z|medium (fi)
 
(3.1)
where |Z|cells (fi) is the frequency-dependent impedance magnitude in the presence of
cells and |Z|medium (fi) the one in the absence of cells. n is the total number of frequency
points at which the impedance was measured. Although this method is very sensitive,
it neglects the dielectric nature of a cell. In fact, the cell-index frequency not only
depends on the membrane relaxation frequency but also on the measurement system
(electrode/electrolyte interface capacitance and parasitic capacitance) and therefore it
remains unclear what exact circuit element is contributing most to the cell index. This
method is suitable for measurements where simply the presence of cells is of interest such
as for cell-substrate attachment.
3. Frequency-dependent cell index. This method considers cells as shell-covered
spheres where cellular parameters can be distinguished within frequency ranges. This is
similar to equivalent circuit fitting, but the analysis is carried out on the raw data and
no equivalent electrical model is required. It is simply assumed that the LF magnitude
mostly informs about Rext and the HF magnitude mostly about Rint. Ideally, LF is
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chosen very small and HF very high in order to avoid the impact of the cell membrane
capacitor. However, due to the natural imperfection of the measurement system (elec-
trical double layer capacitance at LF and parasitic capacitance at HF), it is necessary to
compromise between decreased measurement sensitivity at the extremity frequencies and
increased impact of the cell membrane capacitor (figure 3.2). Therefore, LF and HF are
chosen such that the influence of Cel and Cm as well as of Cm and Cpar are minimized
respectively. In practice, the choice of LF and HF is not trivial since peak resistance
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Figure 3.2.: Choice of LF and HF as a function of relative contribution of capacitive components to
the measured |Z|. The LF and HF impedances are measured at the frequencies where
the capacitive contribution from the interface capacitance, the membrane capacitance and
the parasitic capacitance are minimal and thus where resistive changes are highly sensitive.
The impedance spectrum was simulated according to the equivalent electrical circuit as
depicted in figure 2.5 where the solution was replaced by a tissue circuit as shown in figure
2.3 with a DE approximated as a CPE ( el = 10 7⌦↵ 1F 1, ↵el = 0.9, Rext = 5000⌦,
 c = 10
 7⌦↵ 1F 1, ↵c = 0.7, Rint = 400, Cpar = 10 10F , Rmedium = 150⌦).
frequencies (PRF1) (Mercanzini et al., 2009) for R0 and R1 cannot be identified due
to the complex electrode (↵el < 1) and complex tissue nature (↵c < 1) as well as the
strong impact of all capacitive components in the system (see figure 4.5a on page 43).
Therefore, LF is determined by finding the frequencies where the relative phase change
(due to the presence of cells) has its maximum. 'LF is calculated according to equation
3.2.
1 The peak resistance frequency is the frequency of 1/Z = 1/X1 + 1/(R +X2) where the impedance is
most resistive, i.e. the phase angle is closest to 0°. The corresponding impedance magnitude value
indicates the value of R. X1 and X2 are the reactances of two capacitances (in this case: electrical
double layer capacitance at low and the parasitic capacitance at high frequency).
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'LF = maxi=1,...,n

('cells (fi)  'medium (fi))
'medium (fi)
 
(3.2)
The impedance magnitude at the maximum relative phase angle frequency has been
found to correlate well with the real R0 and is more sensitive to extracellular changes.
R1, on the other hand, is extracted at the frequency where the phase angle is closest to
0° after the membrane relaxation (equation 3.3, figure 3.2).
'HF = maxi=1,...,n ['cells(fi)] (3.3)
In addition to finding the right measurement frequencies to increase the screening
precision, the LF and HF impedance values are corrected by performing calibration
measurements. Such impedimetric post-processing allows obtaining values that are closer
to the real ones and prevents later misinterpretation of kinetics of biological events.
Although the measurement sensitivity remains constant, the corrected values describe
more precisely actual biological changes. According to the tissue circuit with a series
electrode impedance and a parallel parasitic capacitance, the tissue impedance Ztissue is
calculated as follows
Ztissue(f) =
Zm(f) · Zpar(f)
Zpar(f)  Zm(f)   Zel(f) (3.4)
Ztissue is found by correcting the total measured impedance Zm which is measured
with the tissue. The values for the parasitic capacitance Zpar are obtained by perform-
ing an “open” measurement in air. The values of the interface capacitance Zel(f) =
Zmedium(f)   Rsol are found by subtracting the medium resistance Rsol from the mea-
sured impedance of cell medium Zmedium. Rsol corresponds to the impedance magnitude
at the PRF (figure 3.2).
3.7. Statistics
Comparison between two, three and more groups was carried out using student’s t-
test, one-way ANOVA and two-way ANOVA with Bonferroni post-test respectively. The
observed importance level (p-value) of the diﬀerence between two means was considered
significant when p< 0.05 (*), very significant when p < 0.01 (**) and extremely significant
when p < 0.001 (***).
In order to evaluate the goodness of a curve fit, the weighted sum of squares (WSS) was
calculated based on equation 3.5. The sum of squares was weighted with the experimental
impedance magnitudes so that high magnitude values at low frequency have the same
weight as low magnitude values at high frequency Macdonald (2005); Dellis (2010).
WSS =
X ((Re, Im)model   (Re, Im)observation)2
|Z|observation (3.5)
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Domain / boundary Type of condition Equation
Solution Current conservation
r · J = Qj
J =  E + Je
E =  rV
Bounding box Electric insulation  n · J = 0
Stimulation electrode Electric potential V = 10mV
Ground electrode Ground V = 0
Table 3.1.: Boundary conditions and equations employed in the simulations operated in DC. J : current
density, E: electric field vector, n: normal vector,  : conductivity, V : voltage
3.8. Numerical simulations
The finite element simulations presented in this work were carried out using Comsol Mul-
tiphysics ® 4.3a. Table 3.1 displays the boundary conditions and equations employed in
the simulation framework operated in DC. The solution conductivity was set to 1.6S/m.
3.8.1. Measurement penetration depth
The sensitivity of an impedance measurement is proportional to the local power dis-
sipation (Linderholm, 2006, p.47). Therefore, the penetration depth of an impedance
measurement was defined as the depth below which half the electric energy is dissipated
(equation 2.7 on page 24). Regarding a variation of wel/ (wel + sel), a 2D simulation was
carried out by setting lel to 1m (considered as infinite). For a variation of lel/sel, a 3D
simulation was conducted, keeping wel constant at 1000µm.
3.8.2. Bandwidth
The computation of the minimal electrode cut-oﬀ frequency is based on the following
equation:
fel =
1
2⇡RsolCel
(3.6)
Note that when the distance between the two electrodes becomes smaller, most of
the current passes at the inner edges of the electrodes and only a fraction of the real
electrode width contributes to the current flow. Hence, this leads to a decreased electrode
double layer capacitance value Cel. The corresponding apparent electrode width wap was
determined for each pair of wel and sel as follows
ˆ +wel/2
 wel/2
E(x)dx = Euniform · wel (3.7)
where E is the electric field distribution over the electrode width (at 10nm distance
from the electrode for more precision) and where Euniform corresponds to the electric
field value for a (hypothetical) homogeneous field distribution at the electrode surface.
Once Euniform is known, the apparent electrode width is determined as the width where
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Figure 3.3.: 2-box model for simulating toxicity eﬀects.
E > 0.5 · Euniform. Consequently, the electrode region where relatively low current
spreads out into the solution compared to the total current flow is neglected. Cel is then
calculated using wap in
CH = "0"OHP
A
dOHP
= "0"OHP
wap · lel
dOHP
(3.8)
where "0 = 8.85 · 10 12F/m2 is the vacuum permittivity, "OHP = 12.4 is the relative
permittivity of the outer Helmholtz plane with water (Conway et al., 1951), A is the
surface area of the electrode, lel is the electrode length and dOHP = 5A˚ is the outer
Helmholtz plane distance (Conway et al., 1951).
Rsol was obtained according to
Rsol =
V´1
 1
´1
0 J(x, y)dxdy
(3.9)
where V is the voltage set as 10mV and where J is the current density.
3.8.3. Toxicity eﬀect modeling
The model is composed of a first cube which represents the cell medium. A second cube,
which represents the cell volume, is placed into the first one (figure 3.3) . Toxicity eﬀects
such as cell retraction and cell death are simulated by changing the volume and the the
conductivity of the smaller cell cube. The size and conductivity of the larger medium
cube remains constant. Considering a side length A of 100µm for the larger medium
cube, the corresponding cell constant equals
 =
1
A
= 10000m 1 (3.10)
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The cell volume fraction or cell density is calculated as follows
density =
a3
A3
(3.11)
where a is the side length of the smaller cell cube.
R0 and R1 are obtained as follows
R0 = ⇢medium
✓
A  a
A2
+
a
A2   a2
◆
(3.12)
R1 = ⇢medium
 
A  a
A2
+
✓
a
⇢intra
+
A2   a2
⇢mediuma
◆ 1!
(3.13)
⇢0 and ⇢1 of a tissue can consequently be obtained by using equation 2.6 on page 23.
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4. Distinguishing toxicity eﬀects
4.1. Label-free distinction of minor and major cell damage -
the main principle
The analysis of toxic eﬀects on cultured cells is conventionally carried out through col-
orimetric assays such as the MTT test1 or through fluorescence-based live/dead stains.
These tests are end-point assays and require a considerable amount of material and hu-
man resources. Impedance measurements, on the other hand, are simple, inexpensive,
non-invasive, real-time and automatable, all being the reason why impedance screening
has been used extensively to measure toxic eﬀects on cells (Jahnke et al., 2009; Krinke
et al., 2010; Hug, 2003; Cho et al., 2009; Banerjee et al., 2010; Abdelghani, 2002). How-
ever, in most cases it is unknown what exact biological phenomenon is associated with
the impedance that is measured upon toxin exposure. In former studies, the impedance
was recorded over time at a specific frequency where the cellular contribution appeared
maximal (max(|Z|cells |Z|medium), CI). This frequency varies depending on the electrode
measurement system, the cell density and the cell model that is used. The impedance
associated to this frequency may carry information about the extracellular, membrane or
intracellular properties or even a mix of them, depending on the extent to which the mem-
brane capacitor has been short-circuited at the given frequency. Therefore, impedance
measurements have remained unexploited regarding the distinction of toxicity-induced
morphology changes (cell-substrate unbinding) from cell death (membrane rupture and
cell fragmentation), thus rendering this technique unspecific and inadequate to be com-
pared directly with labeling-based viability assays.
Considering a single cell as a shell-covered sphere (Pauly and Schwan, 1959; Gawad,
2004) it is necessary to distinguish cellular events within frequency ranges. At low fre-
quency, cells act as insulators due to the capacitive nature of the cell membrane. At
high frequency, the cell membrane capacitor is short-circuited and intracellular matter
has an eﬀect on the impedance. Hence, frequency dependent impedance screening oﬀers
plethora of information on intra- and extracellular properties. This chapter2 shows how
measurements at diﬀerent and well-chosen frequencies can provide information on both
morphological changes (low frequency) and cell death (high frequency) simultaneously
(figure 4.1) without using any label. Consequently, the resulting two distinct signals
allow distinguishing minor toxic eﬀects (morphology changes) from major cell damage3
1 (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide is reduced to purple formazan in living
cells
2 This chapter has been subject to a publication (see paper I on page 143) (Meissner et al., 2011).
3 A specific definition of the term “cell death” with regard to biochemical mechanisms does not exist. Cell
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Figure 4.1.: Scheme of how frequency-dependent impedance is associated with biological information
when cells are exposed to toxins. The low frequency impedance informs about toxicity-
induced minor cellular changes (“sick” cell) and the high frequency impedance about major
cell damage (cell death).
(membrane rupture, dysfunction of ion channels), rendering this technique not only very
sensitive since early sub-lethal eﬀects can be measured, but also qualitative since two
diﬀerent biological information are obtained.
4.2. Design of a perfusion-based, shear stress-protective
micro-system
4.2.1. Microfluidic chip design
A microfluidic chip with filters inducing mechanical trapping and perfusion for liver cell
culture was designed (figure 4.2). Hepatocytes are versatile cells having high energy
demands. In vivo, hepatocytes are located close or in direct contact to the fenestrated
sinusoid endothelium providing eﬃcient nutrient and oxygen supply (North-Lewis, 2008).
In the here described device, a low hepatocyte-perfusion distance was guaranteed by
introducing four relatively thin filters (100 ⇥ 500mm), separated by 50mm gaps. The
filters were defined by arrays of PDMS pillars (Ø40mm). The total channel height was
60mm. Cell-filled filters cause high flow resistance, resulting in the perfusion medium to
flow between the filters rather than through them. 5mm spacing between neighboring
micro-pillars allowed eﬃcient diﬀusion and exchange of nutrients and waste. In addition,
cells are not directly exposed to the main flow which potentially hinders cell proliferation.
death can be classified according to its morphological appearance, enzymological criteria, functional
aspects or immunological characteristics (Kroemer, 2009). Since no specific biochemical mechanism of
cell death is provided in this study, it will be generally referred to as “major cell injury”.
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Fig. 1: Microfluidic device and electrical interface
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Figure 4.2.: Microfluidic device and electrical interface. a) Photograph of the printed circuit board with
polydimethylsiloxane (PDMS) chip. b) Design of the microfluidic channel. c) Schematic of
cell culture area involving PDMS pillars for cell immobilization and flow stress protection.
The main flow is passing between the filters (large red arrows), and eﬃcient nutrient supply
and waste removal is provided by gentle diﬀusion (curved red and blue arrows). Electrodes
are implemented for impedance recording.
Methods
Fig. 2: Electrode design
Fig. 3: Equivalent circuit modeling
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Figure 4.3.: Electrode design. A bipolar interdigitated electrode pair has been adapted to the mi-
crofluidic four-filter configuration to maximize electrode surface coverage for high-sensitivity
impedance measurement of the cell culture area. A total of 36 electrode fingers are provided
for each electrode (wel = 10µm, lel = 100µm) separated by a gap of 15µm.
4.2.2. Electrode design
Electrodes are implemented in the device for impedance measurements of the hepatic cell
population. Interdigitated electrodes (IDE) were designed so that a larger total electrode
surface area contributes to higher measurement sensitivity. IDEs were adapted to the
microfluidic four-filter configuration such that the sensing area is limited to the region
where cells are trapped in filters (figure 4.3). Thus, each electrode trace carries four arms
(each 20mm wide) with nine fingers (10mm wide, spaced 15mm apart).
4.3. Results
4.3.1. Impedance changes due to cell growth are frequency-dependent
A microfluidic bio-sensing platform on which the culture and toxicity screening of HepG2
/ C3A cells can be performed was developed. The first step involved immobilizing the
cells within the four filters as shown in figure 4.4a and figure 4.4c. Cells, injected in the
microfluidic device, get trapped within the micro-pillar array with some cells escaping
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(a) (b) (c) (d)
(e) (f) (g)
Figure 4.4.: Imaging of cell culture within microfluidic device. a) and c) show nearly full filters after cell
loading. b) and d) show cells after 3 days of culture. The high density culture is characterized
by direct cell-cell contact and multiple cell layers. (bar=100µm at the top and 20µm at the
bottom). e) Viability of cells within filters is shown in green and some cells in perfusion
regions undergo cell death (red) due to exposed shear stress (green: fluoresceine-diacetate,
red: propidium iodide). f) Immunocytochemical staining of occludin indicates presence of
cellular tight junctions (bar= 40µm, green=Cy-2). g) Three cell layers are identified in
z-direction (blue: DAPI). (bar= 10µm).
through the gaps between the filters. It was observed that the amount of cells finally
immobilized strongly depends on the flow rate during cell loading. Flow rates in the range
of 20nl/s were the most suitable for an eﬃcient cell loading, resulting in a trapping of
up to 90% of the injected cells in the filter.
Cell culture in the microchip was performed for 5 days. Cells attached to the surfaces
and to each other during this period (figure 4.4b). This high cell density culture was
characterized by close cell-cell contacts (figure 4.4d and figure 4.4f) and multiple cell
layers in z-direction (figure 4.4b, dark regions). A confocal image showing the xz-plane
in figure 4.4g revealed the presence of three cell layers stacked on top of each other,
indicating a 3D cell culture. In addition, as shown in figure 4.4e, despite high cell density,
cell viability was maintained within the filters with some dead cells in the perfusion region
only.
The hepatic cell population was examined with impedance spectroscopy during the
entire cell culture. The impedance spectra as a function of cell culture time are shown
in figure 4.5a. An increase of |Z| within a frequency range from 5kHz to 3MHz was
observed. Lower frequencies (< 5kHz) are not aﬀected by the growing cell population.
The phase angle increased within a frequency window of 1kHz to 100kHz and decreased
at HF. Phase angles obtained at 3MHz are much closer to 0° compared to those at lower
frequencies, indicating more resistive characteristics at higher frequencies. The largest
diﬀerence between the impedance magnitude profile in the presence of cells and without
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Figure 4.5.: Impedimetric characterization of cell growth. a) Bode plot of spectra recorded on diﬀerent
days of culture. b) Normalized impedance magnitude at 100 kHz for 7 days of culture (n=5).
The solid line is a fit of the data.
the cells was observed at 100kHz. Figure 4.5a shows |Z| at 100kHz, and the cell growth
profile measured by the impedance was confirmed with the cell growth observed under
the microscope. A typical growth curve with initial lag phase and exponential growth was
obtained by the impedance measurement as seen in figure 4.5b. The stationary phase
was reached at the end of seven days once the electrode area was fully covered with
cells. Hence, it was shown that impedance changes due to the cell growth are strongly
frequency-dependent.
4.3.2. Frequency-Dependent impedance profiles upon drug exposure
The eﬀect of acetaminophen4 (AP) on the micro-scale culture was studied. In order
to analyze AP toxicity-induced eﬀects, LF and HF signals were examined separately.
The LF signal provides information about extracellular properties whereas HF signal
reflects intracellular characteristics. The phase angle indicates if the system behaves like
a resistor (! 0°) or a capacitor (! -90°). LF and HF impedance were chosen as 10kHz
and 2MHz according to the maximum phase change method as described in section 3.6.2
on page 32. As already shown in figure 4.5a, a LF phase angle of -40° (10kHz) at high
cell density indicated both resistive and capacitive eﬀects.
AP treatment with diﬀerent concentrations was performed under continuous perfusion
exposure. Figure 4.6 shows impedance magnitude changes at 10kHz and 3MHz for dif-
ferent time points. The long-term impedance magnitude is similar for measurements at
10kHz and 3MHz, but its evolution has diﬀerent profiles for both frequencies. LF signals
drops as early as 2h of drug exposure, whereas the HF signal does not change signifi-
cantly. For AP concentrations above 5mM , longer exposure results in lower impedance
magnitude. Furthermore, increasing concentrations of AP lead to a larger change in
4 Acetaminophen is a widely used analgesic with a well-known severe hepatotoxicity.
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Figure 4.6.: Normalized impedance in the microchip as a function of AP concentration under diﬀerent
drug treatment time. Each value was normalized to their initial (0h) value. Impedance
magnitude changes (mean ± CI) at 10kHz and 3MHz after application of three diﬀerent
concentrations (5mM , 10mM , 20mM) are shown (n = 3). Kinetics of the decrease in |Z|
was found to be frequency-dependent. Statistical analysis of each time point was performed
compared to the initial value at 0 h (* p < 0.05, ** p < 0.01, *** p < 0.001)
impedance magnitude for treatments of similar durations. The impedance magnitude for
an exposure of the cells to a 5mM AP concentration follows a diﬀerent evolution than
that for higher concentrations and actually increases with exposure time.
Immunocytochemical staining of actin was performed on cultured cells exposed to a
20mM concentration and revealed structural changes as early as 2h after AP treatment
as shown in figure 4.7a. Non-treated cells exhibit a fiber-like network of actin filaments,
providing attachment between cells and the substrate and also neighboring cells. This
organizational structure disappeared after 2h of AP exposure. Instead, an even distribu-
tion of actin was observed in the cells with a slightly higher presence at the cell periphery
(figure 4.7a, arrow). Cells that were treated for 24h showed heterogeneous dispersion of
actin. Also, nuclear fragmentation indicated apoptosis in some cells (figure 4.7a, arrows).
The cell viability, on the other hand, decreased significantly after 24h, and no cell death
was observed up to 8 h as shown in figure 4.7b.
4.4. Discussion
It was demonstrated that the presented microfluidic device is a suitable environment
for HepG2/C3A cell growth. It was further shown that impedance changes following cell
growth and exposure to AP are strongly frequency-dependent. More specifically, diﬀerent
impedance kinetics were observed at LF and HF when the cells are treated with AP. The
following sections will discuss why impedance changes are dependent on the frequency
and how they relate to biological events.
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Figure 4.7.: Eﬀect of AP treatment on cell morphology and viability. a) Cytoskeletal changes after AP
exposure. Immunocytochemical staining of actin cytoskeleton revealed structural changes as
early as 2h after 20mM AP treatment. C: Actin forms a fiber-like network in the untreated
sample. 2h: Actin is less organized and dispersed throughout the cytoplasm and displays
slightly higher fluorescence intensity at the cell periphery (arrow). 24h: Actin is heteroge-
neously dispersed in the cell. Apoptosis is observed as indicated by arrows. (bar= 10µm,
green=phalloidin-FITC, blue=DAPI); b) MTT viability assay. % cell viability vs. time.
Mean ± CI of absorbance at 590nm is shown (n = 4). Comparison between time point and
initial value at 0 h (** p < 0.01).
4.4.1. The microfluidic perfusion culture
A microfluidic device was designed in which cell culture can be performed with contin-
uous perfusion of medium and without shear stress applied on the cells because of the
implemented filter design. The experiments showed higher cell viability and cell growth
inside the filters than that of outside owing to the protection of cells from the eﬀect of
shear stress caused by the direct flow. In addition, sterile conditions can easily be main-
tained when using a perfusion system (non-loop) and a PDMS microbioreactor. This
reduces the need for the use of antibiotics that have potential long term eﬀects on cells
(Stieglitz, 2004). The microfluidic cell culture showed very high cell density in the filters
with maximum distance of 50mm for diﬀusion of nutrients as determined by the filter
width. These specifications meet in vivo conditions since the extracellular matrix consti-
tutes a small portion of the normal liver (about 3 %)(Schmitz, 2007) and tight junctions
are important for firm cellular attachment permitting cell-to-cell signaling across com-
munication junctions (North-Lewis, 2008). Although the presented cell culture may not
be considered as 3D (due to the absence of extracellular matrix), formation of multilayer
stack of cells is still important (Bedossa and Paradis, 2003) since most of the cell surface
is in direct contact with adjacent cells. This is not true for standard cell culture in 2D
Petri dish, where cells are cultured on a hard surface and with abundant amount of cell
medium. Based on cell growth and high cell viability, this device and the culture con-
ditions are considered to be eﬀective for drug cytotoxicity studies, although a complete
biochemical analysis (quantification of albumin and CYP450 activity (Prot et al., 2011,
2012; Snouber et al., 2013; Khetani and Bhatia, 2008; Xia et al., 2009)) was not the focus
and hence was not conducted in the framework of this study.
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4.4.2. Impedimetric characterization of the hepatic cell population
The dielectric properties of HepG2/C3A cells were investigated with the microfludic per-
fusion system. Although the maximum cellular contribution to the impedance magnitude
was observed at around 100kHz, the phase angle did not change at this frequency but
varied significantly at 10kHz and 3MHz. On the one hand, this diﬀerence originates in
the impedance being dominated by the electrode impedance at LF, thus making the LF
impedance magnitude less sensitive to the presence of cells. On the other hand, the ex-
tracellular resistance is shorted by the cell membrane capacitor above 10kHz as indicated
by the phase angle. Hence, if one wants to measure predominantly extracellular events,
10kHz appears to be the most sensitive frequency (phase angle is most resistive before
membrane relaxation). At 100kHz phase angles are constant during the cell culture
due to the balance between an increasing extracellular resistance and membrane capaci-
tance. Moreover, intracellular properties can be investigated at HF as mentioned earlier.
The impedance at HF increases with the increasing number of cells because intracellular
matter is less conductive than the surrounding medium (Gawad, 2004). Nevertheless,
the corresponding phase angle decreases due to the increasing tissue capacitance that
was observed up to 3MHz (figure 4.4a). Thus, these experiments provide information
about extracellular, intracellular and cell membrane properties. Such cell specific charac-
teristics can only be distinguished with the interpretation of the impedance spectra with
corresponding phase angle profile, thus making phase angle analysis an indispensable
tool for understanding cellular phenomena.
The phase-component of the impedance has a typical angle of  45  at 10kHz and
of  15  at 3MHz. This indicates a stronger capacitive behavior of the cell population
at LF, originating from the electrode and the tissue capacitance. A correction method
was introduced to eliminate the eﬀect of the electrode-electrolyte interface and to oﬀer
the possibility to theoretically counteract the inherent drawback of bipolar measure-
ment. This technique assumes that electrode characteristics do not change throughout
the whole experiment time. Practical alternatives to eliminate the electrode interface
contribution are multipolar measurements such as tetra-polar configuration. However,
these techniques have a limited practical bandwidth, at least when using micro-electrodes,
as described previously (Linderholm, 2006).
4.4.3. Hypothesized correlation between biological events and impedance
profiles
4.4.3.1. Sequential two-step toxicity eﬀect
It was observed that impedance changes after AP treatment were time and dose-dependent.
Significant changes on the impedance spectra after 2h at 10kHz confirm that impedance
screening is a very sensitive method. When comparing low and high frequency measure-
ments, it was found that |Z|HF decreases later than |Z|LF . This shows that diﬀerent
information can be obtained when investigating diﬀerent frequency ranges as presented
in figure 4.8. At LF, cell membranes act as capacitors and block the current flow through
the cells. This leads to a high extracellular resistance, considering a densely packed in-
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Figure 4.8.: Hypothesized correlation between frequency-dependent impedance changes and cell culture
morphology. After short term drug exposure, cell-cell contacts are loosened and the forma-
tion of intercellular gaps causes current shunting at low frequency (LF), but no significant
impedance change at high frequency (HF) due to their low volume fraction. Cytosol con-
ductivity changes follow cell death after long term drug exposure. This leads to decrease in
the impedance at HF.
sulating cell layer. If cell-substrate and cell-cell contacts are loosened and cells start to
retract, current shunts through the intercellular space which results in an abrupt resis-
tance drop (due to the inverse relationship between Rext and intercellular space). This
phenomenon explains the signal decrease at LF. Such rapid impedance decrease is corre-
lated to cytoskeletal actin changes after AP exposure (figure 4.7a). In cell culture with
stiﬀ substrates and dense cell-cell contacts, the actin cytoskeleton tends to organize in
stress fibers. AP treatment disrupts this fiber-like organization leading to cell-substrate
and cell-cell detachment. Former studies also indicated that AP mediated metabolism
can cause the deactivation of the Rho protein which in turn is responsible for the forma-
tion of actin stress fibers (Besser and Schwarz, 2007).
In long-term drug exposure, cells start dying either through apoptosis or necrosis (Kon
et al., 2007; Pierce et al., 2002) which again leads to signal decrease. This is consistent
with the changes observed in the cell morphology inside the microchip such as cell retrac-
tion and increase in the intercellular space after 2h and cell death after 24h AP exposure.
On the other hand, at HF, the membrane capacitor is considered shorted and both ex-
tracellular and intracellular matter contribute to the measured impedance. Intercellular
gaps formed after AP exposure barely contribute to the decrease of HF impedance due to
their low volume fraction compared to the large intracellular volume at high cell density.
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When cells start dying, ion pumps embedded in the membrane cease functioning and
small pores are formed during cell death, leading to exchange of intra- and extracellular
matter. Considering continuous perfusion of the cell sample, cell cytosol is replaced by
fresh medium, which has two to three times higher conductivity than the cytosol (Gawad,
2004, p.77). The results on HF kinetics indicate that the conductivity change in such
large volume contribute to the impedance decrease. Indeed, the measured HF values
in figure 4.6 follow the same trend as the profile obtained in the MTT viability test
(figure 4.7b) and other reported conventional viability data on HepG2 cells (McHardy
et al., 2005; El-Hassan, 2003). The present data strongly suggests that, in combination
with high cell density and continuous perfusion flow, HF measurements report serious cell
injury, while LF measurements inform about intercellular and morphological phenomena.
In addition, it was measured that |Z|LF was higher at 20h and 60h than initially when
5mM AP was applied. This is due to the continuously growing liver carcinoma cell
line used in the experiments. Cell growth is disrupted after AP exposure, and cell cycle
reentry occurred after a certain ‘adaptation time’. 5mM AP concentration was too low
to cause serious HepG2 cell population damage within 60h.
4.4.3.2. Analytical model confirms relationship between biological and impedance
changes
Analytical modeling was conducted to further understand the kinetics diﬀerence between
the LF and the HF signal decrease (see section 3.8 on page 35). For this, cells were placed
in the electric field of an electrode pair and two timely shifted biological events were
simulated (two-step toxicity): 1) the intercellular space was increased (equivalent to cell
retraction); 2) the intracellular conductivity was step-wise adapted to the conductivity
of the cell medium. Five observations were made:
1. It was found that the increase of the intercellular space causes the impedance at
both frequencies to decrease, but to a diﬀerent extent (figure 4.9, gray area). The
LF signal drop is much more pronounced than the one at HF. This is due to
the direct relationship between |Z|LF and Rext on the one hand and to the lesser
influence of Rext on |Z|HF owing to Cm shortening on the other.
2. It is noted that linear gap changes result in a non-linear decrease of |Z|. This non-
linear decay indicates a lesser sensitivity with an increased intercellular distance
which is due to the inverse relationship of Rext and intercellular space.
3. The intracellular conductivity change, on the contrary, leads to a more evident sig-
nal drop at HF (figure 4.9, orange area). This is explained by the direct relationship
between |Z|HF and  intra.
4. In contrast to the experiments (figure 4.6), the HF signal also decreases slightly
when the intercellular space was increased in the simulations (figure 4.9), indicating
that |Z|HF is dependent on both  intra and the extracellular space. This deviation
between theory and practice may have diﬀerent reasons. Biological events were
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Figure 4.9.: Connection between toxicity-induced biological events and frequency-dependent impedance
profiles. The kinetics of biological events such as the creation of intercellular spaces and the
intracellular conductivity change determine the frequency-dependent impedance kinetics.
Initially, no eﬀect is observed. After a time lag, cells retract and the intercellular space
increases (gray area). The LF signal drops dramatically and the HF signal drops slowly.
When  intra from all cells adjusts to  medium following major cell damage (orange area), the
HF signal drops considerably. This calculation was performed at 95% cell density according
to section 3.8.3 on page 36.
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Figure 4.10.: Impact of cell density on the ability to distinguish LF and HF impedance signals fol-
lowing cell retraction. a) Signal decrease at both frequencies following cell retraction is
illustrated (4 |Z|LF > 4 |Z|HF ). b) Diﬀerence between LF and HF impedance drops
(log
 4 |Z|LF /4 |Z|HF   following cell retraction as a function of initial cell density. High
cell densities are favorable for distinguishing toxicity eﬀects.
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Figure 4.11.: Timely overlap of extracellular space and intracellular conductivity changes. a) Illustration
of bio changes overlap. b) Normalized |Z|HF as a function of  intra and intercellular
space change 4Vintercell. The green and the red field represent the healthy and dead cell
population respectively. Diﬀerent paths from the green to the red field are imaginable with
diﬀerent impacts on the impedance value and consequently its sensitivity towards changes
of  intra.
simulated as linear changes to exemplify their eﬀect on the impedance measure-
ments, however in reality their kinetics are likely to be more complex which in turn
has a direct impact on the precise kinetics of the LF and HF impedance curves.
Also, only two major biological events were considered here, whereas the cellular
toxic reaction is presumably more complex (e.g. temporary increase in  intra might
have leveled the signal drop at HF).
5. A study on the diﬀerence between LF and HF impedance drops following cell
retraction as demonstrated in figure 4.10 pointed out that higher cell densities
enable a sharper distinction.
To further understand the impact of both biological events on |Z|HF , the eﬀect of their
timely overlap was additionally studied. Figure 4.11 shows the normalized impedance
as a function of a crosswise variation of  intra and cell retraction (4Vintercell) with the
green and the red fields representing the healthy ( intra = 0.5Sm 1 and 4Vc = 0%) and
the dead state ( intra = 1.6Sm 1) respectively. It was shown that the HF signal is > 2
times more sensitive to  intra than to intercellular space changes. Furthermore, when
both events timely overlap, the measured |Z| is almost entirely determined by  intra.
Nevertheless, the sensitivity of |Z|HF to  intra decreases with an increasing extracellular
spac. However, these observations also indicate that a change in  intra cannot be fully
covered by a change in intercellular space within |Z|HF . Therefore the HF signal allows
estimating the major health status of a cell population, although it is not an independent
parameter for  intra.
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Figure 4.12.: Eﬀect of cell density on the ability to distinguish minor from major cell damage. The
measurement sensitivities for 1% change of cell volume (equivalent to cell retraction) and
intracellular conductivity were plotted.
4.4.3.3. High cell density for sensitive toxicity distinction
The eﬀect of cell density on the ability to distinguish minor from major cell damage
with LF and HF signals was investigated. For this, the relative change of |Z| before and
after drug treatment was evaluated as a measure for distinguishing toxicity eﬀects. The
relative impedance changes at LF and HF were compared with the relative changes of
intercellular distance and intracellular conductivity respectively. The resulting LF and
HF sensitivities SLF and SHF are calculated as follows
SLF =
4|Z|LF
4Vc =
|Z|LF,b |Z|LF,a
|Z|LF,a
Vintercell,a V intercell,b
Vintercell,b
(4.1)
SHF =
4|Z|HF
4 intra =
|Z|HF,b |Z|HF,a
|Z|HF,a
 intra,a  intra,b
 intra,b
(4.2)
where the indexes “b” and “a” are referred to the |Z|, Vintercell and  intra before and
after drug administration. Figure 4.12 illustrates the sensitivity decrease at LF and HF
when the cell density is decreased. The LF and the HF signal show a sensitivity of more
than 1 for volume fractions of > 0.5 and > 0.75 respectively and accordingly act as
an extracellular space and intracellular conducivity amplifier. All this information indi-
cates that a high cell density culture (confluency) seems to be valuable for the sensitive
distinction of minor from major cell damage.
4.4.4. Summary
It was demonstrated that major biological events such as cell retraction and intracellular
conductivity lead to frequency-dependent impedance changes. The LF signal is highly
sensitive to intercellular space changes. Although the HF signal also changes slightly
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with the intercellular volume, the impedance at this frequency is mostly sensitive to
intracellular conductivity changes. However, it may be possible to normalize the HF
signal using the LF signal resulting in a more independent indicator for  intra changes.
It was further shown that impedance changes do not follow biological changes linearly.
This may be considered as a disadvantage when correlating impedance with biological
kinetics. On the other hand, this same phenomenon is the reason behind the extremely
high sensitivity of impedance measurements for the detection of initial stress and early
cellular changes, a major advantage over traditional screening methods.
Overall, the resulting LF and HF signal kinetics correlate with the ones observed in the
experiments. Although this model is simplified (ignoring cell-cell junctions) as well as the
described toxicity-induced cellular mechanism (intercellular space changes, intracellular
conductivity change), it validates the hypothesis as illustrated in figure 4.8 and points out
how the two major events that were observed with optical and fluorescence microscopy,
alone may justify the observed impedance changes in time.
4.5. Conclusion
In conclusion, a microfluidic-based sensing platform for hepatocyte culture using dielec-
tric screening was presented. It enables direct, continuous, label-free and non-invasive
monitoring of the health status of a cell population. It was shown possible to distinguish
between morphological changes and severe cell injury within a cell population owing to
the combination of high-density culture and the right choice of measurement frequencies
using phase angle analysis. More importantly, cellular changes can be sensed long before
cellular death, oﬀering a very high sensitive technique over standard expensive and time
consuming viability assays.
As a demonstration of drug induced cytotoxicity screening with impedance spectroscopy
within a wide frequency range, this study oﬀers a sensitive detection method for cellular
behavior during cell culture and drug exposure. Real-time monitoring of cell dependent
changes using microfluidics combined with the impedimetric detection of cellular events
allow developing new designs of micro-scale cytotoxicity-based sensing systems for dif-
ferent cell types under various physiological conditions. Overall, this system exemplifies
the significance of microfluidics and cell dielectric properties to create a miniaturized
detection device for cell toxicology studies.
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5.1. Motivation
The toxicity eﬀect of highly concentrated drugs have implications on a cell’s morphology,
metabolism and viability. Intermediate concentrations, on the other hand, may impose
a pressure on a population of cells since individual cells vary in their sensitivity to the
drug. Some tolerate the applied drug concentration while others do not and undergo
cell death (natural distribution, see figure 5.1). Hence, a greater fitness and thus a more
favorable genotype and phenotype enables a cell to survive the treatment. When a slowly
but continuously increasing drug concentration (pressure) is applied, the cell population
becomes subject to evolution as a consequence of genetic mutations and the thereupon
based selection process. Such acquired drug resistance of cells (bacteria and cancer cells)
is a critical issue in clinics and merits particular attention.
Selection concentration
Maximum tolerable drug concentration
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Figure 5.1.: Simplified principle of drug resistance acquisition. Individual cells of a cell population vary in
their sensitivity to a drug, giving rise to a normal distribution over the maximum tolerable
drug concentration. Intermediate concentrations apply a pressure on the cell population.
Only cells with higher concentration tolerance (orange colored part of the distribution)
survive and give rise to a more resistant cell population (orange normal distribution curve).
The distribution curve of the resistant cell population was drawn smaller due to a decreased
population doubling time.
Breast cancer, for example, is one of the most common cancer types and leading causes
of female mortality worldwide (Kols, 2002). Chemotherapy is still one of the main treat-
ment methods, causing cell death in breast tumors treated with various anti-cancer drugs.
Despite the fact that many tumors initially respond to chemotherapy, cells can gain re-
sistance and they can adapt to survive. Drug resistance often involves the transition
of cancer cells from an antiestrogen-sensitive, non-metastatic, hormone dependent phe-
notype to an antiestrogen-insensitive, metastatic and hormone independent phenotype
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(Simstein et al., 2003). Despite the fact that there have been a plethora of studies ad-
dressing the mechanism behind drug resistance (Ueda et al., 1987; Kaufmann and Vaux,
2003; Harris and Hochhauser, 1992; Moscow and Dixon, 1993; Tu et al., 1996; Pessina,
1993; Chen et al., 2002), a comprehensive answer to how the transition from drug sen-
sitivity to drug resistance takes place still remains elusive. Hence, a pressing demand
has directed preclinical studies towards the development of rapid and simple techniques
for the investigation of interactions of cancer cells with drugs at diﬀerent stages of the
disease.
Although cell-based impedance spectroscopy has attracted attention as a tool to char-
acterize drug resistant cells. (Bartholomä et al., 2005), there has been no detailed study
that distinguishes cell models of acquired drug resistance without genetic manipulation
from their parental cells based on their electrical properties, nor investigation of drug
interaction with such cells. Still substantial work needs to be done to demonstrate a
comprehensive explanation why dielectric properties of cancer cells change when they
gain drug resistance and how drug resistant cells interact with drugs compared to their
parental wild type cells. The following chapter1 addresses these issues and it will be
discussed how acquired drug-resistance of MCF-7 breast cancer cells leads to a change
in dielectric properties. Moreover, the eﬀect of doxorubicin, one of the most widely used
anti-tumor antibiotics, on resistant and wild type cells is investigated.
5.2. Results
5.2.1. MCF-7 DOX and MCF-7 WT cells possesses diﬀerent extracellular
properties
It was investigated weather doxorubicin resistant MCF-7 cells (MCF-7 DOX2) can be
singled out from their parental cells (MCF-7 WT) based on their dielectric properties.
For this, the impedance spectra of MCF-7 WT cells and MCF-7 DOX cells with equal
cell density3 were fitted in the absence of drug. Figure 5.2 shows the values of the fitted
circuit components (Rext, Rint, bc) for both wild type and drug resistant cells. Although
Rint, and bc showed negligible change when the cells gained resistance to doxorubicin, a
significant diﬀerence in Rext between these two cell lines was observed. MCF-7 DOX cells
exhibited 50% increase in Rext compared to MCF-7 WT cells when both were cultured
at confluence on platinum electrodes.
In order to find out the reason behind the increase of Rext when the MCF-7 WT cells
gain drug resistance, the nature of MCF-7 cellular tight junctions, adhesive junctions
and cytoskeleton structure was investigated by occluding staining, E-cadherine staining
1 This chapter has been subject to a publication (see paper IV on page 169) (Eker and Meissner et al.,
2013).
2 MCF-7 DOX is a sub-clone of MCF-7 WT cells that was selected by continuous exposure to doxorubicin
and they are functionally and phenotypically distinct from the parental MCF-7 cells (Devarajan et al.,
2002).
3 400µl from the cell suspension of 1million ·ml 1 cell density was injected inside the wells. 400000 cells
on each electrode chip were suﬃcient enough to cover the inside part of the wells (5095cells/mm2).
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Figure 5.2.: Comparison of the dielectric components of MCF-7 WT and MCF-7 DOX cells (mean ±
SEM). The resistant cells display a significant increase in Rext compared to the wild type
cells. The magnitude   of CPEc and Rint do not show significant alterations when the
cells gain drug resistance. (n = 35 for MCF-7 WT and n = 21 for MCF-7 DOX cells,
 = 3660± 50m 1 and  medium = 361mS.cm 1).
and actin labeling respectively (figure 5.3). The presence of cellular tight junctions
and E-cadherin was confirmed for MCF-7 WT cells. Occludin and E-cadherine labeling
was intense and formed a continuous line at the cell contacts. No E-Cadherin could
be identified for MCF-7 DOX cells and tight-junctions were rare. Immunocytochemical
staining of actin cytoskeleton revealed significant structural changes between MCF-7 WT
and MCF-7 DOX cells. Drug resistant cells exhibited a highly dense fiber-like network
of actin filaments while MCF-7 WT cells showed much less labeling for F-actin protein.
5.2.2. MCF-7 DOX and MCF-7 WT cells displayed sharply diﬀerent
response to doxorubicin
The eﬀect of doxorubicin on MCF-7 WT and MCF-7 DOX was studied separately at LF
and HF. First, MCF-7 WT and MCF-7 DOX cells were exposed to a 20µM concentration
of doxorubicin during one day of continuous exposure. Figure 5.4 shows time dependent
impedance magnitude changes at 10kHz. The impedance response to doxorubicin of both
cell lines is substantially diﬀerent. While MCF-7 WT cells were severely aﬀected by the
drug at this concentration, MCF-7 DOX cells showed increasing impedance magnitudes
under drug exposure within 24h. Control experiments showed that both MCF-7 DOX and
MCF-7 WT cells were healthy in the absence of drug and displayed relatively unchanged
impedance profiles within 24h. In order to make sure the impedance magnitude changes
originate from doxorubicin-induced cellular changes, not from the presence of doxorubicin
in the cell medium itself, the spectra of cell medium with and without drug in the absence
of cells were recorded as a control experiment (data not shown). Only a 5% increase in
the impedance when 20µM doxorubicin was introduced to the cell medium was observed.
This is negligible compared to the observed increase of the impedance in the presence of
cells. In addition, the temporal evolution of |Z| of 20µM doxorubicin in cell medium did
not show any change when there are no cells inside the wells.
Doxorubicin treatment with diﬀerent concentrations was performed with MCF-7 WT
55
5. Toxicity-resistance screening
Figure 5.3.: Immunocytochemical staining of cellular tight junctions (green: occludin - Cy-2, blue: DAPI,
bar=50µm), adhesive junctions (Red: E-cadherine - Rhodamine, blue: DAPI, bar=20µm)
and actin (green: Phalloidin-FITC, blue: DAPI, bar=10µm) for MCF-7 WT and MCF-7
DOX cells. Loss of tight junctions and adhesive junctions is observed upon gaining drug
resistance. Drug resistant cells displayed a highly dense fiber-like network of actin filaments
compared to MCF-7 WT cells.
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Figure 5.4.: Drug response of MCF-7 WT cells and MCF-7 DOX cells to 20µM doxorubicin at LF
(10kHz). The impedance drops sharply for MCF-7 WT cells while MCF-7 DOX cells display
increasing impedance compared to their control indicating resistance to this drug concen-
tration and demonstrating the substantial diﬀerences in the drug response of MCF-7 WT
cells and their drug resistant phenotypes.
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 MCF-7 DOX after 48 h of drug exposure
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Figure 5.5.: Normalized |Z| vs. diﬀerent concentrations of doxorubicin at LF (10kHz) and HF (2MHz)
for a) MCF-7 WT: the LF and HF signals exhibit diﬀerent profiles with respect to diﬀerent
drug concentrations. b) MCF-7 DOX: the LF signal increases at non-lethal drug concentra-
tions while the HF signal exhibited a slight increase. At high drug concentrations such as
40mM and higher, the LF and HF signal displayed similar impedance profiles and dropped
sharply. The plots were fitted by nonlinear regression based on the equation for bell-shaped
concentration response only for visual presentation.
cells but one day drug exposure was enough to obtain significant cellular changes for
highly sensitive MCF-7 WT cells4. As seen in figure 5.5a, The LF signal exhibited an
increase in the presence of low drug concentrations while the HF signal was unaltered.
When cells were exposed to higher drug concentrations, the LF signal reversed its direc-
tion and started decreasing after 0.02µM drug intake, while HF signal did not change
significantly up to 2µM drug exposures and decreased much later than the LF signal.
On the other hand, since MCF-7 DOX cells are highly resistant; their temporal evolu-
tion was monitored during drug exposure for a longer period of time (48h). The LF signal
showed considerable increase up to 20µM drug exposures while the HF signal displayed
a slight increase up to the same drug concentration (figure 5.5b). High concentrations
of doxorubicin (from 40µM to 100µM) lead to an impedance drop at both LF and HF,
revealing similar kinetics and decreasing sharply at both frequencies.
In addition, concentration-response curves were obtained by plotting |Z| at 2MHz
after 48h of drug exposure vs. diﬀerent drug concentrations. The half maximal inhibitory
concentrations (IC50) for both MCF-7 WT and MCF-7 DOX cells were extracted from
the fit to sigmoid concentration-response curves as shown in figure 5.6. IC50 values were
obtained as 0.4µM and 70µM for wild-type cells and drug resistant cells respectively.
4 Doxorubicin was dissolved in cell medium and added to the cells at diﬀerent concentrations (from
0.005µM to 40µM for MCF-7 WT and from 2µM to 100µM for MCF-7 DOX).
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Figure 5.6.: Concentration-response curves are obtained by plotting |Z| at 2MHz after exposing the cells
to various concentrations of doxorubicin. The data was fitted to a sigmoid model. Based on
the resulting fit, IC50 values were obtained as 0.4µM and 70µM for MCF-7 WT and MCF-7
DOX respectively.
5.2.3. MCF-7 DOX and MCF-7 WT cells showed remarkable LF
impedance increase at nontoxic drug concentrations
MCF-7 DOX cells showed a concentration-dependent impedance increase when they were
exposed to drug concentrations between 2µM and 20µM and such impedance increase
with respect to the control was more pronounced at LF with very little diﬀerence obtained
at HF (figure 5.5b and 5.7a). When the drug was replaced with medium after MCF-7
DOX cells were exposed to such concentrations of doxorubicin for 48h, the impedance
signals retrieved back to their initial magnitudes (figure 5.7b). In addition, a step-wise
increase of the drug concentration also leads to a step-wise increase of |Z| (figure 5.7c).
The subsequent exposure of the resistant cells to first 5µM and then 20µM doxorubicin
concentrations (each for 24h) resulted in a step-wise increase of |Z|; finally the signal
dropped back to its initial value after incubating the cells in medium for 1h.
Such an impedance increase at nontoxic drug concentrations was also observed for
MCF-7 WT cells (figure 5.5b). MCF-7 WT cells displayed higher impedance when they
were exposed to the nonlethal drug concentrations such as 2 and 5nM compared to
the same cells in the absence of drug (control). Such an increase was observed only
at LF while the HF signal showed negligible change in the presence of non-lethal drug
concentrations.
5.3. Discussion
It was demonstrated that impedance spectroscopy is a useful technique that distinguishes
drug resistant cells from their parental cells based on their dielectric properties. Breast
cancer cells at earlier and later stages of the disease as well as the concentration and
time dependent eﬀects of doxorubicin on cell interior and exterior can be screened. It
was shown that drug resistant variants exert higher extracellular resistance that can be
pinpointed by their impedance profiles. Moreover, it was shown that actin cytoskeletal
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Figure 5.7.: Eﬀect of stimulatory non-toxic drug concentrations on MCF-7 DOX. a) MCF-7 DOX exhibit
a concentration dependent increase in impedance magnitudes during drug treatment with
nontoxic concentrations. The plot was fitted by nonlinear regression using exponential decay
equation only for visual presentation. b) Impedance magnitudes vs. time plots of MCF-7
DOX cells when 20mM doxorubicin was applied for 48h and followed by medium washing
for 24h. This shows that the impedance increase is reversible when the drug is removed. c)
Temporal evolution of |Z| when resistant cells were exposed to 5µM doxorubicin for 24h,
followed by 20µM drug concentration for 24h, then medium washing as a last step for 1h.
This shows that the impedance increase can be sequentially added up; once the stress on
cells is removed, the initial state of extracellular environment is re-obtained.
remodeling could play an important part in higher extracellular resistant behavior of
MCF-7 DOX cells, providing stronger cellular architecture.
5.3.1. Distinction of drug resistant cells with their cell dielectric properties
The dielectric properties of MCF-7 DOX cells and MCF-7 WT cells were investigated.
Based on fitting their impedance profiles to the equivalent circuit model, both cell lines
exhibited similar Rint and  c indicating that there were no measurable alterations in
the electrical properties of the cell membrane and cytosol when MCF-7 cells gain drug
resistance. However, drug resistant cells displayed 50% increase in Rext, implying signif-
icant changes in the cell morphology and structure upon drug resistance. The finding
with Rext is a novel result, however quite unexpected. Rext for drug resistant cells was
expected to be lower since loss of tight junctions and absence of E-cadherin in MCF-7
DOX cells (figure 5.3) should have resulted in shunting of the current flow through the
intercellular space and thereby lowering the Rext. On the other hand, actin staining
shows that MCF-7 DOX cells possessed highly dense F-actin network and had elongated
form of actin fibers in cytoplasm up to the cell peripheral region, while MCF-7 WT cells
had peripheral actin, which is much less dense in their cellular structure. These results
suggest that remodeling of the actin cytoskeleton might probably be the reason behind
the higher extracellular resistance when MCF-7 cells become resistant to doxorubicin.
The actin network is a crucial and complex system that provides base and support
to retain cell morphology, mechanical structure and function such as cell adhesion, cell
migration/motility, cell division, cell exocytosis and endocytosis (Pollard and Cooper,
2009). The extracellular and phenotypical events of a metastatic carcinoma are mainly
governed by structural reorganization of actin (Zhao and Guan, 2009; Olson and Sahai,
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2009). If the MCF-7 cells use the reorganization of the actin cytoskeleton to become resis-
tant to doxorubicin, then a question may arise about the role of dynamic actin remodeling
on transformation of a cancer cell to a drug resistant phenotype. Some studies showed
that actin remodeling may play a part in the inactivation of some actin binding proteins
such as E-cadherins (Perl et al., 1998; Wheelock et al., 2008) and gelsolin (Rao and Li,
2004) that have tumor-suppressor functions, and activation of actin signaling pathways
that leads to malignant phenotypes such as pathways involving Ras (Downward, 2003)
and Src (Winograd-Katz et al., 2011) proteins. A recent study showed lower cell stiﬀness
upon disrupting the actin cytoskeleton with an inhibitor of actin polymerization, imply-
ing the importance of actin remodeling in drug-mediated cell stiﬀness modulation and
drug resistance (Sharma et al., 2012). However, it is still unclear if such highly dense
F-actin network participates in drug eﬄux by limiting the drug intake by drug resistant
cells or if such organization of F-actin filaments participates in drug eﬃcacy through
influencing the cell membrane physical properties. In addition, such actin reorganization
might be a consequence of drug-induced phenotypic events of a signaling pathway that
leads to drug resistance. The exact eﬀect of actin remodeling on the drug resistance
remains to be elucidated and was not the focus here.
Overall, the drug resistant cells were distinguished from their parental cells based on
their higher extracellular resistance. Such detection of drug resistant cells based on their
dielectric properties might allow assessing the stage of the disease by selective recognition
of certain phenotypes and designing the optimum personalized treatment based on the
disease progress.
5.3.2. MCF-7 DOX display a 175 times higher drug resistance
The drug response of MCF-7 DOX cells was compared with the one of MCF-7 WT cells.
It was observed that only strong doxorubicin concentrations such as 40mM for MCF-7
DOX and higher concentrations could decrease the LF and HF impedance signal within
48h (figure 5.5b). MCF-7 WT cells, on the other hand, displayed an impedance decrease
from 0.2µM after 24h already (figure 5.5a). This shows that MCF-7 DOX cells are more
resistant to doxorubicin.
Based on the concentration response curves of these two cell lines (figure 5.6), MCF-7
DOX cells exhibited a 175 times higher IC50 value than that of MCF-7 WT cells, which
is consistent with the findings of Chen et al. (2002) who obtained more than 150 times
more resistance with MCF-7 DOX cells compared to their parental cells by applying
conventional viability assay to the same cell lines (Chen et al., 2002). This shows that
impedance screening oﬀers a highly sensitive label-free technique that can assess the
eﬀect of the drug on the diﬀerent phenotypes of the same cell type with high accuracy.
5.3.3. Impedance profiles revealed four distinct drug responses within
specific ranges of drug concentrations
As was also shown in chapter 4, HF and LF impedance signals exhibited diﬀerent kinetics
when cells were exposed to drug, revealing diﬀerent information about cell properties
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Figure 5.8.: Hypothesized impedimetric concentration-response map. (1) At low nontoxic drug concen-
trations, the drug has no eﬀect on cells which results in unchanged LF and HF signal. (2)
There is a drug concentration range where stimulatory eﬀect takes place and reflects in higher
impedance owing to the changes in the cellular structure and cell-cell interaction. (3) At
toxic drug concentrations, there are two diﬀerent circumstances that need to be taken into
account. (3) At mild drug concentrations, the drug induces minor morphological changes
while cell interior is intact, reflecting in lower LF with HF remaining the same. (4) At
high inhibitory concentrations, the LF and HF signal drop sharply due to the substantial
morphological changes and major cell damage.
(figure 5.5b). In addition to that, two more distinct responses at LF within specific
concentration ranges were observed (figure 5.8). First, the drug has no eﬀect, resulting
in unaltered LF and HF signals. Second, at higher nontoxic drug concentrations, an
increase in impedance at LF is observed. The cell morphology might adapt itself in a
way that cells show stimulatory response upon drug interaction and impede the current
more with enhanced cell-substrate contact, resulting in higher impedance at LF while the
HF signal remains the same. When the drug is toxic at higher concentrations, there are
two circumstances that need to be taken into account. At mild toxic drug concentrations,
there might be an intermediate phase where drug induced morphological changes result
in lower LF while cell interior is unaﬀected with no change in HF signal. At higher toxic
drug concentrations, the drug might induce substantial changes in the extracellular and
intracellular environment, reflecting in a sharp and simultaneous decrease in both LF and
HF signal. These findings indicate that impedance spectroscopy not only distinguishes
minor morphological changes from major cellular damage based on diﬀerent kinetics of
LF and HF signals, but also provides useful information when applying non toxic drug
concentrations, i.e. distinguishing concentrations that induce a stimulatory response
from concentrations that result in no measurable eﬀect.
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5.3.4. Increased LF impedance at non-toxic drug concentrations
When low doxorubicin concentrations (2 5nM for MCF-7 WT and 2 20mM for MCF-7
DOX) were added to the cell medium, |Z| showed remarkable increase especially at LF
compared to that of cells in the absence of drug (figure 5.5b). The HF signal was relatively
unchanged. In addition, there was no impedance change when such drug concentrations
were added to the cell medium itself in the absence of cells. These results imply that drug
at low and non-toxic concentrations might influence the biophysical and bio-mechanical
properties of cells as hypothesized in figure 5.8 and the cellular structure might adapt
its organization in a way to fight against the drug by gaining cell stiﬀness. In fact,
while a disease state causes biological and functional changes in cells, it also leads to the
significant changes in the morphological properties of cells (Suresh, 2007). Cytoskeletal
actin has a crucial role in governing mechanical properties of cells (Satcher and Dewey,
1996; Janmey et al., 1991) and it is prone to dynamic changes during progression of
cancer in all forms (Suresh, 2007). Some studies showed increased cell stiﬀness when
normal cells evolve to be cancerous cells (Cross et al., 2008) and some showed reduced
cell stiﬀness upon metastasis using diﬀerent biomechanical assays (Suresh et al., 2005;
Guck et al., 2005). Moreover, it was revealed that chemotherapy drugs such as taxol
and cisplatin resulted in an increase in cell stiﬀness of metastatic cancer cells (Cross
et al., 2011) and increased cell stiﬀness of drug sensitive ovarian cancer cells upon sub-
lethal concentrations of cisplatin was shown by using atomic force microscopy (AFM)
(Sharma et al., 2012). Here, pronounced and intense changes in the actin cytoskeleton
structure and organization were also observed when cells gain resistance . However, cell
stiﬀness might still play a part behind the 50% increase of |Z| in the presence of non-
toxic concentrations of doxorubicin, but possibly other factors regarding drug-induced
extracellular events might also contribute to such an impedance increase at LF.
In addition, it was shown that the drug-induced impedance increase is concentration-
dependent (figure 5.7a) and reversible (figure 5.7b and figure 5.7c). This implies that cells
temporarily adapt to the drug either as part of a protection mechanism or due to a direct
action of the drug on actin remodeling for example. Furthermore, it may be interesting
in future studies investigating weather the time delay to reverse the impedance increase
is concentration dependent as well. Such impedance-based information may provide
important biochemical kinetics information.
Overall, potential stimulatory drug eﬀects such as cell stiﬀness of drug resistant cells
at nontoxic drug concentrations were measured. These findings confirm that impedance
spectroscopy is suitable for detecting and quantifying the increasing cell stiﬀness of drug
sensitive cancer cells upon drug exposure and sensing the alterations of biomechanical
properties of cancer cells on the onset of drug resistance.
5.4. Conclusion
In conclusion, it was demonstrated that drug resistant breast cancer cells can be dis-
tinguished from their parental cell population based on the diﬀerences in their dielectric
properties such as Rext. It was also shown that these two cell lines demonstrate a sharply
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diﬀerent impedance response to doxorubicin. Moreover, a reversible increase in the cell
stiﬀness in the presence of nontoxic drug concentrations is implied by the impedimet-
ric measurements, indicating that structural reorganization of F-actin due to the drug
could play a significant role on the onset of gaining drug resistance. Such stimulatory
response with simultaneous LF and HF analysis enabled the creation of impedimetric
concentration response map.
Future investigations may include testing tissue samples from patients and the use
of multiple assays running in parallel within an automatic system in order to develop a
high-throughput platform that meets the needs of clinical diagnostics and pharmaceutical
industry more comprehensively. Cell-based impedimetric sensing opens new avenues in
personalized medicine to create new classes of detection devices for drug induced cellular
events. Such sensing of cellular phenomena using impedance analysis combined with
real-time imaging might represent a useful technique for identification of cancer cells at
diﬀerent stages and their interaction with drug during the progress of the disease. In this
context, it may be possible to optimize drug treatment of a patient in chemotherapy.
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6. Three-dimensional bio-impedance
measurements
6.1. Design and fabrication of a device for 3D impedance
measurements
The device from chapter 4 has the advantage of being simple to fabricate, however, it
does not allow screening the entire 3D tissue sample. Although multiple layers of cells
and thus a three-dimensional culture were present (figure 4.3f), the electrode geome-
try limited the measurement depth to the first cell layer only (small sel), resulting in
a “two-dimensional impedance measurement”. In addition, the elliptic current distribu-
tion causes the field to be inhomogeneous in z-direction resulting in an inhomogeneous
measurement contribution of diﬀerent tissue depths.
To measure the entire tissue thickness, parallel electric field lines are required, which
give rise to a homogeneous current distribution through the sample. This can be achieved
by using parallel electrodes, however, these are very diﬃcult to fabricate at the micro-
scale (figure 6.1, left). Therefore, a microfluidic channel with a top insulating wall was
employed to guide the electric field lines from the distantly placed planar electrodes
towards the tissue sample. This leads to equipotentials on the tissue sample surface,
thus resulting in virtual parallel electrodes (figure 6.1, top). A conductive hydrogel is
used to separate and keep apart the tissue sample from the planar metal electrodes (figure
6.1, bottom). In addition to being conductive, hydrogels are a porous physical barrier
hindering convective flow but allowing the diﬀusion of small molecules. By consequence,
perfusion channels were included on the lateral sides of the hydrogel to account for a
constant and gentle supply of nutrients and removal of waste as well as the delivery of
drugs for toxicity testing. In summary, the cell culture area is entirely separated from
the measurement electrodes as well as from the perfusion area owing to a stable hydrogel
scaﬀold readily allowing diﬀusion.
6.1.1. Fabrication of hydrogel walls
The fabrication of the device required two silicon masters, one for molding the PDMS
casing and a second for molding the hydrogel walls (figure 6.2). First, the PDMS is cured
in the oven on top of the first silicon master and holes are thereafter punched to define
the inlets and outlets. The structured PDMS chip is then aligned on top of the second
silicon master and the liquid hydrogel is injected into the cell area inlet where it fills the
empty space between the PDMS and the hydrogel master. This fabrication method was
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In vitro tissue sample
at the microscale
Equipotentials on tissue surface
Separation with conductive hydrogel
Technical realizationGoal
Figure 6.1.: Concept for measuring 3D tissue samples in vitro and at the micro-scale. To measure the
entire sample thickness, parallel field lines from parallel electrodes are required (left). This
can be achieved with distantly placed planar electrodes by guiding the field lines with a
top insulating wall (microchannel). Quasi-equipotentials are obtained at the tissue surface
(top) and thus parallel field lines. The cells can be separated from the electrodes with a
conductive hydrogel that also functions as a permeable wall for nutrient supply from the
perfusion channels (bottom).
termed two-step soft-lithography and a detailed process flow is provided in figure A.1 on
page 94.
Although three diﬀerent hydrogels have been tested as conductive spacers, agarose
was revealed to be the most suitable one for various reasons as is pointed out in table
6.1. A highly permeable hydrogel is essential for large molecules to diﬀuse from the
perfusion channel to the cell area. Although poly(ethylene) glycol-diacrylate (PEG-DA)
was relatively simple to fabricate and reproducible due to its synthetic nature, it has only
a small pore size that cannot account for the diﬀusion of large molecules such as albumin
which are necessary for the cells to survive. The fabrication of hydrogel walls made of
gelatin was not only much longer (9h) compared to PEG-DA and agarose (both 1.5h), but
+ =
Structured PDMS Hydrogel master Combined
Hydrogel injection
Molded hydrogel within PDMS chip
Hydrogel Cell area Perfusion
Figure 6.2.: Two-step soft-lithography. The PDMS that was structured with a PDMS master is aligned
onto the hydrogel master followed by hydrogel injection in the cell channel inlet. After
gelation, the PDMS chip with molded hydrogel is detached from the hydrogel master, cell
inlets are freed from the remaining hydrogel and transferred onto a glass chip (e.g. with
electrodes).
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Peg-DA Gelatin Agarose
Concentration 10% 10% 2%
Fabrication time 1.5h 9h 1.5h
Polymerization UV light exposure Enzyme cross-linking Low temperature
Origin synthetic natural (collagen) natural (red algae)
Adsorption MW=575: 90% less protein adsorption than glas [1]
strong protein and cell 
adsorption [4] no adsorption
Flouresceine solubility 
(compared to PBS) same
higher solubility, leading to 
osmosis and gel swelling same
Mesh size (for comparison: 
albumin: 14x4x4nm) 4.2nm [2] 9-30nm [5] 200nm [3]
DMPA: H334 / 400; PEG-DA: 
H315 / 317 / 318; Octyl-silane: 
H314
APTES: H302 / 314; 
Glutaraldehyde: H302 / 314 / 
317 / 332 / 334 / 335 / 400, 
Octyl-silane: H314
Octyl-silane: H314
Fabrication
Hydrogel 
properties
Operator safety issues during fabrication 
process (according to EC regulations No 
1272/2008 CLP)
Hydrogel
Table 6.1.: Comparison of physical properties of agarose, PEG-DA and gelatin with regard to their
fabrication and utilization as hydrogel walls. References: 1: Shrivastava et al. (2008), 2:
Garagorri et al. (2008), 3: Pluen et al. (1999), 4: Liu and Vrana (2009), 5: Yang and Mishra
(2007)
the gel itself possessed a higher solubility to small molecules such as fluorescein leading
to osmosis and consequently gel swelling. This decreases the stability of the hydrogel
which is essential for reliable experiments. In contrast to PEG-DA and agarose, cells
interact with gelatin (attachment, digestion), representing a further drawback for the
use of gelatin as a stable hydrogel wall material. Besides, working with agarose instead
of PEG-DA and gelatin represents less hazards regarding all chemicals used during the
fabrication.
6.1.2. Gentle drug delivery through a porous hydrogel
Figure 6.3b shows the fabricated chip with agarose hydrogel walls. The walls are straight,
intact and correctly positioned thus validating the two-step soft-lithography protocol. In
addition, the shape of the hydrogel remains unaltered when a pressure is applied to the
perfusion channel to create a flow. Both, the perfusion culture of MCF-7 cells in 2D and
3D (cells in 0.5% agarose) in the cell area was carried out (figure 6.3c and 6.3d) and
displayed a high cell viability. The developed device, therefore, is considered cell culture-
friendly with a cell area that is supplied with nutrients under minimal stress conditions,
similarily to the conditions found in vivo.
To study the diﬀusion kinetics of the agarose hydrogel walls, a 10µM solution of fluores-
cein isothiocyanate-dextran was perfused (figure 6.4a). It was found that the fluorescein
concentration in the cell area reaches saturation with a time constant of 10min. A sim-
ilar kinetics was observed when the fluorescein was removed through perfusion of pure
PBS (figure 6.4b). Considering an experimental time period of more than 24h, approxi-
mate 30min time delay until a concentration of 100% is reached represents a negligible
time window. In addition, drug delivery to specific tissues in the human body after oral
administration never reaches saturation, but rather experiences a fluent transition from
concentration increase to decrease. For the matter of precision, the exact applied concen-
tration may be found by calculating the area under curve (AUC) in a control experiment
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Hydrogel
Cell area
Perfusion channels
150µm
200µm
300µm
400µm
300µm
200µm
(a) (b)
(c) (d)
Figure 6.3.: Hydrogel wall-based device. a) Scheme of hydrogel walls that separate the cell area from
the perfusion channel; b) Bright field image of fabricated agarose walls; c) & d) Live/dead
stain of a 2D and 3D culture of MCF-7 cells one day after cell seeding (green: fluorescein
diacetate, red: propidium iodide).
(a) (b)
Figure 6.4.: Diﬀusion kinetics of fluoresceine through the agarose hydrogel walls. a) Fluorescein perfusion
indicates a saturation in the cell area with a time constant of 10min; b) Washing with pure
PBS indicates a fluoresceine elimination from the cell area with a time constant of 10min.
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Figure 6.5.: Concept of gel electrodes. a) Top view and b) side view of microfluidicly generated gel
electrodes. c) Numerical simulation of the potential on a gel electrode surface. Quasi-
equipotentials are obtained in z-direction.
with a fluorescent molecule that has a comparable diﬀusion coeﬃcient.
6.1.3. Gel electrodes
The goal is to establish a homogenous electric field through the entire tissue thickness.
One solution would be the fabrication of three-dimensional electrodes, e.g. by electro-
plating. This, however, complicates the fabrication dramatically and unnecessarily. Here,
relatively large, planar electrodes (Ael = 0.15mm2) were used which provide high interfa-
cial capacitance. The current path was defined by the geometry of the PDMS insulating
top wall in z-direction that guides the electric field lines and determines the electric
field distribution on the tissue sample surface (figure 6.5b). Given the almost entirely
homogeneous voltage distribution on the tissue surface in z-direction (figure 6.5c, more
than 99% homogeneity in the height), the vertical boundary between the hydrogel and
the tissue sample was referred to as “gel electrodes”. Nevertheless, such homogeneous
distribution of the voltage was not guaranteed in y-direction (figure 6.5c) (1) due to the
absence of an electric field line-guiding insulator and (2) due to sel > lel which results
in non-homogeneous edge eﬀects (figure 6.5a). However, a uniform field distribution in
y-direction was not essential considering that the tissue sample is much longer than the
electrodes (ltissue   lel) and that the voltage drops to 20% of its maximum on the gel
electrode surface at 2⇥ lel already. In conclusion, leakage currents were eliminated owing
the newly developed fabrication process that accounts for leakage current reduction with
a top and bottom insulating wall and a very long tissue sample and therefore represents
a major advancement compared to previous devices (Kloss et al., 2008).
The potentials of the gel electrodes are diﬀerent from the potentials applied at the
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Figure 6.6.: High cell density culture is required for detectable impedance signal. a) Actin staining of a
3D MCF-7 culture indicates a high cell density; b) The corresponding impedance spectrum.
metal surface due to the voltage drop through the hydrogel. The appropriate model for
the “gel electrode” is a vertical but diﬀuse electrode in y-direction with a known access
resistance Raccess.
6.1.4. Dielectric properties of the artificial MCF-7 cell tissue
Having fabricated the agarose hydrogel walls which serve as equipotential surfaces (at
least in z-direction), it is examined whether these “gel electrodes” detect the presence of a
3D cell culture. As depicted through an actin staining in figure 6.6a, a large cell density is
necessary to obtain a signal that is three times more resistive than the one in the absence
of cells (figure 6.6b). The parameters that characterize the dielectric properties of the
artificially created MCF-7 tissue were further extracted1 and compared with the ones
from ex vivo tissues (mouse liver, mouse muscle and human blood). These parameters
comprise the low and high frequency reactivities (⇢0 and ⇢1), the dielectric constant
(" ) at the characteristic frequency of the  -dispersion2 (see figure 2.12a on page 27) and
the CPE exponent ↵c. They are measurement system-independent and therefore allow
their comparison with values from tissues that have a diﬀerent geometry and that have
been measured with diﬀerent electrodes 3. Accordingly, the cell constant of the central
channel is calculated first. It is obtained from a measurement in cell medium using the
ratio between the access resistance Raccess and the resistance of the central channel Rch
1 The tissue is considered homogenous for this calculation owing to the relatively large tissue dimensions
compared to the ones of a single cell and to the large inter-electrode spacing.
2 The characteristic frequency is the frequency where |Z| = pR0R1
3 Two parallel platinum wires with a cell constant of 1100m 1 were used to measure the impedance of
the ex vivo tissues (rel = 150µm, sel = 2.54mm, lel = 0.8mm)
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REXT
RINTDE
Raccess,1 Raccess,2Rch
Rtot = 5039 ± 293Ω (n=11)
Raccess = 0.7 · Rtot (Comsol) =  3582 ± 244Ω (n=11)
Rch = 0.3 · Rtot (Comsol) =  1511 ± 88Ω (n=11)
κch = 2419 ± 140m-1 (n=11)
= 1.98 ± 0.19Ωm
Cell medium in the central channel:
With cells in the central channel:
Raccess,1 Raccess,2
ρ0  = 5.96 ± 0.19Ωm
αm  = 0.61 ± 0.02
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Figure 6.7.: Extraction of parameters characterizing the artificial tissue. a) The cell constant of the
central channel is needed to calculate the measurement system-independent values of the
tissue circuit elements. The tissue is considered homogenous for this calculation owing to
the relatively large tissue dimensions compared to the one of a single cell. b) ⇢0, ⇢1 and
4 logR are plotted as a function of cell density. The parallel lines represent measured values
and the vertical lines literature values. The area fill is flanked by the calculated curves for
⇢int = 2...5⇥⇢med with ⇢med = 0.625⌦m. The ex vivo measurements are single experiments.
which was found through numerical simulation (figure 6.7a). The corresponding values
were then calculated according to equation 2.6 on page 23 and are shown in figure 6.7b.
Based on the theoretically determined curves (see section 3.8.3 on page 36), the cell
density of the MCF-7 tissue is estimated to be between 0.8 and 0.9. Microscopic images
(figure 6.6a) however, suggest an even more dense cell culture. This diﬀerence may be
due to a weaker cell to cell contact than what is found between hepatocytes in the liver
with a large number of intercellular junctions (tight junctions, adhesive junctions). In
fact, proteins that are responsible for the adhesion of one cell to another were shown
to be absent in this type of cells (figure 5.3), ultimately leading to a mismatch between
the cell density and the cell volume fraction which is plotted in figure 6.7b. A further
potential explanation for the non-expected relatively low value of the cell density might
be a weak adhesion of the cells to the glass (at the bottom) and to the PDMS (at the
top), leading to small leak currents. If the case, this can be prevented through surface
treatment (e.g. fibronectin or laminin) for stronger cell attachment. Finally, the results
indicate a cell population with a similar “dielectric structure” than the one of muscle
tissue (provided that no leak currents are present).
Overall, the information about tissue-inherent dielectric properties can be a guidance
for tissue engineering by estimating to what extent the in vitro recreated tissue resembles
the real tissue. For example, cell density and employed cell types or clones may be
adapted (which in turn modifies the dielectric constants) until a match is found with a
specific in vivo tissue.
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Figure 6.8.: Concept of internal tissue control for toxicity experiments. a) The scheme illustrates the
localized toxin perfusion of the tissue sample (red perfusion channels). The part that is
perfused with clean medium is used as a control (green perfusion channels); b) Simulation
of the established toxin gradient within the device at steady state. Red color indicates 100%
and blue 0% concentration. The electric field illustrates the measurement region of both
electrode pairs.
6.1.5. Internal tissue control
The device design allows perfusing separate regions of the entire “tissue tube” (cell channel
with a high density 3D cell culture) as illustrated by the diﬀerent perfusion channel colors
in figure 6.8a. Such perfusion separation was included (1) to locally treat a specific part
of the tissue with a drug and (2) to use another local part of the tissue as a reference
or internal control. It is noted that the cells from the treated and the untreated parts
share the same history and experience the same culture conditions (apart from the drug
treatment) owing to the device symmetry and a common perfusion pumping system.
This in vitro control measurement concept is referred to as “internal tissue control”.
Since reference and treated part are fluidically connected, it is assumed that drug
molecules can diﬀuse from one side to the other. Figure 6.8b illustrates the steady state
concentrations along the cell channel. Following the continuous resupply and removal
of drug on the treated and control side, a concentration gradient with its center on the
symmetry axis is obtained. The treated and the reference side have a concentration of
> 99% and < 1% respectively, indicating a non-ideal but suﬃcient control condition.
Figure 6.8b also shows the spatial distribution of the electric fields pointing out that
the main measurement contributions are limited to the sides where the concentration is
either close to 100% (treated) or to 0% (control). In conclusion, treated and non-treated
parts of the same tissue are obtained by localized perfusion and the impedance of each
region is measured with localized electrodes.
The concept of internal tissue control has been validated in a cell toxicity application
where cells were locally treated with 1mM SDS. It is shown in figure 6.9a that the
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Figure 6.9.: Toxicological validation of internal tissue control. a) Impedance recording over time before
and after local treatment with 1mM SDS. The untreated side remains highly resistive in
contrast to the exposed side; b) Dead stain reveals selective toxin exposure with a large
number of dead cells on the treated side.
impedance of the treated part decreased shortly after exposure while the signal of the
control population remained more or less constant. This result was compared with a
dead staining of the same tissue after the impedance experiment (figure 6.9b). A large
number of dead cells and intercellular spaces characterize the treated part of the tissue
sample. The control part, on the other hand, displayed almost no dead cell. These
results validate the presented in vitro method of using distinct parts of the same tissue
as testing and reference samples, and additionally points out its advantage of decreasing
inter-population variations.
6.2. Conclusion and outlook
Impedance screening is a suitable technique to study toxicity eﬀects on cell cultures since
measurement points can be recorded continuously and therefore conclusions about the
kinetics of cell injury and recovery can be drawn. However, when investigating three-
dimensional cultures, electrodes that are in contact with the tissue result in localized
(large inter-electrode spacing) or two-dimensional impedance measurements (small inter-
electrode spacing). Also, separating the electrodes from the tissue by the means of a
conductive solution generally leads to increased para-tissue currents (see figure 2.4), thus
lowering the sensitivity of the measurement for tissue-inherent characteristics.
In this chapter, a strategy to measure the impedance of a three-dimensional cell culture
has been presented. For this purpose, a microfluidic chip was designed that allows for
the decrease of para-tissue currents on the one hand and for the probing of the entire
3D culture on the other. This was achieved by (1) recessing the electrodes from the
tissue, (2) avoiding leak currents owing to the specific design and fabrication process
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which involves PDMS and hydrogel molding (2-step soft lithography) and (3) limiting
the tissue growth to the central channel through hydrogel walls. This screening platform
additionally comprises the possibility to test two distinct parts of the same tissue allowing
for the integration of an internal tissue control.
It was found that a confluent cell culture involves a three-fold increase of the impedance
and is characterized by a ⇢0 of 5.7⌦m which is comparable to muscle tissue for example
with an estimated cell density of 80   85% and lower than liver tissue (⇢0 = 33⌦m)
with an approximate cell density of 97%. Further validation is necessary to find out
whether this relatively low value at signal saturation (cell confluency) is caused by leaky
cell-to-cell contacts and thus by the tissue itself or whether leak currents between the
tissue and the top (PDMS) or bottom wall (glass) lead to shunting eﬀects. However, the
characterization and comparison of such inherent tissue properties provides additional
hints for tissue engineering and merits a more profound study.
The sensitivity of the impedance measurement for the central channel was found to be
lowered due to a relatively high voltage drop in the access regions. To counteract this
drop, future designs should involve larger electrode surfaces while respecting the design
rules established in section 2.3 more rigorously with wider (decreasing Raccess) and longer
(avoiding edge eﬀect) electrodes. Although leading to a stronger impedance signature of
the cells, the increase of the tissue width would be compromised by a longer diﬀusion
distance and thus a decreased cell viability.
The design and fabrication of the developed platform has not been valued with experi-
ments involving repeated drug perfusions for example. Given the absence of a computer-
controlled switch system that manages multiple platforms in parallel, a statistically rele-
vant investigation would have exceeded the time length of this thesis. However, ground-
work has been laid evoking the challenges of three-dimensional impedance screening and
providing hints about design rules, material choices, fabrication methods and data anal-
ysis.
It is believed that impedance screening of in vitro cell cultures has not realized its
full potential yet. Being the major advantage of this technique, the continuity of ac-
quiring data points without interfering with the cells oﬀers favorable conditions for long
term studies of drug exposures at long term and in repeated patterns and therefore will
experience increased attention in near future.
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7.1. Simultaneous measurement of multiple samples with
only one electrode
Many cell-based assays rely on the impedance as a cell status indicator for drug response
and toxicity (Meissner et al., 2011; Hug, 2003; Kloss et al., 2008; Tarantola et al., 2010;
Stolwijk et al., 2011). A great variety of applications have also been demonstrated with
small biological components such as proteins (Cornell et al., 1997; Chuang et al., 2011),
antibodies (Steude et al., 2011; Rickert et al., 1996) and nucleic acids (Souteyrand et al.,
1997; van Grinsven et al., 2011). In all these cases, one electrode pair is used to screen
one specific sample only. The automatized measurement of the dielectric properties of
various samples results in a multitude of electrodes, each of them additionally connected
to a common multiplexing switch that is controlled by multiplexing software. These
setups are not only complex, but also add noise to the recorded biological signals.
Similarly, impedance spectroscopy has been used for biomedical purposes where micro-
probes are implanted in a tissue in vivo to measure their resistivity at diﬀerent sites
(Kasi et al., 2011; Mercanzini et al., 2009; Tijero et al., 2009) To access these sites,
the micro-probe had to be either displaced within the tissue leading to cellular damage,
or be equipped with an array of separate micro-electrodes along the probe. Separate
electrodes require corresponding electrode traces that are placed in parallel on the shaft.
This increases the size of the entire micro probe and potentially leads to tissue damage
and inflammatory reaction. Thus, there is a great need for very small devices that are,
nevertheless, equipped with a multitude of spatially dispersed sensors.
Figure 7.1.: Simplified illustration of a frequency multiplexing impedance sensor (FMIS). The sensor is
able to measure multiple signals simultaneously by exploiting the frequency dimension and
diﬀerent local electrode geometries.
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Figure 7.2.: Concept of microfluidic-based frequency multiplexing. Left: Standard measurements of three
samples in diﬀerent channels with three electrode pairs and a switch system. Right: The
same measurements using one single frequency-multiplexing impedance sensor (FMIS)
This chapter1 describes the development of a frequency multiplexing impedance sensor
(FMIS) as simplified in figure 7.1. The FMIS technology allows for the screening of
multiple sites or channels with one single electrode pair only. A theoretical model for
designing a FMIS was developed and devices with up to three sub-sensors were fabricated.
Subsequently, the functionality of a FMIS system that records two signals simultaneously
is demonstrated. Cell-based toxicity screening is tested and demonstrates the impact that
the FMIS technology might have in future applications.
7.2. Concept of microfluidic-based frequency multiplexing
7.2.1. The main principle
The purpose of this device is to screen the bulk resistance in multiple microfluidic chan-
nels with a single electrode pair (figure 7.2). Instead of using individual sensors that
are accessed through a switch, a “switch-free” simultaneous recording with one FMIS is
aimed. This can be achieved by connecting a single electrode pair to diﬀerent parallelized
channels. All channels with their embedded electrode segment define one “sub-sensor”
respectively. Due to diﬀerent geometries of the electrode segments, each sub-sensor has
a specific PRF where the sample resistance from the corresponding micro channel can
be probed. Accordingly, the impedimetric information is obtained by choosing the corre-
sponding measurement frequency. In conclusion, frequency-dependent current pathways
are created where the interface capacitors act as gates.
1 This chapter has been subject to a publication (see paper III on page 161) (Meissner et al., 2012).
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Figure 7.3.: Cross-section of the planar bipolar sensor with corresponding equivalent circuit and dimen-
sion parameters
7.2.2. Modeling a sub-sensor
Hereafter, the equivalent circuit model of a sub-sensor is discussed more in detail. As was
already mentioned in section 2.2.1 on page 20, an electrical double layer is built up at
the electrode–electrolyte interface when an electrode is in contact with a solution. This
double layer can be modeled as a capacitor (CI) and adds up in series to the solution
resistance (Rsol). The cross-section of the sensor that was used in this study is illustrated
in figure 7.3.
The electrical double layer capacitance can be calculated with the simple mathematical
Helmholtz–Perrin model (V < 50mV ) (Kovacs, 1994):
CH =
1
2
"0"OHP
Ael
dOHP
=
1
2
"0"OHP
wel · lel
dOHP
(7.1)
where "0 = 8.85 · 10 12F/m2 is the vacuum permittivity, "OHP = 12.42 is the rela-
tive permittivity of water (Conway et al., 1951), Ael is the surface area of the electrode,
wel is the width of the electrode, lel is the electrode length (= channel width wch) and
dOHP = 5A˚ is the outer Helmholtz plane distance (Conway et al., 1951). The ca-
pacitance is divided by 2 to account for both measurement electrodes (in series). It
has been described earlier that the double layer capacitance is potential dependent (Ko-
vacs, 1994) (Gouy–Chapman capacitance). For simplicity, the eﬀect of voltage-dependent
space charge was not considered because its eﬀect on the sensor design optimization is
negligible.
The cell constant can be calculated according to equation 2.6 on page 23 and depends
on the shape of the sample and the electrodes. Two cases have been employed in this
study (see table 2.2 on page 22 for comparison). For the case where large electrodes are
spaced far from each other, the cell constant calculates as follows (Braschler, 2009) (a
derivation is provided in appendix B)
 =
1
wch
✓
sel
h
+
4ln(2)
⇡
◆
(7.2)
2 The relative permittivity at an outer helmholtz distance of 5A˚ corresponds to 24.8 (and "r = 0 at
dOHP = 0A˚) according to Conway et al. (1951). An average value of 12.4 for the entire electrical
double layer was used in this study. This is valid because of the linear relationship between d and er.
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Figure 7.4.: Simplified impedance magnitude-frequency spectrum according to a triple sensor. All cut-
oﬀ frequencies necessary for the optimization process are shown. Cn is the double layer
capacitance and Rn is the bulk resistance of the nth electrode-channel segment.
where sel is the inter-electrode spacing, wch is the channel width and h is the channel
height. The first term can be interpreted as the resistance through the channel and the
second term as the series resistance due to the curving of the field lines down towards
the metal electrode. For the case where small electrodes are placed in proximity, the cell
constant calculates as follows (Olthuis et al., 1995)
 =
1
lel
K(k)
K
⇣p
1  k2
⌘ (7.3)
where K(k) is the complete elliptic integral of the first kind and k = sel/(sel + 2wel).
7.2.3. Optimization of frequency-multiplexing
For the FMIS, several sub-sensors characterized by diﬀerent geometries are connected in
parallel. In order to perform reliable impedance measurements in the diﬀerent channels,
a number of parameters need to be optimized. Two factors influencing the measurement
sensitivity have to be taken into account. First, the PRF of the diﬀerent sub-sensors
needs to be well-defined and well-separated for good identification of all sensor-specific
measurement frequencies. Second, the total resistance range needs to be maximal in order
to avoid cross-talk between the sensors and to guarantee a large resistance measurement
window (4R). It is obvious, however, that these two conditions are guaranteed by sep-
arating the diﬀerent cut-oﬀ frequencies. This process is named the frequency separation
method (FSM). All relevant frequencies for the FSM are illustrated in figure 7.4.
As a specific case, all the following considerations apply to a triple-sensor (a similar
reasoning is valid for any number of sensors). A maximal separation of the PRFs re-
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Figure 7.5.: Simulation of M as a function of wel and sel. (a) Sub-sensor 1 indicates a large M with
larger values for wel,1 and sel,1, (b) Sub-sensor 2 indicates an optimum ofM at wel,2 ⇡ 50µm
and sel,2 ⇡ 1000µm; (c) Sub-sensor 3 maximizes M for small values of wel,3 and sel,3. All
simulations were carried out with the fabrication values (wel,1 = 500µm, wel,2 = 51µm,
wel,3 = 5µm, sel,1 = 8000µm, sel,2 = 1150µm, sel,3 = 5µm,)
quires the diﬀerences of all cut-oﬀ frequencies (4f1–4) to be as large as possible. This is
guaranteed by maximizing the product of all the 4f . This product is further referred to
as M :
M = (4f1 ·4f3) · (4f2 ·4f4) = P · D
=
✓
log
✓
f2
f1
◆
· log
✓
f4
f3
◆◆
·
✓
log
✓
f3
f2
◆
· log
✓
f5
f4
◆◆
(7.4)
where 4fn = log(fn+1/fn) is defined as the cut-oﬀ frequency diﬀerence, P as the
plateau length parameter and D = 4R1 ·4R2 as the total resistance range. In figure
7.4 the diﬀerent cut-oﬀ frequencies are given by fc = 1/(2⇡RsolCH). Consequently, the
maximization of M has implications on all the experimental parameters from equation
7.1-7.3. It becomes nevertheless apparent that only wel and sel are relevant for the
optimization process since lel is canceled out (if kept the same for all channels) and ⇢
cannot diﬀer in cell culture applications. Finally, M can be simplified as
M = log
✓
wel,1
wel,2
◆
· log
✓
wel,1
wel,2
◆
· log
✓
1
2
◆
· log
✓
2
3
◆
(7.5)
where  is calculated according to the electrode size by using one of the equations from
table 2.2 on page 22. M was simulated for all three sensors as a function of wel and
sel as shown in figure 7.5. According to figure 7.5a, both electrode spacing and width
have to be as large as possible for sub-sensor 1. In this case, the main size limitations
are given by the available space on chip and by the lowest AC measurement frequency.
Similarly, according to figure 7.5c, the geometrical dimensions have to be as small as
possible for sub-sensor 3, the main limitation being now given by the microfabrication
process. Once the dimensions of sub-sensors 1 and 3 are set, the electrode spacing and
width of sub-sensor 2 can be optimized by maximizing the function M (figure 7.5b).
Note that the dimensions of sub-sensors 1 and 3 determine respectively the lowest
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Figure 7.6.: Electrode (black) and channel (gray) design. The bipolar electrode pair is characterized by
three sub-regions that diﬀer in electrode width and spacing. Three microfluidic channels
are implemented to create a sample separation aligned onto the three sub-sensors. Four
PCB connection pads are used since the shortening of the current injection and the voltage
pick-up electrodes is done on-chip (higher sensitivity).
and highest cut-oﬀ frequencies of the FMIS, and consequently its total frequency range
(= f1/f5) and total resistance range (= R3/R1). The optimization of the dimensions of
sub-sensor 2 determines the other cut-oﬀ frequencies such that they are distributed as
equally as possible over the total frequency range, especially P1 = P2 (4f1 = 4f3) and
D1 = D2 (4f2 = 4f4). Moreover, the total resistance range D can be further increased
by introducing interdigitated electrodes, simultaneously decreasing the plateau lengths
(P ). A model was developed that provides the number of interdigitated electrode fingers
for a desired resistance range (see appendix C for detailed information).
7.3. FMIS sensor design
7.3.1. Electrode design
The electrode dimensions were based on the simulations presented in figure 7.5. Large
sel,1 and wel,1 (8000µm and 500µm) were chosen as indicated by figure 7.5a. The param-
eters of the third sensor, sel,3 and wel,3, were chosen small (both 5µm). In the case of
the triple sensor, the additional parameters sel,2 and wel,2 were chosen according to the
resulting optimum as demonstrated in figure 7.5b (wel,2 = 51µm and sel,2 = 1150µm).
The FMIS is shown in figure 7.6 (double sensor: only the upper and lower channel was
used; triple sensor: all channels).
7.3.2. Microfluidic chip design
A microfluidic chip made of PDMS was used to separate the sensing areas. Two (double
sensor) or three (triple sensor) microfluidic channels were embedded, all with a channel
width of wch (lel) = 500µm and a channel height of h = 120µm. The channel height
was defined by the fabrication process (thickness of the structured tape that was used
for PDMS molding).
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Parameters Calculated Experimental
R1 82 k⌦ 104 k⌦
R2 1.2 k⌦ 1.5 k⌦
C1 27.4nF 28.4nF
C2 0.35nF 0.29nF
f1 70Hz 40Hz
f2 5.6kHz 5.6kHz
f3 383kHz 357kHz
1 139 · 103m 1 169 · 103m 1
2 2026m 1 2156m 1
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Figure 7.7.: Simulated and experimental impedance data of double sensor. left: Table with theoretical
and experimental values for equivalent circuit parameters. Calculated data was obtained by
equations 7.1-7.3. Experimental data was extracted through equivalent circuit fitting (mean,
n=5). right: Simulated and experimental impedance spectrum
7.3.3. FMIS testing method
The microfluidic channels were filled with diﬀerent concentrations of PBS (phosphate
buﬀered saline) (0.125⇥, 0.25⇥, 0.5⇥, 1⇥, 2⇥). First, only one channel was filled with
liquid while the other ones contained air (mono sensor). Second, all channels were filled
with PBS and the concentration was varied crosswise (double/triple sensor). The so-
lution resistances were obtained through fitting of the recorded impedance spectra to
the equivalent circuit. For sensitivity determination (⇢meas/⇢real), the measured resis-
tivity ⇢meas was obtained by dividing the mean resistance by the average experimental
cell constant. The resistivity of the diﬀerent solutions ⇢real (= ⇢sol) was measured with
a conductivity meter (Seven Easy, Mettler Toledo). It is assumed hereafter that these
values are the real resistivities of the solutions.
7.4. Testing the concept of FMIS
7.4.1. Characterization of the double sensor
The goal of this study was to demonstrate the ability to measure two or more signals with
one single electrode pair. For this, the frequency dimension was exploited to separate
the diﬀerent signals. The major challenge was to design the sensor such that a maximal
frequency separation of the PRFs (figure 7.2) and thus a maximal M (equation 7.4)
could be achieved. In the first step, the device was characterized experimentally to verify
the validity of our simulations and the consequential chip design. All system specific
parameters and the corresponding impedance spectra are presented in figure 7.7. The
small deviations in cell constant, resistance and capacitance values were attributed to the
flexible PDMS that cannot guarantee very precise fabrication dimensions. In addition,
the dimensions of the electrode after fabrication were not exactly 5µm each (sel2 = 3.4µm
and wel2 = 6.3µm).
Concurrently, the experimental impedance magnitude and phase curves are found to
be more flattened than the simulated one (figure 7.7). This is explained by the complex
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c(PBS) (⇢sol) 0.125x (4.37⌦m) 0.25x (2.24⌦m) 0.5x (1.15⌦m) 1x (0.61⌦m) 2x (0.32⌦m)
Mono sensor 1 748.6±13.3 380.7±7.9 195.8±4.5 103.5±2.4 55.2±1.6
Mono sensor 2 9.1±0.20 4.79±0.06 2.49±0.03 1.32±0.02 0.71±0.01
Double sensor 1 768.3±11.8 393.2±5.5 204.6±1.6 107.1±0.7 57.4±1.0
Double sensor 2 9.30±0.07 4.80±0.03 2.53±0.04 1.37±0.02 0.71±0.01
Table 7.1.: Measured solution resistance values (in kW) in channel 1 and 2 in the mono- and double
sensor mode as a function of PBS concentration (mean ± SEM, n=5).
nature of the electrode–electrolyte interface (see section 2.2.1 on page 20). Surface rough-
ening and steric eﬀects lead to a multitude of diﬀerent capacitor–resistor circuits resulting
in a descending slope that is inferior to 45  (which is the slope angle of an ideal capaci-
tor). This complex behavior is conventionally described by a constant phase element (De
Levie, 1965). However, for the sensor optimization the interface capacitance is considered
as a perfect capacitor since the goal here is to simply separate cut-oﬀ frequencies. For
this purpose, an approximate value for the capacitance is suﬃcient. A double sensor was
fabricated that meets the initial requirement of well frequency-separated PRFs. Small
deviations in the cell constant of sensor 1 and the capacitance of sensor 2 were attributed
to setup and fabrication. Nevertheless, it has been shown that the double sensor complies
with the design specifications.
7.4.2. Validation of the FMIS
In order to validate the FMIS, the similarity of the measurement results of both sub-
sensors compared to their corresponding mono sensors was verified on the one hand, and
their measurement sensitivity on the other. Channel 1 and 2 were measured individually
(mono sensing) and simultaneously (double sensing). The mono sensor measurements
were done by leaving one channel filled with air. The double sensor measurements were
carried out by varying the PBS concentration in channel 1 and 2 crosswise. The results
are shown in table 7.1 and illustrated in figure 7.8. The values for the mono and double
sensors match well for both channels with a maximum deviation of less than 4% for
sensor 1 at 0.5⇥ PBS (196k⌦ vs. 205k⌦). No significant deviation diﬀerence from the
mono to double sensor is observed between channel 1 and 2 (3.4% vs. 1.5%). Thus,
both sensors are considered equally functional. Next, the sensitivity of sub-sensor 1 and
2 was evaluated. Figure 7.8b shows the ratio of the measured resistivity against the real
resistivity at diﬀerent dilutions of PBS. Both sensors show a very high sensitivity with
a maximal median deviation of 3.8% for sensor 2 at 1⇥ PBS. Nevertheless, sub-sensor 2
reveals a larger average deviation of the means than sub-sensor 1 (2.2% vs. 0.7%). This
is explained by the inherent higher sensitivity of sub-sensor 2, due to its lower resistance
compared to sub-sensor 1. In conclusion, no significant value diﬀerences between the
mono sensors and the FMIS were observed and a high sensitivity was demonstrated.
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Figure 7.8.: Double sensor validation. (a) Measured solution resistance values in channel 1 and 2 in the
mono- and double sensor mode are plotted against the PBS concentration (mono sensor:
mean + connecting line; double sensor: mean ± SEM, n=5). Error bars not shown are
smaller than the symbol size. The double sensor values correlate well with those from the
mono mode. (b) Box plot of the ratio of measured resistivity and real resistivity as a function
of PBS concentration (whiskers: min to max). The measured resistivities were calculated
dividing the solution resistance by the average experimental cell constant (see figure 7.7).
Both sensors show high sensitivity with a maximal median deviation of 3.9 % (sensor 2 at
1x PBS)
7.4.3. Cell toxicity application
The applicability of the FMIS to cell culture experiments was verified. MCF-7 cells
were seeded in both microfluidic channels (10Mio cells/ml) and cultured for a period of
24h. Then, the cells were treated with 100µM doxorubicin in one channel after another
with a time delay of 45 min. Accordingly, the sensor selectivity of the FMIS measure-
ment method was investigated for utility in cell toxicity platforms. Figure 7.9 shows the
impedance magnitude spectra in the absence and presence of cells (a) as well as the tem-
poral evolution of the cellular impedance for both channels after drug treatment (b). The
frequency where the impedance change is largest (following cell– electrode attachment)
depends on the sensor geometry. Consequently, diﬀerent geometrical constants among
sensors 1 and 2 lead to two diﬀerent screening frequencies (|Z|rel- maxima in figure 7.9a).
Furthermore, it was observed that the relative impedance change is larger for sensor 2
than for sensor 1. This may be explained by the diﬀerent electrode sizes. One cell is
able to cover the entire electrode width of sensor 2, thus insulating this one completely.
The electrode of sensor 1, on the other hand, is too large and the current can shunt
in between the cells resulting in a leaky insulation and a less strong relative impedance
increase. Being treated first with doxorubicin, the resistance of channel 1 dropped by
40% within 30min. The measured resistance in channel 2, on the other hand, remained
constant at 100%. Once channel 2 was treated after 45 min, the corresponding resistance
decreased as well.
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Figure 7.9.: Cell toxicity experiment. a) Impedance magnitude spectra and relative |Z| change (|Z|rel =
(|Z|cell · |Z|cell free)/|Z|cell free) due to cell attachment in channel 1 and 2 are shown.
Each channel has its specific |Z|rel maxima. b) The cell impedance |Z|cell is shown for both
sub-sensors at the |Z|rel-maxima-frequencies. MCF-7 cells cultured in both channels were
exposed to 100mM doxorubicin with a time delay of 45min. ‘1’ and ‘2’ indicate the drug
application in channel 1 and 2.
This experiment demonstrates the high selectivity of the FMIS measurement method.
Two distinct cell populations have been screened separately with only one electrode pair.
Although two identical microfluidic channels have been used, the electrode geometry
diﬀered. This might be a problem in cell culture applications where identical conditions
are required, e.g. current penetration depth or cell–substrate contact. For those cases,
the implementation of an additional electrode–electrolyte capacitor using a simple liquid-
filled channel is suggested in order to modify the sub-sensor capacitance value (‘capacitive
bridge’) (an example is provided in appendix D on page 101). In such a case, the final
electrode–cell contact region can be identical.
7.4.4. Multi-channel sensing and sensor limitations
The functionality of the double sensor by validation with a cell-based application has
been demonstrated. Now, the implementation of more than two sub-sensors is discussed.
Instead of using multiple separated electrodes, such a FMIS would not only open the
door to very simple multi-channel screening, but also allow the minimization of the total
sensor size. A triple sensor has been designed, as illustrated in figure 7.6, according
to the simulations presented in figure 7.5. This optimization process aims at both a
maximum PRF separation and maximum resistance range. The corresponding impedance
spectrum of the fabricated triple sensor is depicted in figure 7.10a. The experimental and
the theoretical curve match well, although there are some deviations. These deviations
are explained, as already mentioned for the double sensor, by the complex nature of the
electrode–electrolyte interface and by the sensor fabrication (see section 2.2.1 on page 20).
However, our fabricated triple sensor fulfills the most important requirements, i.e. the
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Figure 7.10.: Multi-channel sensing. (a) Simulated and experimental impedance spectrum of the fabri-
cated triple sensor with 1x PBS. Three PRFs are identified indicating three well frequency-
separated sub-sensors. The resistance ranges are similar for all sensors (D1 = D2). (b)
The calculated values of P1,2, D1,2 and frequency range are shown for the double-, triple-
and triple-interdigitated sensor. All values correspond to optimized sensors (Mmax) where
P1 = P2 and D1 = D2. The resistance ranges of the triple sub-sensors are halved compared
to the double sub-sensors while the total frequency range remains constant. In contrary, the
resistance ranges of the triple-IDE sub-sensors are increased by the expense of a decreased
total frequency range.
distinct separation of the PRFs and equally distributed sub-resistance ranges (D1 ⇡ D2),
within the total resistance range (D). This total resistance range is predefined by the
parameters indexed 1 and 3 and equals the one of the double sensor. As a logical
consequence, a common total sensor resistance range for the double and triple sensor
results in halved sub-sensor resistance ranges for the triple sensor. This eﬀect is illustrated
in figure 7.10b. Hence, the resistance range linearly decreases with an increasing number
of sub-sensors. Such a decrease can be opposed by introducing interdigitated electrodes as
sub-sensor 3. IDEs decrease the cell constant and thus increase the total resistance range.
This eﬀect is shown in figure 7.10b where D is increased by the expense of a decreased
P and also a decreased frequency range. In this context, the number of electrode fingers
of the IDE can be determined for a desired resistance range (detailed information about
this optimization is provided in appendix C on page 99). Despite a decreased frequency
range, an increased resistance range can be particularly useful when large resistance
changes are measured. In conclusion, a triple sensor using the optimization function M
was fabricated. A higher number of sub-sensors at a constant total resistance range is
accompanied by a lower measurement resistance range for the individual sub-sensors.
This eﬀect may be avoided by selectively increasing D, e.g. by introducing IDEs.
7.5. Future applications of the FMIS
The concept of a FMIS that is capable of screening more than one channel at the same
time has been introduced. The simultaneous measurement of these channels was achieved
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through frequency multiplexing. The frequency division (FSM) for all sub-sensors re-
quired the optimization of the chip design. For this purpose, a simulation model for
simple rectangular electrode pairs as well as for interdigitated electrodes was developed.
The fabricated chips corresponded well to the model and allowed very precise conductiv-
ity measurements in all channels in parallel. The applicability for biological experiments
was demonstrated with a cell-based toxicity experiment. It has been shown that two
distinct cell populations are monitored separately and simultaneously with only one elec-
trode pair. This technology may also find applications in impedance measurements that
are carried out in vivo. Micro-probes implanted in tissues to measure the resistivity at
diﬀerent sites can be simplified by reducing the total probe width since parallel electrode
traces become unnecessary. Therefore, the invasiveness of a probe using this technology
would be decreased. The measurements, as they were carried out in this study, comprised
sub-sensors that diﬀered in shape and positioning. When identical experimental condi-
tions are required, e.g. in biological applications, the introduction of “capacitive bridges”
is recommended. Capacitive bridges are referred to as capacitors that are placed between
the individual sub-sensors, that do not contribute to the resistance measurement, but
that modify the capacitance of this sensor. An additional liquid-filled channel, for ex-
ample, that adds an electrode–electrolyte interface capacitor, may be integrated. On the
other hand, the geometry diﬀerences may be considered as an advantage since diﬀerent
sensor sizes and geometries lead to diﬀerent measurement depths. As an application, one
FMIS may be used to probe the thickness of a tissue as it has been shown previously with
a complex switch system (Linderholm, 2006). Altogether, an easy technique to screen
multiple channels at the same time with a simple measurement setup has been developed.
In addition to toxicological studies where parallelized screenings are essential, a demand
for such devices is also seen in in vivo applications where the size of the implanting
probes is limited, but multiple sensors are required; as well as in in vitro applications
where diﬀerent measurement depths are needed.
86
8. Conclusions
8.1. Summary of results
This thesis strives to contribute to a more profound understanding on how cellular re-
sponses to toxins can be detected using electrical impedance spectroscopy. Important
aspects regarding in vitro culture and impedimetric analysis of cells in general have been
raised and investigated. Several advances contribute to this achievement:
• The frequency domain has been exploited to distinguish toxicity eﬀects on cell pop-
ulations. Cellular retraction as well as the loss of cell-cell and cell-substrate contacts
represent an initial stress response of cells to a toxic compound and precedes severe
cellular damage (cell death). Both cell responses (stress and cell death) can be
distinguished label-free and continuously by performing impedance measurements
at diﬀerent frequencies. The choice of these frequencies requires the eﬀects from
non-biological measurement parameters as well as from the relaxation distribution
within a tissue to be taken into account by analyzing the phase angle over fre-
quency. It was further found that the ability to distinguish minor from major cell
damage is increased at higher cell densities.
• Acquired resistance of breast cancer cells to doxorubicin has been detected dielectri-
cally. Cells that become resistant possess a higher cell stiﬀness and were shown to be
175 times more resistive compared to their non-resistant parental cells as was indi-
cated by the low and high frequency impedance signals. In this context, the depen-
dance of the impedance magnitude on the measurement frequency and on the drug
concentration resulted in the creation of an impedimetric concentration-response
map which distinguishes cellular responses within four concentration ranges.
• Gel electrodes have been designed and fabricated for measuring the three-dimensional
impedance of three-dimensional cell populations. In this context, a 2-step soft-
lithography fabrication process was developed to mold agarose hydrogel within a
PDMS casing. The hydrogel is multipurpose allowing for the creation of three-
dimensional gel electrodes and for the gentle perfusion of the cell culture. The
specific design of the PDMS-hydrogel chip leads to decreased leak currents, a com-
mon problem when performing three-dimensional impedance measurements. In
addition, the microfluidic chip is symmetrical with two identical areas where one
of them can be used as an internal control.
• A method for multiplexing impedance measurements without the use of a switch
nor a multiplexer and with only one electrode was developed. Diﬀerent parts of
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the electrode sensor have diﬀerent geometries resulting in distinct measurement
frequencies. Impedimetric information about each part of the electrode is obtained
by screening their specific peak resistance frequency. A”double sensor” and a “triple
sensor” have been fabricated and validated with conductivity and cell toxicity ex-
periments.
• With regard to theory, the diﬀerence between single cell and cell population impedance
characteristics have been expounded. Challenges concerning tissue impedance mea-
surements and their analysis were discussed and design rules for planar bipolar
impedance sensors adapted to every tissue’s geometry were provided regarding
measurement penetration and sensitivity.
8.2. On the control of parameters in bio-impedance
measurements
In this thesis, in vitro cell cultures have been characterized by performing impedance
measurements. An important outcome of this work has been the fact that impedance
values and thereto linked biological information can be substantially diﬀerent for the
same biological sample. Non-biological parameters do not only change the practical
 -dispersion bandwidth and thus the measurement sensitivity as was described in chap-
ter 2 already, but also determine which properties of the examined biological specimen
are primarily recorded. (1) The insulator geometry has a tremendous impact on the
preferred current path. For example, an impedance measurement of a tissue within a
solution will be less sensitive to para-tissue currents than an insulated tissue and thus
mostly informs about the size of this tissue. By adapting the insulation to a specific
tissue shape, as was shown in chapter 6, the current passes through the tissue and tis-
sue intrinsic dielectric properties, which inform about density and intercellular spacing,
can be extracted. (2) The electrode position impacts the biological information that is
gathered. As was shown in chapter 5, when cells are in direct contact with two closely
spaced electrodes, adhesive properties and thus the cytoskeleton are represented by the
measured impedance since most of the current passes below the cell monolayer between
the inner edges of the electrodes and thus indicate the ability of the cells to adhere on
the substrate. Considering this, an increased distance between the two electrodes would
result in a current path that preferably spreads out into the overlaid solution rather than
passing below the cells. Such a configuration would lead to a screening similar to TEER
measurements where intercellular junctions mainly contribute to the insulating nature
of the overlaid cell layer. Therefore, it is hypothesized that the extracellular resistance
diﬀerence between MCF-7 WT cells and MCF-7 DOX cells which was observed in fig-
ure 5.2 on page 55 would be reversed. In that case, two distinct biological phenomena
could be investigated separately on the exact same cell layer with the same measurement
method, by changing the electrode dimensions only. (3) The electrode size determines the
volume of the tissue that is screened. As was mentioned in chapter 2, a large tissue that
is probed with large electrodes can be considered homogenous and the experimentally
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determined cell constant using an electrolyte can be employed for tissue calculations.
However, when decreasing the size of the electrode, the measurement volume does not
only become smaller (localized measurement), but also the impedance becomes more
prone to changes at the scale of a cell rather than at the one of a tissue. Impedance
scaling laws exist that must be taken into account when designing electrodes for the
investigation of specific tissue- or cell-related events. (4) The measurement frequency
determines whether the current is blocked by or passes through the cell membrane, ul-
timately providing information either about extracellular-, intracellular-, cell membrane
properties or even about the distribution width of each of them. It was found in chapter
4 that this frequency-dependence of the current path can be exploited to distinguish
initial cell stress from major cell damage when exposed to a toxin. In addition, chapter 5
has shown that when studying the concentration dependance of the frequency-dependent
impedance, cells experience an increased stiﬀness when exposed to lower non-toxic drug
concentrations and this cell response is expressed through an increased impedance at low
frequency only. Such inter-dependance of concentration and frequency on the impedance
value shows that this technique is complex, but it is precisely this complexity that ren-
ders this method useful. Many diﬀerent biological phenomena can be detected given the
technique is well-understood and well-controlled.
Altogether, the measured impedance of a biological specimen depends on numerous
parameters. All these physical phenomena are rather well-known, however, their ap-
plication to biological samples and consequences on gained biological information was
incompletely studied until now. A thorough understanding of their influence on the
impedance value and the linked biological information seems necessary for the study of
biological processes. This thesis represents an attempt to understand some of them,
however a large amount of work is still necessary.
8.3. Significance of impedance technology for toxicology
Although impedance spectroscopy is a non-specific method where the measured impedance
changes for the same sample according to a variety of parameters, it remains an attractive
technology. This is mainly due to its devoid of sample-interfering substances. Measure-
ments can be recorded continuously on the in vitro cell culture. Therefore, the study of
treatments with repeated doses becomes highly interesting. In fact, the current animal-
based perception of “no observed adverse eﬀect levels”1 has been challenged by the high
sensitivity of emerging techniques such as genomics, proteomics, metabonomics, enabling
the detection of responses at very low compound doses (Roggen, 2011). It appears imper-
ative to understand the mechanistic diﬀerences between adverse and adaptive responses
to a compound, especially with regard to the repeated exposure of cells to a drug (Hsieh
et al., 2009; Grotto et al., 2009). In fact, relatively little is known about the diﬀerences
in mechanisms relevant for repeated dose and acute toxicity. Repeated dose toxicity may
be simply a consequence of the prolonged activity of the same toxic pathway that causes
1 NOAEL, denotes the level of exposure of an organism at which there is no biologically significant
increase of adverse eﬀects
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acute toxicity, however, this is not necessarily the case as has been shown previously
(Hengstler et al., 2012). Single administration of high doses of CCl4 causes cell death to
a fraction of hepatocytes. In less than 10 days, the liver regenerates and is functionally
and morphologically indistinguishable from control livers. If lower doses of CCl4 are ad-
ministered over 6 weeks, liver fibrosis is observed which may be explained by the release
of cytokines by stressed or dying hepatocytes (Hengstler et al., 2012). The integration
of in vitro techniques that allow for the study of proteomic or genomic changes would
improve the understanding of the action mechanisms of low and repeated doses of a test
compound significantly (Roggen, 2011). However, few studies have been carried out so far
(Lee et al., 2011; Tostoes et al., 2012; Mueller et al., 2012; Heussner et al., 2007). In addi-
tion to the challenge of maintaining cells viable and functional for long term, most of the
employed techniques are end-point assays, rendering them laborious and costly and thus
practically unsuitable for continuous measurements on the same sample under repeated
drug exposure. Recent tests on hepatocytes, for example, comprised three measurement
points (viability and CYP450 activity) during a culture period of 23 days (Mueller et al.,
2012). Important information regarding injury and recovery kinetics might have been
missed out. Bio-impedance screening, on the contrary, oﬀers a new level for studying
toxicity eﬀects.
Impedance-based toxicology is sensitive to electrode positioning, sample geometry and
movements as was described above. Therefore, microsystems have the major advantage of
representing a controlled environment where highly sensitive and repeatable toxicity tests
can be carried out. The miniaturization of such tests is additionally useful for multiplexed
systems where a large number of samples are analyzed in parallel for drug screening
purposes for example. A further advantage of miniature systems is that portable devices
can be built to perform toxicity tests outside the laboratory for water testing for example.
This would require the control and measurement apparatus to be downsized and the
sample solution to be pretreated (Lichtenberg et al., 2002).
The combined impedimetric analysis of single cells (small electrodes) and of the en-
tire tissue (larger electrodes) from the same culture may allow acquiring new kind of
data. Distribution information about the size and intracellular conductivity from var-
ious single cells can be compared with distribution information from the tissue (see
paper V on page 183) where intercellular interaction is additionally detected. Moreover,
the simultaneous measurement of the same tissue with various electrode geometries can
provide further biological information. As was outlined above, a thorough understand-
ing of the impedance measurement system potentially oﬀers the integration of multiple
impedance sensors for diﬀerent detection purposes (cell attachment/cytoskeleton, cell-cell
contacts/tight junctions), thus rendering this technique more specific.
From a toxicological point of view, the probing of toxic eﬀects of substances on the hu-
man organism are ideally performed at the point of care, more precisely within the target
organ or tissue itself. In vivo toxicity probing of drugs within a patient’s liver for exam-
ple may be a fantasy scenario given the rigorous regulations of biomedical devices and
more importantly the readiness of healthy humans to accept an electrical implant for pre-
vention purposes; however, the necessary technology with extremely compact impedance
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devices on integrated circuits for example and wireless (telemetry) are available already2
Overly et al. (2008); Min and Song (2010). In addition, the liver is a very active organ
with a strong capability to regenerate where impedimetric changes due to cell stress and
cell death seem to be easily detectable. Toxic eﬀects of alcohol or drug ingestion may
be monitored live and the corresponding data sent directly to the person’s smartphone
or treating doctor. The scenario seems fantasy today, but this medical technology might
come sooner as one thinks.
2 http://www.analog.com/en/prod/0,2877,AD5933,00.html. Accessed 23 May 2013.
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A. Fabrication of “gel electrodes”
A.1. Process flow for the fabrication of hydrogel walls
The fabrication of the PDMS chip, the hydrogel master and the electrode chip were car-
ried out according to standard fabrication procedures that have been employed previously
and, therefore, will not be discussed more in detail. The surface treatment of the PDMS
chip (1), the hydrogel master (2) and the hydrogel molding (3), on the other hand, are
described in this work for the first time and will be explained in detail hereafter. The
fabrication protocol has been developed for three diﬀerent hydrogels, i.e. gelatin (Sigma-
Aldrich), PEG-DA (MW = 575g/mol, Sigma-Aldrich) and agarose (high gel strength,
Sigma-Aldrich).
1. PDMS surface treatment: The main goal of the PDMS surface treatment is
to reinforce the adhesion of the subsequently molded hydrogel to the PDMS. The
surface activation diﬀered depending on the hydrogel that was used:
a) Gelatin: Covalent bonding between PDMS and gelatin can be achieved through
the following surface treatment. The PDMS is O2-plasma treated (100W ,
0.1min, 0.6mbar). This is followed by one hour exposure to vaporized (3-
aminopropyl)-triethoxysilane (APTES, Sigma-Aldrich) using a desiccator. The
PDMS surface is then put into contact with glutaraldehyde (25%, Sigma-
Aldrich), a protein binding promoter, for one hour.
b) PEG-DA: The PDMS surface is O2-plasma treated (100W , 0.1min, 0.6mbar),
then moistured with a 2,2-dimethoxy-2-phenylacetophenone (DMPA) solution
(0.1g DMPA in 1ml ethanol) and exposed to 365nm UV light for 1min. The
PDMS is slightly washed with pure ethanol.
c) Agarose: The PDMS was O2-plasma treated (100W , 0.1min, 0.6mbar).
2. Hydrogel-master surface treatment: The surface modification of the oxidized
silicon-based hydrogel master was common to all hydrogels. The objective is to ren-
der the silicon surface hydrophobic to decrease the interaction with the hydrophilic
hydrogels. Therefore, the master was exposed to vaporized trichloro(1H,1H,2H,2H-
perfluorooctyl)silane (Sigma-Aldrich) in a desiccator for at least one hour.
3. Hydrogel polymerization: The diﬀerent hydrogels have diﬀerent gelation mech-
anisms, requiring diﬀerent protocols.
a) Gelatin: Gelatin gels exist over only a small temperature range with a melt-
ing point lying below 37°C. However, gelatin can be enzymatically cross-
linked (Paguirigan and Beebe, 2007) making it stable at 37 C. For this, a
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Figure A.1.: Process flow for the fabrication of hydrogel walls and virtual gel electrodes. APTES -
(3-aminopropyl)triethoxysilane, PEG-DA - poly(ethylene glycol) diacrylate, DMPA - 2,2-
dimethoxy-2-phenylacetophenone, mTG - microbial transglutaminase. (1): surface treat-
ment of PDMS, (2) hydrogel-master surface treatment, (3) hydrogel molding
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gelatin/microbial transglutaminase (mTG) mixture using a 12.5wt% gelatin
solution in PBS needs to be made. A gelatin/PBS solution is heated to not
higher than 70 C to solubilize and fully hydrate the gelatin. Then, mTG
is dissolved in PBS and added to the hydrated gelatin at 37 C to give 10U
mTG per gram of gelatin (e.g. 0.1g mTG in 1ml PBS). The final concen-
tration will be 10wt% gelatin. To avoid too early cross-linking, the gelatin is
injected into the device within maximum 5min. The device is then incubated
at 37 C for 5h, subsequently cooled down to 4 C and again heated to 65 C
to heat-inactivate the remaining enzyme.
b) PEG-DA: 0.5g liquid PEG-DA is mixed with 15µl of DMPA solution (0.1g
DMPA in 1ml ethanol) and vortexed. PBS is added up to 5g to obtain a final
concentration of 10%.
c) Agarose: 2% agarose in PBS is injected into the chip and cooled down to 4 C
for 10min. The PDMS chip with the molded hydrogel is then removed from
the hydrogel master and dried at 110°C for 30min. After that, the agarose
molding is repeated. The dried agarose subsequently represents a mechanical
anchor between the PDMS and the second agarose mold.
A.2. Cell loading and culture protocol
• The PDMS/hydrogel chip is placed and aligned on the electrode chip within 5min
to avoid evaporation and shrinking of the hydrogel. The chip is then filled and
incubated with ethanol for at least 30min to disinfect the chip, and subsequently
rinsed with cell medium. 0.5cm long teflon tubes (1.06⇥1.68mm, Fisher Scientific)
are placed into the perfusion in- and outlets.
• 4% agarose (agarose type VII-A, low gelling temperature, Sigma-Aldrich) is sol-
ubilized in PBS at > 80°C and cooled down to 37°C and then mixed with cell
medium at 37°C to obtain 2% agarose in PBS/cell medium. (a dry bath was used
to maintain a constant temperature of 37°C to avoid gelation of the hydrogel)
• Cells in the flask are trypsinzed and counted. The desired number of cells (in
cell medium) is mixed with the agarose solution at 1 : 4 to obtain a final agarose
concentration of 0.5%.
• The cell/agarose mixture is injected into the cell channel and an oil droplet (mineral
oil, Sigma-Aldrich) is then placed on top of the in- and outlet to avoid evaporation
and contamination.
• The chip is placed into the incubator and connected to a syringe pump (using long
teflon tubes which reach out of the incubator,1.06⇥1.68mm, Fisher Scientific) (the
perfusion channels on the same side were fluidically short-circuited resulting in two
syringes por each chip) as well as to the signal cables.
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B. Cell constant of distant and large
electrodes within a micro-channel
The complete derivation involves the theory of conformal mapping and integral calcula-
tion. Here, only the main steps are described. More details can be found in (Braschler,
2009, p.200). Applying the general conformal mapping theory to planar metal electrode
within a long access channel, it can be shown that the two-dimensional cell constant is
given by
2D =
2K
 
k2
 
K
 
1  k22
  (B.1)
where K(x) is the complete elliptic integral of the first kind
K (x) =
ˆ
dtp
(1  t2) (1  x2t2) (B.2)
and the parameter k is given by
k ⇡ 1  2
s
2
cosh
 
⇡ rdh
  (B.3)
where h is the channel height and rd is the channel length. Since rd   h, and hence
k2 ! 1, one obtains the following approximations
k22 ⇡ 1  4
s
2
cosh
 
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  (B.4)
and
2D =
4
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By inserting B.3 in B.5 and some simplifications, one obtains
2D ⇡ 2ln (2)
⇡
+
rd
h
(B.6)
The corresponding three-dimensional cell constant  is given by
 =
1
wch
✓
2ln (2)
⇡
+
rd
h
◆
(B.7)
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where wch is the width of the channel. The first term accounts for the curving of the
field lines down towards the metal electrode and the second term corresponds to the
resistance due to a channel length equal to rd.
For two electrodes that are spaced by a distance sel from each other, one consequently
obtains
 =
1
wch
✓
4ln (2)
⇡
+
sel
h
◆
(B.8)
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C. Resistance range extension with
interdigitated electrodes
The measured resistance of sub-sensor 3 is decreased by using interdigitated electrodes.
This leads to an increased total resistance range D (R1 is constant). Simultaneously,
P decreases because of a decreased fc,5. This means that the resistance range can be
increased by the expense of a decreased resistance plateau length P . This might be
acceptable to the extent where the PRFs and their corresponding Rmay still be identified.
Both, D and P are a function of the number of interdigitated electrode fingers n (Olthuis
et al., 1995).
It is now possible to calculate the plateau length for a desired resistance range and
thus a given n. For this P calculates as follows
P = log
✓
f3
f2
◆
· log
✓
f5
f4
◆
= P1 · P2 (C.1)
where P1 = P2 and thus f3f2 =
f5
f4
for a maximized M . We summarize the ratio of the
frequencies as m
m =
f3
f2
=
f5
f4
(C.2)
Consequently, for a given n, m can be calculated as follows
m = 10
p
Pn (C.3)
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Figure C.1.: The resistance range and the P -specific ratio m are plotted as a function of the number of
interdigitated electrode fingers.
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The resistance range and the frequency ratio m were plotted as a function of n in
figure C.1. In conclusion, it is possible to extend the total resistance range and thus the
resistance ranges of each sub-sensor by increasing n. This is accompanied by a decreased
resistance plateau ratio m which makes the identification of the PRFs more diﬃcult.
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D. Capacitive bridge
The value of the low frequency capacitance can be modified by implementing a “bridge ca-
pacitor”. An additional microfluidic channel is used to create a series electrode-electrolyte
capacitor. This one adds up to the double layer capacitor of channel 2 and consequently
changes the total capacitor value of sub-sensor 2. The resistance in the bridge channel
may be neglected if this one contains a highly concentrated ionic solution. Thus, an
identical electrode width for sensor 1 and 2 can be used.
Rsol 1Cdl
Rsol 2Cdl
Cbridge
Channel 1
Channel 2
Bridge 
channel
(a)
Cdl
Cdl Cdl
Cdl
Rsol 2
Rsol 1
Cbridge Cbridge
Cdl 1
Cdl 2 Cdl 2
Cdl 1
Rsol 2
Rsol 1
=
(b)
Figure D.1.: Capacitive bridge. a) Scheme of a potential chip design with a capacitive bridge. b) Equiv-
alent electrical circuit of a). (Cdl = CI)
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E. Microfluidic-based neuronal cell
cultures for Alzheimer studies
E.1. Alzheimer’s disease - increased mortality rates and still
incurable
Alzheimer’s disease (AD) is the most common cause of dementia and develops when
nerve cells no longer function normally. This process results in memory loss and aﬀects
the individual’s thinking and behavior. Basic human functions such as walking and
swallowing become diﬃcult to carry out. AD is a fatal disease (Alzheimer’s Association,
2012).
More than 35 million people worldwide are aﬀected by AD and this number is expected
to double every 20 years. Worldwide costs of dementia represent over US$600 billion
only in 2010 (Wimo and Prince, 2010). Although death rates decreased significantly
for 7 of the 15 leading causes of death in the US Murphy et al. (2010), those from
AD experienced a rise of 66% between 2000 and 2008 (Alzheimer’s Association, 2012).
Despite much eﬀort on the part of academic research and industry the causes of AD
are not yet known and no treatment is currently available to slow or stop synaptic and
neuronal decline in Alzheimer’s disease4. The need for a substantial change with regard
to new testing strategies and tools seems to be indispensable. In fact, studies on living
animals are diﬃcult to carry out due to a high number of uncontrollable parameters
and the diﬃculty of in situ observation. Conventional cell culture, on the other hand, is
limited by the inability to precisely control the environment of cells. A comprehensive
study of AD requires the highly polarized neurons to be arranged in a complex but
well-defined way, a condition that conventional cell culture is not able to fulfill.
To overcome limitations of conventional cell culture assays, microfluidic platforms have
been developed for neuroscience applications. Microfluidic systems are capable of regu-
lating fluid flow precisely owing to a laminar flow pattern, structuring cells since many
biological species are on the same length scale and manipulating the extracellular envi-
ronment. This chapter1 reviews recent developments in microfluidic culture platforms for
structured neuronal cell culture and AD research. The first part describes the importance
of neuronal networks in AD and how micro-systems may be a key in understanding AD
progression in the brain. The second part reviews microfluidic-based in vitro Alzheimer
models and points out what specific questions may be addressed in future.
1 This chapter will be suject to a review in the book “Microfluidics for medical applications” from the
Royal Society of Chemistry
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Figure E.1.: Major hallmarks in AD. a) Extracellular deposits of A  plaques and intracellular aggregation
of pathological Tau to NFTs lead to neuronal decline in AD. b) A  plaque production is
obtained through cleavage of the precursor protein APP by a  -secretase and the subsequent
cleavage of the left membrane-bound fragment by a  -secretase. A  is released into the
extracellular space. c) Balance of Tau-microtubule phosphorylation and dephosphorylation
is disturbed in AD leading to hyperphosphorylated Tau proteins that do not bind to the
microtubules and that aggregate to NFTs in the cytoplasm (Reprinted by permission from
Wiley: Biotechnology and Bioengineering (Kunze et al., 2011b), copyright (2011))
E.2. Unknowns of Alzheimer’s disease
E.2.1. Molecular key players of AD
AD is characterized by mainly two abnormalities; extracellular deposits of beta-amyloid
(Ab) (Hardy and Selkoe, 2002) and intracellular aggregates neurofibrillary tangles (NFTs)
(Geschwind, 2003) (figure E.1 a). Ab is a fragment of the amyloid precursor protein
(APP), a protein that has been shown to be implicated in synapse formation and trans-
mission (Priller et al., 2006). Arising from the proteolytique cleavage of APP (figure
E.1b), Ab is broken down and eliminated in healthy brains. In Alzheimer diseased
brains, however, this process is disrupted and Ab aggregates to plaques outside the
cell. NFTs, on the other hand, are mainly comprised of the microtubule-binding Tau
protein. Its major function is to stabilize the microtubules and hence to promote struc-
tural support and nutrient transport within neurons. The Tau protein can dissociate
from the microtubules when being phosphorylated and re-associate when being dephos-
phorylated, a dynamic process that is mediated by enzymes called kinases (e.g. GSK)
and phosphatases (e.g. PP2A) (figure E.1c). Possessing a multitude of phosphorylation
sites, Tau can hence undergo conformational changes that are necessary to carry out its
microtubule-supportive function. In diseased brains, however, the process of phospho-
rylation and dephosphorylation is unbalanced and numerous phosphorylation sites have
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Figure E.2.: Temporo-spatial spreading of Tau-positive neurofibrillary lesions and A  plaques in the
process of Alzheimer’s disease. A -plaques (top) and NFTs (bottom) spread through AD
brains in specific patterns. Shading intensities are proportional to the clump density over
time. (Reprinted by permission from Wiley: Annals of Neurology (Jucker and Walker,
2011), copyright (2011))
been found to be hyperphosphorylated leading to the complete dissociation of Tau from
the microtubules (Bulinski and Gundersen, 2005). As a result, hyperphosphorylated Tau
aggregates to NFTs within the cell.
Although many studies have investigated the molecular mechanism of this disease, the
reason behind the disrupted Ab elimination and the increased Tau phosphorylation is still
unclear (Ittner and Götz, 2011). Moreover, the sequential order and the cause and eﬀect,
especially with regard to the interplay of Ab and Tau, remain unsolved (Geschwind,
2003).
E.2.2. From molecules to neuronal networks
AD is a progressive disease that spreads throughout the brain according to a predictable
pattern (figure E.2). It starts in the entorhinal cortex (EC), where the large projection
neurons, that link the cerebral cortex with the hippocampus, are aﬀected first Braak and
Braak (1991); Hyman et al. (1984); Hyman and Hoesen (1987); Gomez Isla and West
(1996). It then propagates across the limbic system and association cortices (de Calignon
et al., 2012). Despite good knowledge about the hierarchical accumulation pattern of
Ab and Tau in the brain, little is known about the mechanism of the initiation and
progression of these protein accumulations: why does it start in the EC and why is there
a specific spreading pattern (Soto, 2012)?
Recent findings have indicated that Tau aggregates can transfer to neighboring cells and
to synaptically connected neurons in distant parts of the brain in a prion-like manner
(de Calignon et al., 2012). In fact, a transgenic mouse model with overexpression of
human mutant Tau exclusively in layer II of the EC has been established. Several months
after lesions in the EC, the Tau pathology appeared in other brain regions with neurons
that exhibited no detectable transgene expression; first to neighboring cells and then
to neurons downstream in the synaptic circuit. These experiments proved the transfer
and progression of misfolded Tau proteins from neuron to neuron in a neuronal circuit-
based manner. Moreover, the migrating pathological Tau aggregates were shown to be
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endocytosed by healthy neurons (Clavaguera and Bolmont, 2009) where they act as seeds
to induce the misfolding of intracellular native Tau proteins and their conversion into
NFTs (Frost et al., 2009; Guo and Lee, 2011; Nonaka et al., 2010). In fact, this is a process
that was previously reported in other cases where the accumulation of misfolded protein
aggregates is mediated by the intercellular spreading of oligomeric seeds. Although the
experimental proof of aggregated Tau-spreading may explain the formation of NFTs in a
stepwise characteristic pattern Soto (2012), it still remains unclear why only some of the
interconnected neurons develop NFTs. There may be conditions that favor or prevent
pathological Tau proteins from being transferred and/or from acting as seeds.
In addition to the spreading of pathological Tau, the progression of Ab deposition
was also reported. Experiments where Ab oligomers were micro-injected into electro-
physiologically defined primary hippocampal rat neurons revealed their neuron-to-neuron
transfer (Nath et al., 2012). Moreover, a transgenic mice model with spatially restricted
overexpression of mutant APP in the EC, demonstrated that Ab-induced molecular and
functional impairments can cross synapses (Harris and Hochhauser, 1992).
All these studies have proven the characteristic spreading of NFTs and Ab deposits
in the brain and have consequently shown the importance of neuronal networks in the
progression of AD. Additional elucidation of the detailed mechanism behind the specific
spatiotemporal pattern of neuropathology in AD potentially may open new avenues to
develop long-awaited strategies to stop the progression of this dreadful disease (Nath
et al., 2012).
E.3. Why micro-systems may be a key in understanding the
propagation of AD
Although the latest important in vivo findings about the transfer of toxic species of
Tau and Ab from transfected brain parts to distinct regions have been a break-through
in neurosciences, researchers cannot rule out that a low expression of the transgene Tau
(below the level of detection) in other areas than the EC, may have occurred (Soto, 2012)
as observed previously (Santacruz et al., 2005). More importantly, detailed investigation
at the cellular level is limited: functional and live analysis such as signal recordings or
live cell imaging can hardly be performed in vivo; stereology and immunocytochemistry
are tedious to carry out; too many parameters that cannot be controlled tightly make
it diﬃcult to account for a specific phenomenon; and living organisms exhibit a great
variability. This section describes how microtechnology-based platforms may provide the
essential support for in vitro neuronal cell culture and its analysis that may fill the gap
between current findings and a thorough understanding of disease progression in AD.
E.3.1. Requirements for in vitro studies on AD progression
Experimental models such as animals (e.g. rats, mice) are used for brain studies ow-
ing to the preservation of anatomical structures. Diﬀerent neuronal populations are
connected with well-defined topologies and polarities. This directionality exists in devel-
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Figure E.3.: Requirements for in vitro studies on AD progression. a) Conventional Petri dish cell culture
is characterized by intermingled networks with random connections. b) Compartmentaliza-
tion of diﬀerent cellular sub-types that are interconnected allows local treatment of specific
sub-populations. c) Orientation of neuritic processes leads to well-defined topologies and
polarization. d) Three-dimensional, structured and oriented neuronal cultures resemble the
most in vivo brain tissues.
opmental mechanisms (connection of diﬀerent neuronal subtypes) (Stiles and Jernigan,
2010) as well as in degeneration of neuronal networks in mature brains (Nath et al.,
2012; Peyrin et al., 2011). Conventional cell cultures, on the other hand, are missing the
anatomical structure with its highly ordered connectivity of neurons and do not satisfy
the requirements of directionality and orientation that are necessary for the study of
neuropathology in AD. In fact, conventional cell cultures are characterized by random
connections and intermingled networks that vary from one sample to another (Peyrin
et al., 2011) (figure E.3). Therefore, in order to study network phenomena and disease
progression, (1) diﬀerent populations of cells need to be separated (spatial compart-
mentalization) while allowing them to interconnect (connectivity) in (2) a polarized and
oriented way (directionality). Moreover, (3) to mimic the in vivo tissue structure closely,
those interconnected but distinct cell populations need to be dispersed in three dimen-
sions (3D cell culture). Advances in microfluidics and microfabrication have enabled such
micro-structuring with the creation of micro-chips as tools for in vivo-like anatomically
organized neuronal cell cultures on the one hand, and simultaneous cell culture analysis
(e.g. signal transmission analysis and on-chip protein analysis) on the other.
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Collagen coated surface
Collagen scratches
Teflon devider with silicon grease
Soma compartmentNeurite compartment
Figure E.4.: Schematic of Campenot chamber. Neurons are cultured in one compartment and neurites
can grow through the grease under the Teflon divider into the second chamber allowing the
separation of cell soma and neuronal processes. Hence, neurites and soma can be separately
exposed to molecules. Scratches on collagen-coated surface were made to hinder neurite
outgrowth between neurons within the same compartment
E.3.2. Establishing ordered neuronal cultures with microfluidics
E.3.2.1. Compartmentalization of neuronal cell populations
While continuously striving for a better understanding of AD and simultaneously be-
ing limited in the direct observation of living organisms, researchers have made great
advances in the last 40 years in reconstructing typical brain patterns in vitro. Microtech-
nology has played the essential role in establishing brain structures that may enable basic
neuroscience research as well as pharmaceutical industry to find strategies to counteract
AD with its dreadful consequences on people’s life.
One of the first steps from random neuronal cell culture towards guided neurite out-
growth was achieved by Robert B. Campenot in 1977 (Campenot, 1977). He was able
to compartmentalize somas and their axons by having the processes grow from a soma-
containing chamber to a side chamber that contained or not nerve growth factor (NGF).
Both chambers were separated by a Teflon divider that adhered on a collagen coated
Petri dish by sealing with silicone grease (figure E.4). The seals could be penetrated by
growing neurites, but not by the cell soma. He found out that neurites did not only pen-
etrate into the grease, but also grew the full distance under the grease and emerged into
the side chamber if a high concentration of NGF was present, but they never appeared
in the side chamber if no NGF was added. In this way, he was able to control the local
environment of the distal part of the neurites and the one of the somas separately. Inter-
estingly, the method that was used to separate cell soma and distal part of neurites was
relatively simple. It was based upon the fact that neurites squeezed themselves between
the Teflon and the Petri dish surface through the grease (a gap in the micrometer range).
Here, the micro-scale range was exploited to create a mechanical constraint for neuronal
processes without the use of any of today’s standard microfabrication techniques such
as photo-lithography. Nonetheless, these devices were diﬃcult to assemble and hard to
image as well as prone to leakage.
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Figure E.5.: Microfluidic-based cell culture platform according to Taylor et al. a) Perspective view of the
PDMS culture chamber containing the relief pattern of the soma and axon compartment.
Both are connected through microgrooves (10µm wide and 3µm high); b) Side view of the
PDMS device. A volume diﬀerence between the reservoirs on each site allows chemical
environments to be isolated for 20h due to the high resistance of the microgrooves c) Axons
grew from one chamber to the other one (red: Tau). Dendrites on the other hand did
not pass the microgrooves (green: MAP2). (Reprinted with permission from Macmillan
Publishers Ltd: Nature methods (Taylor et al., 2005), copyright (2005))
A refinement of this mechanical-constraint-strategy has been achieved by several fol-
lowing studies (Park et al., 2009; Taylor et al., 2005). As an example, Taylor et al.
fabricated a microfluidic culture platform consisting of a PDMS mold placed against a
coverslip (Figure 5). The design of the device incorporates two culture chambers that
are separated by a physical barrier with embedded microgrooves. Those microgrooves
are 10µm wide and 3µm high and allowed the neuritic processes, but not the cell bod-
ies, to extent from one chamber to the other. Compared to its predecessor, the major
advantages of this device such as reliability, reproducibility and precision are due to its
standardized fabrication process (photo-lithography, soft-lithography, replica molding).
Furthermore, it was shown that the axonal growth can be polarized without the use
of targeting neurotrophins and that the biochemical analysis of pure axonal fractions is
facilitated.
Overall, mechanical constraints are a reliable technique to separate cell bodies from
each other while allowing neurite connectivity by the means of micro-channels for ex-
ample. Their fabrication is relatively simple and consistent, especially with standard
microfabrication techniques. Also, the cell loading and culturing protocols are straight
forward which is why such micro-fabricated microfluidic devices have found repeatedly
use in neuroscientific studies (Taylor et al., 2005; Park et al., 2009; Yang et al., 2009;
Hayashi et al., 2004; Bertrand et al., 2005; Ishibashi et al., 2006; Campenot, 1982).
A diﬀerent technique towards reestablishing an ordered arrangement of neuronal cells
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in vitro can be achieved through surface patterning. Commonly used procedures include
a combination of surface chemistry and photo-lithographic techniques (Kleinfeld, 1988) or
soft-lithography. Small organic molecules bind to a surface such as glass or silicon, whose
presence promotes (laminin, fibronectin) or inhibits (alkane (Kleinfeld, 1988), untreated
silicon (Grattarola et al., 1988) or glass (Schacher and Proshansky, 1983), albumin)
neuronal cell attachment. Molecules that promote cell attachment generally have amino
acid fragments that interact with specific cell membrane receptors such as integrins.
Receptor binding to these sequences can initiate second messenger systems within the cell
that promote growth, gene expression and diﬀerentiation (Ranieri et al., 1994). Adhesion
promoters or inhibitors can be immobilized through simple adsorption. However, the
coatings are easily washed oﬀ. To avoid this problem, covalent binding may be employed
and can be virtually achieved for any molecule. For example, molecules that cannot be
formed into silane derivative, such as the glycoproteins fibronectin (Kleinman et al., 1981)
or laminin (Timpl et al., 1979), can be patterned by first binding an amine derivative
in the desired pattern and then binding the glycoprotein to the amine with chemical
cross-linking reagents (Kleinfeld, 1988). Surface patterning with photo-lithography, for
example, is attained with a photoresist (e.g. lift-oﬀ resist) that protects specific regions
from being surface treated. The desired patterning structure on the surface is obtained
after the removal of the photoresist (figure E.6a).
Surface patterning through soft-lithography, on the other hand, is a set of techniques
that uses elastomeric stamps made of PDMS with patterned relief features in order to
immobilize the adhesion molecules onto a surface (figure E.6b) (Kaji et al., 2011; Heller
et al., 2005; Franks et al., 2007). Early studies demonstrated the applicability of surface
patterning techniques to the patterning of neuronal cell cultures (Heller et al., 2005;
Ivanova and Margolis, 1973; Letourneau, 1975) but both the viability and the pattern of
outgrowth were not maintained long enough for developing neurons that attain electrical
excitability. Later studies showed extended maintenance of viability as well as higher
resolution patterns with cells being maintained on lines as fine as 5µm (Kleinfeld, 1988)
(see figure E.6c). More recent studies generated more precise micro- and even nanoscale
patterns (Kane et al., 1999). Overall, surface patterning allows the separation of cell
bodies and cell migration outside the surface patterning area is hindered (which results
in a preserved ordered culture). On the other hand, localized chemical treatments of cell
bodies and axons separately, for example, is not possible and would require additional
mechanical constraints (e.g. for the formation of chemical gradients).
A more recent technique to create patterned neuronal cell cultures is by using hydrogels.
Samples of hydrogels are first premixed with diﬀerent cell populations and are then
polymerized in layers that are located in direct contact to each other. Hence cells from
diﬀerent layers can interact through the hydrogel by the diﬀusion of cellular factors, by
neurite outgrowth from one hydrogel layer to the other or by cell migration. Hydrogel
layers can be stacked on top of each other (Tan and Desai, 2004) or horizontally side-
by-side (Kunze et al., 2011a). As an example, Kunze et al. exploited the laminar flow
at microscale to pattern up to four agarose/alginate hydrogel layers (figure E.7a). The
device was comprised of four microchannels that were connected to a common main
channel. The laminar flow pattern of the hydrogel mixtures resulted in parallel hydrogel
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Photo-lithography Soft-lithographya) b) c)
Figure E.6.: Monolayer patterning through surface functionalization. a) Schematic of photolithography-
based patterning. Regions protected by the photoresist retain their initial surface when
being exposed to the functionalization molecules and subsequently stripped; b) Soft-
lithography-based patterning. An elastomeric stamp with patterned relief features is used
to print molecules on a surface. First, the stamp is dipped into a solution containing the
functionalization molecules and then it is brought into contact with the surface, thus leaving
molecules only on the contact area; c) Patterned growth of neurons on a patterned substrate
(Reprinted with permission from E. Ujhelyi).
layers flowing side-by-side in the main channel (figure E.7b left). After having thermally-
gelled the agarose-alginate hydrogels, their parallel pattern within the main channel was
maintained (figure E.7b right). The diﬀerent hydrogel layers were premixed or not with
primary cortical neurons and cultured for up to three weeks. Within that time, cell
populations from diﬀerent layers connected through the outgrowth of neuritic processes
(figure E.7c). Furthermore, by pre-mixing specific hydrogel layers with B27 and the
subsequent establishment of a timely limited gradient allowed the enhancement of neurite
outgrowth into a specific direction.
Overall, hydrogel layers are a very elegant way of patterning cells in 3D (as will be
discussed more in detail in section E.3.2.3) and thus of mimicking more closely the native
state of neurons within the brain. For this, patterning hydrogels horizontally allows for
easier microscopic observation compared to vertically stacked hydrogel with very thick
samples. On the other hand, cell loading protocols are more complicated and delicate
since all hydrogel-cell mixtures need to be loaded at the same time while establishing
more or less identical flows in all microchannels; this technique is still suﬀering from
reproducibility. An automated processing with a cell loader-device that is mostly free
of human interaction would potentially enable a very reproducible fabrication of such
three-dimensional patterned neuronal cell cultures.
E.3.2.2. Directionality of neurite outgrowth
It has been shown that relatively simple microfabrication tools can be used to spatially
isolate the soma of a neuron from its axon. It has furthermore been shown that diﬀerent
cell populations can be separated from each other while maintaining their connectivity.
In the brain, however, diﬀerent neuronal populations are connected with well-defined
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a)
b)
c)
Figure E.7.: Patterned 3D neuronal cell culture in hydrogels. a) Illustration of the layered structure of
the 3D neural cell culture. The device is composed of four inlet channels that lead into a
main channel with one outlet channel. The two inserts show the final microfluidic device
fabricated using PDMS and three devices placed in a Petri dish for incubation during cell
culture. b) Fluorescence images taken in the main channel area present the four laminar
hydrogel microstructure before (left) and after (right) gelling of the agarose components by
cooling down under 26°C. c) DIC images of the main channel at 0 (left) and 5 DIV (right).
Single neurites were traced with NeuronJ. (Reprinted from Kunze et al. (2011a), Copyright
(2010), with permission from Elsevier)
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Figure E.8.: Orienting neurite outgrowth with physical constraints. a) 3D view of the microfluidic device
used by Peyrin et al. (2011); b) 3D view of the funnel-shaped micro-channels as observed by
white-light optical profiling; c) Immunofluorescent images of microfluidic cultures (green:
a-tubulin, blue: Hoechst) in which cortical neurons were seeded either on the c) wide (15
µm) or the d) narrow (3 µm) side (bar=50mm). e) Neurite outgrowth to opposite chamber
is much higher when seeded on the wide side, bar=50µm (Reproduced from Peyrin et al.
(2011)).
polarities (Peyrin et al., 2011), a crucial condition of neuronal networks to guarantee
the proper information flow. Hence, the in vitro study of polarized neurite outgrowth
is essential for the investigation of cellular mechanisms that influence axonal plasticity
and response to injury as well as etiology of neurodegenerative diseases. While the study
of these phenomena with traditional technologies on a conventional scale is very diﬃ-
cult, axon growth guidance based on microfluidics creates new opportunities for research
(Wang et al., 2009).
Peyrin et al. established a microfluidic platform comprising independent cell culture
chambers that are connected by an array of asymmetrical micro-channels, so-called “ax-
onal diodes” (figure E.8a and b). The asymmetrical geometry acts as a directional se-
lective filter for axons due to two eﬀects. First, asymmetry imposes directionality by a
probabilistic eﬀect easing the entrance of axons on the wide side of the diode compared
to the narrow side. Second, axons from neurons, seeded in the receiving chamber, once
encountering the diode wall instead of the micro- channels entrance tend to grow per-
pendicularly to the diode along the chamber wall, without entering to a great extent
the narrow side of the diodes; an eﬀect that was correlated to the axonal stiﬀness that
prevents frequent axonal turning. Accordingly, a cortico-striatal oriented network was
established, cultured for 3 weeks and proven active through structural (immunostaining
of synaptic contacts) and functional analysis (KCl depolarization and electrical record-
ing). The unidirectional axon connectivity was shown to have a very high selectivity of
97% (figure E.8e) (Peyrin et al., 2011).
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a) b)
Figure E.9.: Orienting neurite outgrowth using guidance molecules; a) Illustration of experimental setup.
Empty polydimethylsiloxane (PDMS) reservoirs are selectively filled with medium (red:
enriched NGF/B27 medium, green: pure medium). A 2h perfusion flow due to liquid height
diﬀerences in the reservoirs establishes a linear gradient of NGF/B27. The long perfusion
channels maintain the gradient in the main channel once the perfusion flow stops. Every
other day, refilling was repeated. b) Schematic view of synergistic gradient of B27 and NGF
and DIC image of neuronal culture with traced neurites at 9DIV, bar = 0.1 mm (Reproduced
from Kunze et al. (2011d))
Another very frequently used method for directing neurite outgrowth is by using axon
guidance molecules (growth factors, neurotransmitters, netrins, adhesion molecules) or
repellents (semaphorins, slits). For this, neuronal cells need to be exposed to biomolecule
gradients that are controllable and that mimic those that are present in vivo (Keenan
and Folch, 2008). Biomolecule gradients can be established either by substrate-bound
molecules (Jeon et al., 2002) or by a constant supply and removal of molecules at precise
locations Kunze et al. (2011d). Kunze et al. (2011d) reported the use of a microfluidic
device to expose a patterned three-dimensional culture of primary neurons to gradients
of B27 and nerve growth factor (NGF). The hydrogel-based patterned 3D culture region
was separated from two lateral perfusion channels (that acted as a ‘source’ and ‘sink’) by
small micro-channels that delivered the biomolecules on one side of the hydrogel culture
and removed them on the other side (figure E.9a). By this means, it was shown that
cortical neurons responded only to synergistic NGF-B27 gradients and that the synaptic
density increased proportionally to these gradients (figure E.9b).
Unlike physical constraints as presented by Peyrin et al., directionality obtained through
biomolecular gradients enables the creation of directed neurite networks through three-
dimensional neuronal cultures. On the other hand, neurite guidance by “axonal diodes”
attracts specific attention owing to its ease of fabrication and use as well as to its high
eﬃciency. No complicated setup with a pumping system for long term maintenance
of biomolecule gradients is necessary. Moreover, directional eﬃciency does not depend
on the neuronal type that is used since diﬀerent neuronal cell types may have diﬀerent
responses to various biomolecules (receptor-dependence). Also, the selectivity of physi-
cal constraints seems to be higher than the one obtained by the means of biomolecular
114
E.3. Why micro-systems may be a key in understanding the propagation of AD
cues, apart from the fact that an additional culturing dimension renders high selectivity-
eﬃciency more diﬃcult to achieve. Finally, in view of the study of higher order networks,
e.g. to study inter-neuronal transport of pathological Tau species from one neuron to
another that is located multiple neuronal connections further, the axonal diode-technique
seems being a highly promising approach.
E.3.2.3. Three-dimensional neuronal culture
In vivo tissues have a very complex but well-organized 3D structure. Culturing cells
in 3D provides another dimension for external mechanical inputs and for cell adhesion,
which dramatically aﬀects integrin ligation, cell contraction and associated intracellular
signaling (Griﬃth and Swartz, 2006; Knight et al., 2000; Roskelley, 1994). Moreover, the
diﬀusion of soluble factors changes dramatically compared to 2D cultures. Hence, cultur-
ing cells in a 3D environment seems highly promising since the eﬀect of mechanical and
chemical stimuli on 3D neuronal cultures as well as its propagation from one population
to the other can be studied.
Establishing patterned 3D cell cultures is a challenging task. It requires a set of bioma-
terials, scaﬀold and devices that can support the formation and maintenance of 3D tissue
structures and that can be used for specific applications. As already described in section
E.3.2.1, Kunze et al. showed that an agarose-alginate mixture can be gelled thermally
(figure E.7). It is therefore an excellent candidate for forming horizontal multi-layered
scaﬀolds for micropatterning embedded cells. A further technique, named layer-by-layer
deposition, enabled the creation of vertically stacked cell-matrix assemblies (Tan and
Desai, 2004). This method involved the stacking of cell-matrix assemblies (collagen, ma-
trigel). The first layer was immobilized on a pre-treated surface using a PDMS stamp; it
then contracted and allowed the subsequent overlaying with another cell-matrix assem-
bly. However, vertically stacked cell-hydrogel mixtures make optical observation diﬃcult.
Using confocal microscopy, for example, the thickness of the samples may exceed the
working distance of the microscope. In addition, images of a specific focal plan observed
under standard transmission microscope comprise a wide range of planes that are out of
focus, resulting in lower image quality.
A hydrogel-free method to establish 3D neuronal networks was reported by Pautot
et al. (2008). This technique involves the culture on silica beads that provide a growth
surface for neuronal cells (figure E.10). The use of beads allows moving them without
disrupting the neuronal adhesion. They can be assembled to form 3D layered arrays
containing distinct subsets of neurons in diﬀerent layers with constrained connectivity
between neurons on diﬀerent beads. This system could prove very useful for future appli-
cations, especially because cell manipulation and culturing is simpler than cell-hydrogel
mixture-based protocols. Their future integration into a microfluidic system where dif-
ferent beads (with diﬀerent neuronal cells) can be patterned and used to build up an
oriented neuronal network thanks to biomolecular gradients or physical constraints may
allow further refining this technique and obtaining in vivo-like orientations of neuronal
networks.
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a) b)
Figure E.10.: Neuronal culture on silica beads. (a) Schematic of the silica beads culture: a 2D culture of
neurons was overlayed by cAMP (attractant signaling molecule) coated 45mm beads and a
third layer of beads containing GFP-expressing neurons. B) A 3D reconstruction of axons
(blue) from neurons on the coverslip (layer 1) growing up into the intermediate layer of
cAMP beads (layer 2) and encountering there descending dendrites from bead layer (layer
3) of GFP-expressing cells (green). (Reprinted by permission from Macmillan Publishers
Ltd: Nature methods (Pautot et al., 2008), copyright (2008))
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Table E.1.: Categorical chart of prerequisites for studying disease progression in microfluidic devices and
how recent studies fit into these categories (only cell soma and axons were compartmentalized)
E.4. Micro-devices-based in vitro Alzheimer models
Microtechnology-based devices are the key to structuring neuronal cells in vitro such
that in vivo-like neuronal networks can be reconstructed; i.e. in terms of connected
but distinct cell layers, directionality and three-dimensional structures. Although all
these prerequisites for establishing an environment similar to the human brain have been
achieved individually, no integrated device or technology that is fulfilling all conditions
was reported yet (Table E.1). However, avenues for preliminary studies of AD with
simplified models are open already and should be pursued in order to obtain important
insights into how AD is progressing in the brain and how it can be stopped.
E.4.1. First microtechnology-based experimental models
A first microfluidic approach that allows for the study of axonal biology in AD includ-
ing transport within neurons was carried out by Poon et al. (2011). Transgenic mouse
neurons that overexpressed Ab (Tg2576) were cultured in a microfluidic device (similar
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to the one reported by Taylor et al. (2005)) where cell somas and axons were compart-
mentalized. Neuritic processes grew from the seeding chamber through >150µm long
microgrooves to another chamber that consequently allowed the selective application of
a neurotrophin (brain-derived neurotrophic factor (BDNF)) to the axonal terminals. In
healthy neurons, BDNF binds to its receptor tropomyosin-related kinase B (TrkB) at the
axon terminal; the signal is propagated along the axon to the cell body, where it regulates
gene expression and neuronal function. By locally applying BDNF to the axonal termi-
nals, it was shown that the TrkB processing was impaired in transgenic Ab neurons, but
not in non-transgenic mouse neurons (WT). Also, the BDNF vesicle retrograde trans-
port was slower in Tg2576 when compared to WT. Furthermore, it was reported that
WT neurons that were exposed to Ab oligomers prepared in vitro exhibited an impaired
retrograde transport of axonally applied BDNF and demonstrated a threefold reduc-
tion in the accumulation of somal BDNF. Altogether, these findings strongly supported
the hypothesis that the presence of either intracellular overexpressed Ab or extracellu-
lar oligomers of Ab impaired BDNF retrograde transport. More importantly, this study
essentially foretasted the potential that underlies studies of compartmentalized neuronal
cells and their axons.
A further study on the impact of Ab was carried out by Kim et al. (2012) where it was
shown that Ab induced rupture of axonal transport can be restored by manipulating the
level of a-tubulin acetylation. Axons were separated from their soma by using the Taylor
device. Accordingly, the authors were able to examine the mitochondrial movement
velocity within axons thanks to their spatial isolation from cell somas in a precise manner.
This study demonstrates the utility of structured neuronal cultures for the investigation
of transport kinetics within axons after local treatments of cell somas and can therefore
provide essential clues for the discovery of potential drug targets.
Kunze and Meissner et al. (2011b, paper II on page 155) reported the culture of two
spatially distinct, but interconnected cell populations where one of them was set into
a Tau-pathological state. This model represents the first approach for studying disease
progression from one cell population to another in a microfluidic device. For this, a mi-
crofluidic chip with three compartments was used: two lateral channels where primary
cortical neurons were cultured and one main channel where the neuritic processes could
interconnect (figure E.11a). Neurites started to grow out after 2 DIV and neurite density
in the main channel saturated after 8 DIV (figure E.11b top). That followed, okadaic acid
(OA), a protein phosphatase 2A inhibitor, was perfused over one cell culture compart-
ment leading to a linear gradient in the main channel within one minute and a quasi-zero
concentration in the second cell compartment. The OA treatment of only one cell pop-
ulation resulted in Tau protein hyperphosphorylation of these cells and hence generated
an imbalance of the Tau phosphorylation states between the two connected cell popula-
tions (figure E.11b bottom). This controlled generation of two diﬀerent phosphorylation
states within one cell population was referred to as a “co-pathological state”. The chem-
ical gradient of okadaic acid induced a Tau phosphorylation gradient throughout the
whole cell culture. This metabolic gradient was visualized through immunostaining of
the Tau phosphorylation site Ser262. Okadaic acid-exposed cells displayed high intensity
Tau aggregates within the cell soma and neurites whereas non-exposed cells exhibited a
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a)
b)
Figure E.11.: Generation of a co-pathological neural cell culture. a) Concept of establishing a co-
patholical culture: Two cell populations are spatially separated while being interconnected.
Only one of them is treated with okadaic acid (OA), leading to a local hyperphosphoryla-
tion of Tau and thus a co-culture of “healthy” and “diseased” neurons; b) Top: DIC image
of neuronal culture with two lateral cell soma compartments and a central neurite intercon-
nection chamber. Bottom: Tau phosphorylation imbalance within the entire cell culture is
visualized (green: Tau Ser262 – Cy2, blue: DAPI) (Reprinted by permission from Wiley:
Biotechnology and Bioengineering Kunze and Meissner et al. (2011), copyright (2011))
much less intense and homogeneous distribution of Tau.
In conclusion, the established model included (1) gradient controlled Tau phosphory-
lation states and (2) connected diseased and healthy neuronal cell populations and thus
illustrated the feasibility of reconstructing typical disease patterns in vitro. In addition,
Kunze and Meissner et al. demonstrated the application of this concept to a 3D neuronal
cell culture (Kunze et al., 2011c). For this, neuronal cells were micropatterend as de-
scribed in section E.3.2.1 before being exposed to an okadaic acid gradient. Altogether,
this new strategy of artificially creating disease states of only precise parts of a neuronal
tissue may be an important step towards a thorough understanding of how pathological
states of Tau proteins propagate to some cells and not to others. No less important
is the question of what eﬀect potential drugs, that counteract the disease progression,
have on non-pathological healthy neurons (potential side eﬀects). This is an issue that
is especially important in terms of prevention treatment.
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E.4.2. Requirements of future microdevice-based studies
Ideally, for reliable in vitro studies, experiments should be carried out on tissues that
resemble entirely the one of the human brain, but this strategy is thwarted for three
reasons. (1) The high complexity of the human brain’s macro and micro structure makes
it impossible to be artificially reproduced. In addition, reported models that strive for
more sophistication are often diﬃcult to fabricate and to use (complicated protocols)
and they are lacking in reproducibility, an aspect that is especially important when the
application is for drug discovery. (2) Primary cell sources are very limited, even unavail-
able for human origin. Most of the in vitro studies for AD use primary animal cells (e.g.
from rats). These sources require costly and time consuming brain tissue extraction pro-
tocols and they are controversial due to species diﬀerences between animals and humans.
Immortal human cell lines (e.g. SHSY-5Y), on the other hand, are abundantly available,
but they have undergone genotypic and phenotypic changes and are thus metabolically
diﬀerent from the original primary cells. (3) The observation of disease related phe-
nomena within the tissue is a big challenge in complex tissue samples (especially 3D
cell cultures). In fact, visual characterization with fluorescence labeling and confocal
microscopy for example is expensive and time consuming. Label-free methods such as
impedance spectroscopy, on the other hand, may not provide the deepness of information
that is necessary to understand molecular processes. In addition, neuronal signals upon
chemical stimulation are diﬃcult to record due to the larger distance between neuronal
cells and planar recording electrodes.
Finally, the points mentioned above imply that compromises specific to certain applica-
tions may be the key to elucidating disease related questions. Simple detection methods
can be used at the expense of decreased tissue sophistication or vice versa. For example,
reconstructing complex oriented networks with multiple cellular compartments combined
with signal recording electrodes (Linder et al., 2006) and simple microscopic character-
ization may be acceptable at the expense of three-dimensionality (figure E.12a). Also,
the study of disease propagation in a 3D context under confocal microscopy analysis
may be tolerable at the cost of decreased neurite orientation eﬃciency. Furthermore, cell
lines may be turned into more neuron-like cells in terms of morphology and biochemistry
of human mature neurons by treatment with diﬀerentiation promoting chemicals such
as retinoic acid (Jones-Villeneuve, 1983) and staurosporine (Shea and Beermann, 1991).
Moreover, upcoming suppliers of stem cell- or induced pluripotent stem cell-derived neu-
rons that are reliable and low-priced may represent a further alternative to primary cells.
The possibility to analyze the biological specimen is a fundamental condition for study-
ing disease propagation in microsystems. Representing the ideal case, in situ observation
of specific phenomena within the neuronal network may not always be possible depend-
ing on the technique that is used. Although fluorescence microscopy and electrical signal
recording techniques can be carried out exactly at their experimental location, other
methods for protein or RNA quantification require the cells to be isolated from the mi-
crosystem. Western blot analysis, for example, may be used to address if pathological Tau
or Ab proteins are spread to downstream synaptically connected neurons. For this, cells
from specific compartments or locations need to be removed selectively and eﬃciently.
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Network functionality testa) b) Gentle molecule delivery
Figure E.12.: Example requirements for future microfluidic-based neuroscience applications. a) Function-
ality of an oriented neuronal network can be probed as a function of disease progression;
b) Molecules can be delivered to the cells in a gentle way, either through a porous hydrogel
wall or through small high-resistance microchannels.
Following that, protein lysates are separated on a polyacrylamide gel and visualized on a
nitrocellulose membrane with protein-specific antibodies. Due to a decreased number of
cells in microfluidic channels in general and thus less total protein amount, it is necessary
(1) to extract a maximum number of cells from the microsystem and (2) to guarantee
a highly concentrated sample (thus avoiding dilution) in order to obtain a strong signal
(coloration).
Moreover, local treatment of specific parts of the neuronal network requires the supply
of molecules to each cell sub-population separately. The molecule delivery process needs
to be carried out such that the treated cells are not disturbed and do not respond to
unwanted stress (flow stress, vibration). For this, special attention is to be paid during
pipetting. Alternatively, a molecule injection chamber may be spatially separated from
the cell compartment by either high resistance microgrooves or by a permeable hydrogel
wall, both allowing the molecule penetration while hindering fluid flow (figure E.12b).
Altogether, complexity and sophistication of artificial neuronal tissues most often
stands in contrast to the ease with which the sample is examined and also exposed
to stimuli (e.g. molecule delivery). Therefore a compromise for each application specific
to a biological question needs to be found. Similarly, metabolically relevant cell models
are rare and costly (primary cells, stem cell-derived neuronal cells), while easily available
cells lines may be physiologically diﬀerent than their original cells. Again, the tolerable
type of cells used in an experiment strongly depends on the biological question.
E.5. Questions that may be addressed by micro-controlled
cultures
Microsystems have shown to be an important tool for studying cell interactions because
they allow both, an in vivo-like reconstitution of tissue structures and a more precise func-
tional analysis of neuronal networks. The high potential that underlies microtechnology
implies its indispensable use in future neuroscience research. Therefore an interdisci-
plinary exchange between neuroscientists and microtechnologists seems inevitable.
In fact, local treatment of specific sub-populations of cells within a larger neuronal
network requires an accurate control of the cells microenvironment that is reliant on
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microfluidics. In addition, in situ and live observation of the sample under investigation
necessitates experiments to be carried out on artificial tissues that are reconstituted on
thin glass slides. Also, the analysis of electrical functioning of the entire neuronal network
depends on the use of signal recording electrodes that share the same size as neuronal
cells (i.e. in the micrometer range). Overall, microfabrication techniques can help to
elucidate a large number of still open questions:
What factors and mechanisms are responsible for the formation of the first misfolded
Tau seeds? This may be due to spontaneous triggers (mutations, transcriptional or
translational errors, tissue injury) or exogenous triggers (exposure to preformed aggre-
gates). Misfolded aggregates of an additional protein may promote Tau aggregation
(cross-seeding) (Morales et al., 2009). To find an answer to this question, tests may
involve the examination of Tau aggregation upon cell exposure to diﬀerent protein ag-
gregates in order to find out what conditions make healthy cells turn into pathological
ones?
How do diﬀerent stages of Tau aggregation (kinetics, extent) influence the communica-
tion between neuronal cells? Following studies may involve the examination of patholog-
ical protein transfer to neighboring cells as well as its mechanisms and kinetics. Further
questions include how protein aggregates are transferred from one cell to another (secre-
tion, damage of host cell – cell injury) (Guo and Lee, 2011; Nonaka et al., 2010) and what
are the mechanisms that lead to the release of those pathological proteins (freely emerged
Tau, sequestered within exosomes)? Which species of Tau is specifically responsible for
the propagation of NFTs? Also, how are synaptic destruction and neurodegeneration
related in time (dying back terminal degeneration, release of Tau is toxic)? Moreover,
only some of the interconnected neurons develop NFTs; what conditions prevent the Tau
proteins from being transferred? This issue can be investigated by using microsystems
where pathologic protein aggregation may be achieved by locally applying exogenous
factors or by compartmentalized co-culture of a variety of transgenic diseased cells with
healthy cells.
The answers to these questions are of enormous therapeutic interest. Eﬀective drug
targets may be developed to counteract not only the symptoms, but the fatal conse-
quences as close as possible at the origin of the pathology. In addition, knowledge about
the reason behind individual-dependent progression rates may give rise to personalized
treatments (type of medication, doses). Altogether, there is a gap of understanding that
may be filled by the means of microtechnology, a tool that has hardly been exploited in
AD research with regard to the various studies that can and have to be carried out in
order to make head against AD.
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We present a novel perfusion-based microfluidic platform for label-free drug toxicity screening which
can single out non-lethal morphological changes from cellular death using electrical impedance
spectroscopy. Minor cellular changes such as cell–cell contacts and major cell injury were identified via
impedance phase angle analysis and follow-up of impedance magnitude at different frequencies.
Having exposed HepG2/C3A cells to acetaminophen (AP), we showed that continuous drug perfusion
caused a time and concentration-dependent impedance decrease. Moreover, perfusion of repeated
doses revealed altered dielectric properties of the cell culture after recovery from AP exposure. This
study highlights the possibility to sense cellular changes long before cellular death takes place, pointing
out the remarkable sensitivity advantage of this technique over standard endpoint viability tests and its
interest for toxicology.
1 Introduction
During the last decade, liver toxicity has been one of the most
frequent reasons for pharmacovigilance safety reports and drug
withdrawal from the market.1–3 Around one million animals are
used every year in Europe in toxicology tests causing ethical
problems as well as enormous costs.4 Moreover, in a large
number of cases, animal studies cannot be used to perform
human liver toxicity testing because of species differences5 indi-
cating that preclinical evaluation of new drugs is of high
importance.1 Issues related to the animal use in the safety eval-
uation of pharmaceuticals and chemicals have directed the
researchers to investigate alternative testing methods.
Miniaturized bioanalytical tools fulfill many conditions
required by modern diagnostics such as low consumption of
reagents and analytes, reduced transport time, simultaneous and
fast monitoring of multiple signals.6 In addition, they allow very
precise control of fluid flows creating new methods for tissue
engineering.7 The culture of hepatocytes in microsystems has
been described previously. Microsystems have shown to offer
more suitable environments than traditional cell culture flasks
owing to the optimized perfusion flow,8 shear stress protec-
tion,9,10 3D culture11–13 and co-culture of parenchymal and non-
parenchymal cells.14 Nonetheless, most functional and morpho-
logical characterization of on chip hepatocyte cell cultures have
been evaluated by biochemical analysis of the perfused cell-
culture medium (albumin and ammonia production, glucose and
glutamine consumption, CYP450 enzyme activity assays9,10,14–16).
This results in substantial time costs as well as human and
material resources evoking the demand for alternative,
economical and automatized screening methods.
Cell-based impedance spectroscopy is a label-free and non-
destructive method to measure dielectric properties of biological
samples. Electric signals are convenient parameters for recording
and processing compared to other techniques such as optical
detection, e.g. no light source and detectors are required.
Impedance screening has previously been employed to measure
a wide range of cell culture dependent parameters such as cell
growth and cell adhesion,17–19 epithelial layer thickness,20 fibro-
blast motion,21 muscle cell contractility,22 stem cell migration,23
transient receptor channel activity24 and cell viability.25 More-
over, it has become a convenient tool to estimate toxicity
kinetics.26,27 In all these studies, the temporal evolution of a given
cellular parameter was monitored by impedance measurements
performed at one frequency only where the cellular contribution
appeared maximal. Considering a single cell as a shell-covered
sphere,28,29 it is further necessary to distinguish cellular events
within frequency ranges. At low frequency (LF), cells act as
insulators due to the capacitive nature of the cell membrane. At
high frequency (HF), the cell membrane capacitor is short-
circuited and intracellular matter has an effect on the impedance.
Hence, frequency dependent impedance screening offers plethora
of information on intra- and extracellular properties.
Herein, we developed a microelectronics-based microfluidic
perfusion system for hepatocyte culture and real-time moni-
toring of drug toxicity-induced effects. To our knowledge, this is
the first study that investigates hepatocyte culture dependent
changes as a function of impedance changes over a wide
frequency range. We were able to distinguish between
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morphological changes and cell viability by studying the
impedance with phase angle analysis and introducing a novel low
frequency correction method based on bipolar (two-point)
measurements. In order to study drug induced cytotoxicity,
acetaminophen (AP), one of the widely used analgesic with
a well-known severe hepatotoxicity, was perfused continuously
and in repeated doses in our microfluidic system.
2 Materials and methods
2.1 Microfluidic chip design and fabrication
Amicrofluidic chip with filters inducing mechanical trapping and
perfusion for cell culture was designed (Fig. 1). Hepatocytes are
versatile cells having high energy demands. In vivo, hepatocytes
are located close or in direct contact to the fenestrated sinusoid
endothelium providing efficient nutrient and oxygen supply.30 In
our device, a low hepatocyte-perfusion distance was guaranteed
by introducing four relatively thin filters (100 ! 500 mm), sepa-
rated by 50 mm gaps. The filters were defined by arrays of PDMS
pillars (Ø 40 mm). The total channel height was 60 mm. Cell-filled
filters cause high flow resistance, resulting in the perfusion
medium to flow between the filters rather than through them. 5
mm spacing between neighboring micropillars allowed efficient
diffusion and exchange of nutrients and waste. In addition, cells
are not directly exposed to the main flow which potentially
hinders cell proliferation.
The device fabrication was performed as described previ-
ously.31 Briefly, a silicon wafer with oxidized surface (1 mm) was
structured by photolithography and deep reactive ion etching.
The obtained silicon master was then used to mold PDMS with
a molding tool. The PDMS block is further placed on top of
a glass slide with microfabricated electrodes.
2.2 Electrode design and fabrication
Electrodes are implemented in the device for impedance
measurements of the hepatic cell population. We designed
interdigitated electrodes (IDEs) so that the larger total electrode
surface area contributes to higher measurement sensitivity. IDEs
were adapted to the microfluidic four-filter configuration such
that the sensing area is limited to the region where cells are
trapped in filters (Fig. 2). Thus, each electrode trace carries four
arms (each 20 mm wide) with nine fingers (10 mm wide, spaced
15 mm apart). Electrode edges are rounded up to reduce fringing
effects and local current concentration.32 We used platinum as
electrode material since it is biocompatible33 and highly polar-
izable, thus minimizing faradaic currents and reducing the risk of
generation of cytotoxic compounds.34 A 20 nm thick titanium
adhesion layer and a 200 nm thick platinum layer were evapo-
rated in that order and structured on a 4 inch glass substrate
using standard photolithographic lift-off technique.
2.3 Microfluidic cell culture and experimental setup
HepG2/C3A cells were cultured in a 75 cm2 flask before loading
them in the microfluidic chip. Cells were incubated in Dulbecco’s
Modified Eagle’s Medium (DMEM) (Invitrogen, Switzerland),
containing 10% fetal calf serum (Invitrogen, Switzerland), at
37 "C and 5% CO2. Medium was changed every three days. Once
cell confluency was reached, cells were detached with 0.25%
trypsin/EDTA (Invitrogen, Switzerland) and used for micro-
fluidic cell culture.
All materials were autoclaved before use except poly(methyl
methacrylate) (PMMA) holders which were disinfected with 70%
ethanol. The glass chip with electrodes and the PDMS chip were
surface treated (50 W, 0.6 min, 0.6 bar) using oxygen plasma
(Femto SLS, Diener electronic, Germany). Glass chip, printed
circuit board, PDMS chip and PMMA holder were assembled
and #20 000 cells in medium were injected in the inlet reservoir
of the PDMS chip. Tubing was used to connect the PDMS chip
to the medium reservoir. The device was placed into the CO2-
Fig. 1 Microfluidic device and electrical interface. (Left) Photograph of the printed circuit board with polydimethylsiloxane (PDMS) chip. (Middle)
Design of the microfluidic channel. (Right) Schematic of cell culture area involving PDMS pillars for cell immobilization and flow stress protection. The
main flow is passing between the filters (large red arrows), and efficient nutrient supply and waste removal are provided by gentle diffusion (curved red
and blue arrows). Electrodes are implemented for impedance recording.
Fig. 2 Electrode design. A bipolar interdigitated electrode (IDE) pair
has been adapted to the microfluidic four-filter configuration to maximize
electrode surface coverage for high-sensitivity impedance measurement
of the cell culture area. Total of 36 electrode fingers are provided for each
electrode (w ¼ 10 mm, l ¼ 100 mm) separated by a gap of 15 mm.
This journal is ª The Royal Society of Chemistry 2011 Lab Chip, 2011, 11, 2352–2361 | 2353
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incubator on top of a microscope with a humidity-protected
objective (Precise Eye, Navitar, USA) connected to a C-mount
camera (uEye, IDS Imaging, Germany) and an optical light fiber
attached to a light source. The tube from the outlet reservoir of
the PDMS chip was then connected to a syringe pump (NE-300,
TSE-Systems, USA). Coaxial cables were used to connect the
device to an impedance analyzer (Agilent 4294A, Agilent tech-
nologies, USA). A small hole at the back of the incubator
connects the inside equipment with the humidity sensitive outside
equipment. The impedance analyzer was connected to a PC via
a GPIB controller (Universal Serial Bus (USB)-GPIB-HS,
National Instruments, USA).
Cell culture was performed in the microchip for 5 days in
order to make sure the cells proliferated and were healthy inside
the filters. The cell medium was perfused continuously during
the cell culture at the flow rate of 10 nl s%1. Acetaminophen
(Sigma-Aldrich, Switzerland) was dissolved in cell medium and
added to the perfusion medium at different concentrations (5,
10 and 20 mM). The treatment time was 48 h for continuous
and 72 h for repeated dose perfusion. Impedance spectra were
recorded every minute from 100 Hz to 4 MHz (10 mV ampli-
tude, 0 mV bias) using Matlab software.35 10 mV was chosen
since it results in an electric field of #5 V cm%1 (data not shown)
close to the electrode surface. This is three orders of magnitude
lower than the membrane permeation limit of 1–4 kV cm%1 (for
1 ms to a few ms)36 and can be considered as safe. Simulta-
neously, the objective inside the incubator allowed visual
follow-up of the microfluidic culture.
2.4 Fluorescence microscopy
For immunocytochemical staining, cultures were fixed with 4%
paraformaldehyde in phosphate buffered saline (PBS) (Invi-
trogen, Switzerland) for 20 min. After washing, cells were dried
and stored at %20 "C until use. After thawing, HepG2/C3A cells
were treated with 3% BSA/0.1% Triton X-100 (both Sigma-
Aldrich, Switzerland) for 45 min. For tight junction staining,
cells were first incubated with the primary antibody monoclonal
rabbit-anti-occludin (1 : 200, Invitrogen, Switzerland) for 90 min
and subsequently with the Cy-2 coupled secondary antibody
(1 : 150, Dianova GmbH, Germany) for 2 h. For actin staining,
cells were incubated with FITC coupled phalloidin (Sigma-
Aldrich, Switzerland) for 2 h. Subsequently; samples were incu-
bated with 0.1 mg ml%1 DAPI in PBS (Sigma-Aldrich, Switzer-
land) for 30 min. After repeated washing, cells were observed
with a confocal laser scanning microscope (LSM 700 inverted,
Zeiss, Germany). 3D Images were obtained from z-stack acqui-
sition mode by using the 3D image processor Imaris
(Switzerland).
For live/dead staining, cells were washed with PBS and incu-
bated with staining solution of fluorescein diacetate and propi-
dium iodide (1 : 1000, Sigma-Aldrich, Switzerland) for 10 min.
Samples were examined with a fluorescence microscope (LSM
700 inverted, Zeiss, Germany).
2.5 Cell viability assay
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) stock solution was prepared by dissolving 2.5 mg MTT
ml%1 in PBS without Ca Mg%1. Cells were seeded into a 96-well
plate and incubated for 2 days. Cell medium was removed and
cells were incubated in 200 ml AP solution (20 mM) at different
times (2 h, 6 h, 8 h, 24 h). After drug exposure, cytotoxicity was
determined by removing the drug solution and adding 200 ml of
fresh medium + 50 ml of MTT stock solution. Following 3 h
incubation at 37 "C, MTT-DMEM medium solution was
removed and 150 ml of DMSO was added. After shaking well for
30 min, absorbance was analyzed at 590 nm using a microplate
reader.
2.6 Electrode-cell population model
The electrical properties of a cell can be described with an
equivalent circuit made of a membrane capacitorCm with a series
intracellular resistance Rintra and a parallel extracellular resis-
tance Rextra.
37 However, a cell population comprises many cells
with different microenvironments implying a multitude of such
equivalent circuits with different time constants.38 Consequently,
Cm is replaced by a constant phase element (eqn (1)) which
attributes a resistive component to the observed cell population
relaxation.39
CPEcells ¼ 1
bcellsð juÞacells (1)
where bcells is the CPEcells-magnitude, acells the CPEcells-expo-
nent, u the circular frequency and j the imaginary number. The
electrode–electrolyte interface is represented by an electrode
constant phase element CPEel. It accounts for the non-ideal
capacitive behavior due to surface roughness40 and protein
adsorption41 on the metal surface. Cpar is the parasitic capaci-
tance between the electrodes. This model is presented in Fig. 3a
and is shown to be in accordance with a typical measured
impedance spectrum (Fig. 3b).
In this study we have utilized different analysis methods to
evaluate recorded impedance data. Cell growth in the microchip
was first plotted as a single frequency time scan at 100 kHz. We
specifically chose 100 kHz since the maximum difference was
obtained between the impedance profile in the presence of cell
population and that in the absence of cells, thus providing
highest sensitivity in the impedance measurements. In addition,
drug toxicity effects were examined at low frequency (LF) and
high frequency (HF). LF is defined as the frequency before
membrane relaxation‡ takes place (high impedance of CPEcells)
and gives information about extracellular properties. Low
frequency signals are generally affected by electrode–electrolyte
interface contribution in the bipolar measurement method,
resulting in higher impedance magnitudes as shown in Fig. 4.
Although the absolute electrode-interface impedance ZCPE_el
value is considered constant at a specific frequency, its relative
contribution to measured impedance magnitude |Z| varies with
‡ Membrane relaxation terms the shortening of the membrane capacitor
and thus its frequency dependency. With increasing frequency,
polarization of charges and permittivity will decrease because the
direction of the applied electric field varies more quickly than the
displacement and accumulation of charges. Cell membrane is not
a barrier to current anymore above membrane relaxation and
information regarding heterogeneous structure and dielectric properties
of cell interior can be obtained.
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changing Rextra (see Fig. S1 in the ESI† for detailed explanation).
This leads to imprecision and misinterpretation of measurement
results.
Here, we introduce a new electrode correction method for
bipolar measurements. In this corrected method, we remove the
electrode–electrolyte interface contribution from the measured
impedance magnitude by subtraction. In order to determine
ZCPE_el, a control experiment was performed by monitoring the
impedance in only cell medium without the cells for the whole
experimental period (bel was found to be 1.5 ! 10%8 Ua%1 Fa and
0.91 for ael). The choice of LF depends mainly on two parame-
ters. LF is ideally chosen very low to eliminate the influence of
the cell membrane capacitance. However, ZCPE_el dominates the
measured impedance magnitude at very low frequencies, making
the |Z| relatively insensitive to cellular parameters, even after
correction.
In our experiments, LF was chosen between #1 kHz and
#30 kHz to mediate between these two factors. In order to
achieve highest measurement sensitivity, 10 kHz was selected
since the corresponding phase angle variation with changing
extracellular environment was nearly maximal while aiming less
influence from the membrane capacitance (Fig. 6a and S2 in the
ESI†). Meanwhile, the choice of HF is less tedious. HF is defined
as the frequency where the membrane capacitor is short-circuited
and provides information about the cell interior. At HF, elec-
trode contributions are negligible as shown in Fig. 4 and Cpar can
be ignored since the measured phase angle is close to 0" and
reveals an almost purely resistive behavior. Thus, we have chosen
HF as 3 MHz.
2.7 Statistical analysis
Impedance magnitude values and absorbance at 590 nm (MTT
viability assay) at different time points after AP addition were
expressed as means with 95% confidence interval. Statistical
analysis of each time point was performed compared to the initial
value at 0 h using two-way ANOVA and Bonferroni post-test.
The observed importance level (p-value) of the difference
between two means was considered significant when p < 0.05,
very significant when p < 0.01 and extremely significant when
p < 0.001.
3 Results
3.1 An artificial sinusoid-like hepatocyte culture
The goal of this study was to develop a microfluidic biosensing
platform on which the culture and toxicity screening of HepG2/
C3A cells can be performed. The first step involved immobilizing
the cells within the four filters as shown in Fig. 5a and c. Cells,
injected in the microfluidic device, get trapped within the
micropillar array with some cells escaping through the gaps
between the filters. It was observed that the amount of cells
finally immobilized strongly depends on the flow rate during cell
loading. Flow rates in the range of 20 nl s%1 were the most suit-
able for an efficient cell loading, resulting in a trapping of up to
90% of the injected cells in the filter.
Fig. 3 Equivalent circuit modeling. (a) The cell population is represented by the Cole model with an extracellular resistance (Rextra) in parallel to the
tissue constant phase element (CPEcells) and a high frequency intracellular current pathway (Rintra). The electrode/electrolyte interface is modeled by
a CPE (CPEel). A parallel capacitance (Cpar) characterizes parasitic current shunts at high frequency. (b) Impedance plot of a high density cell culture.
The equivalent circuit was used to fit the plot. Chi-squared ¼ 1.9 ! 10%4, sum of squares ¼ 3.4 ! 10%2.
Fig. 4 Low frequency signal correction. Exemplary impedance magni-
tude–frequency spectrum for cell covered electrodes and simulated
spectrum without CPEel. The simulated curve was obtained through
fitting of the experimental curve to the equivalent circuit (Fig. 3a) and
redrawing without the CPEel. The low frequency (LF) signal is influenced
by the electrode capacitance, while the high frequency (HF) signal
remains unaffected. The choice of a suitable frequency to screen extra-
cellular events is a compromise between low CPEel, low CPEcells and high
resolution.
This journal is ª The Royal Society of Chemistry 2011 Lab Chip, 2011, 11, 2352–2361 | 2355
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Cell culture in the microchip was performed for 5 days. Cells
attached to the surfaces and to each other during this period
(Fig. 5b). This high cell density culture was characterized by close
cell–cell contacts (Fig. 5d and f) and multiple cell layers in the z-
direction (Fig. 5b, dark regions). A confocal image showing the
xz-plane in Fig. 5g revealed the presence of three cell layers
stacked on top of each other, indicating a 3D cell culture. In
addition, as shown in Fig. 5e, despite high cell density, cell
viability was maintained within the filters with some dead cells in
the perfusion region only.
3.2 Impedimetric characterization of cell growth
We examined the hepatic cell population with impedance spec-
troscopy during the entire cell culture. The impedance spectra as
a function of cell culture time are shown in Fig. 6a. We observed
an increase of |Z| within a frequency range from 5 kHz to 3MHz.
Lower frequencies (<5 kHz) are not affected by the growing cell
population. The phase angle increased within a frequency
window of 1 kHz to 100 kHz and decreased at HF.
Phase angles obtained at 3 MHz are much closer to
0" compared to those at lower frequencies, indicating more
resistive characteristics at higher frequencies. The largest differ-
ence between the impedance profile in the presence of cells and
that without the cells was observed at 100 kHz. Fig. 6b shows |Z|
at 100 kHz, and the cell growth profile measured by the imped-
ance was confirmed with the cell growth observed under the
microscope (see Fig. S3 in the ESI†). A typical growth curve with
initial lag phase and exponential growth was obtained by the
impedance measurement as seen in Fig. 6b. The stationary phase
was reached at the end of seven days once the electrode area was
fully covered with cells. Hence, we have shown that impedance
changes due to the cell growth are strongly frequency-dependent.
3.3 Label-free monitoring of AP-induced toxicity
We studied the effect of AP on the microscale culture using
impedance spectroscopy. In order to analyze AP toxicity-induced
effects, we examined the LF and HF signals separately. The LF
signal provides information about extracellular properties
whereas HF signal reflects intracellular characteristics. The phase
angle indicates if the system behaves like a resistor (/ 0") or
a capacitor (/ %90"). As already shown in Fig. 6a, a LF phase
angle of %40" (10 kHz) at high cell density indicated both
resistive and capacitive effects. To reliably analyze cell dependent
extracellular changes and their kinetics, all impedance analyses
involve correction of |Z| values by subtracting the electrode
interface effect from measured impedance magnitudes at 10 kHz
(see Fig. S1 in the ESI† for detailed information). Such correc-
tion provides the approximation of experimental values to the
ideal linear profile of a simple resistance circuit and permits to
eliminate the effect of the electrode-interface capacitance.
We performed AP treatment with different concentrations
under continuous perfusion exposure. Fig. 7a shows impedance
magnitude changes at 10 kHz and 3 MHz for different time
points. The long-term impedance magnitude is similar for
measurements at 10 kHz and 3 MHz, but its evolution has
Fig. 5 Imaging of cell culture within the microfluidic device. (a) and (c)
show nearly full filters after cell loading. (b) and (d) show cells after 3 days
of culture. The high density culture is characterized by direct cell–cell
contact (arrow 2) andmultiple cell layers (arrows 1 and 3) (bar¼ 80 mm at
the top and 20 mm at the bottom). (e) Viability of cells within filters is
shown in green and some cells in perfusion regions undergo cell death
(red) (green: fluorescein diacetate, red: propidium iodide). (f) Immuno-
cytochemical staining of occludin indicates the presence of cellular tight
junctions (bar ¼ 40 mm, green ¼ Cy-2). (g) Three cell layers are identified
in the z direction (blue: DAPI) (bar ¼ 10 mm).
Fig. 6 Impedimetric characterization of cell growth. (a) Bode plot of
spectra recorded on different days of culture. (b) Normalized impedance
magnitude at 100 kHz for 7 days of culture (n ¼ 5). We normalized each
value to their final (day 7) value. The solid line presents a fit of the data.
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different profiles for both frequencies. LF signal drops as early as
2 h of drug exposure, whereas the HF signal does not change
significantly. For AP concentrations above 5 mM, longer expo-
sure results in lower impedance magnitude. Furthermore,
increasing concentrations of AP lead to a larger change in
impedance magnitude for treatments of similar durations. The
impedance magnitude for an exposure of the cells to a 5 mM AP
concentration follows a different evolution than that for higher
concentrations and actually increases with exposure time.
In order to make sure that the impedance magnitude changes
originate from the AP-induced cellular changes and not from the
presence of AP in the cell medium itself, we have recorded the
spectra of cell medium with and without AP in the absence of
cells as a control experiment. We observed an impedance change
of only 10 U after AP addition (see Fig. S4 in the ESI†). Such
small resistance changes can be neglected when the observed
variation in the impedance is more than 1000 U in the presence of
cells.
Immunocytochemical staining of actin was performed on
cultured cells exposed to a 20 mM concentration and revealed
structural changes as early as 2 h after AP treatment as shown in
Fig. 7b. Non-treated cells exhibit a fiberlike network of actin
filaments, providing attachment between cells and the substrate
and also neighboring cells. This organizational structure dis-
appeared after 2 h of AP exposure. Instead, an even distribution
of actin was observed in the cells with a slightly higher presence
at the cell periphery (Fig. 7b, 2 h arrow). Cells that were treated
for 24 h showed heterogeneous dispersion of actin. Also, nuclear
fragmentation indicated apoptosis in some cells (Fig. 7b, 24 h
arrows). The cell viability, on the other hand, decreased signifi-
cantly after 24 h, and no cell death was observed up to 8 h as
shown in Fig. 7c.
We examined the ability of HepG2/C3A cells to recover from
AP induced cell injury. Five days after the cells were seeded in the
microfluidic device, 10 mM AP was perfused for 3 h. The cell
culture was then washed with clean medium for 21 h. A second
AP perfusion was performed for 24 h before perfusing the cells
again with fresh medium. Fig. 8a shows the normalized imped-
ance magnitude vs. time at 10 kHz and 3 MHz. During the first
AP treatment, |Z|10 kHz dropped by 13% whereas |Z|3 MHz
remained constant. After flushing with fresh medium, we
observed complete recovery of the 10 kHz signal and no change
was observed at 3MHz. During the second AP treatment, the LF
signal dropped sharply by 20% within 3.5 h, followed by a slower
decrease around 21% in the next 21.5 h. At HF, the signal
decreased only 20% in 24 h. When the AP was rinsed away with
Fig. 7 Effect of AP treatment. (a) Normalized impedance in the microchip as a function of AP concentration under different drug treatment times. We
normalized each value to their initial (0 h) value. Impedance magnitude changes (mean ( 95% CI) at 10 kHz and 3 MHz after application of three
different concentrations (5 mM, 10 mM, 20 mM) are shown. Kinetics of the decrease in |Z| was found to be frequency-dependent. (b) Cytoskeletal
changes after AP exposure. Immunocytochemical staining of actin cytoskeleton revealed structural changes as early as 2 h after 20 mMAP treatment. C:
actin forms a fiber-like network in the untreated sample. 2 h: actin is less organized and dispersed throughout the cytoplasm and displays slightly higher
fluorescence intensity at the cell periphery (arrow). 24 h: actin is heterogeneously dispersed in the cell. Apoptosis is observed as indicated by arrows (bar
¼ 10 mm, green ¼ Cy-2, blue ¼ DAPI). (c) MTT viability assay. % cell viability vs. time. Mean ( 95% CI of absorbance at 590 nm is shown. Statistical
analysis of each time point in (a) and (c) was performed compared to the initial value at 0 h (n ¼ 4; *p < 0.05, **p < 0.01, ***p < 0.001).
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cell medium one more time, |Z|10 kHz increased again and almost
full recovery was obtained after 40 h. The full recovery of
|Z|3 MHz was also obtained after showing no change for around
8 h in the impedance when the drug was removed from cells.
The relative change of phase angle during the AP exposure and
cell recovery with impedance magnitude is shown in Fig. 8b. The
signal at 10 kHz measured during the cell recovery is more
capacitive than that before AP treatment. The same applies to
the HF signal, having a more capacitive signal than that before
drug inducement. In conclusion, 10 mM treatment of HepG2/
C3A cells results in frequency-dependent impedance changes and
kinetics. LF and HF signals both show that the recovery signal is
inherently more capacitive after AP exposure.
4 Discussion
In the current study, we have shown that impedance spectros-
copy is a useful non-end point technique that distinguishes
between extracellular phenomena and cell viability. We demon-
strated that our microfluidic device is a suitable environment for
HepG2/C3A cell growth. The possibility to perform impedance
spectroscopy on-chip is an easy and fast screening technique of
cell growth and concentration-dependent drug induced changes
on the intracellular and extracellular environment. We further
demonstrated that cell recovery can be monitored when cells are
treated with doses of AP. Moreover, we have shown that non-
drug treated and recovered cell populations possess different
dielectric properties (Fig. 8b).
4.1 The microfluidic perfusion culture
We designed a microfluidic device in which cell culture can be
performed with continuous perfusion of medium and without
shear stress applied on the cells because of the implemented filter
design. Our experiments showed higher cell viability and cell
growth inside the filters than that of outside potentially owing to
the protection of cells from the effect of shear stress caused by the
direct flow. In addition, sterile conditions can easily be main-
tained when using a perfusion system (non-loop) and a PDMS
microbioreactor. This reduces the need for the use of antibiotics
that have potential long term effects on cells.42 Our microfluidic
cell culture showed very high cell density in the filters with
a maximum distance of 50 mm for diffusion of nutrients as
determined by the filter width. These specifications meet in vivo
conditions since extracellular matrix constitutes a small portion
of the normal liver (around 3%)43 and tight junctions are
important for firm cellular attachment permitting cell-to-cell
signaling across communication junctions.30 Although the pre-
sented cell culture may not be considered as 3D (due to the
absence of extracellular matrix), formation of multi-layer stack
of cells is still important44 since most of the cell surface is in direct
contact with adjacent cells. This is not true for standard cell
culture in 2D Petri dish, where cells are cultured on a hard
surface and with abundant amount of cell medium. Based on cell
growth and high cell viability, we consider our device and culture
conditions to be effective for drug cytotoxicity studies, although
a complete biochemical analysis (quantification of albumin and
CYP450 activity9,14) was not our focus and hence was not con-
ducted in the framework of this study.
4.2 Impedimetric characterization of the hepatic cell population
We investigated dielectric properties of HepG2/C3A cells with
our system. Although the maximum cellular contribution to the
impedance magnitude was observed at around #100 kHz, the
phase angle did not change at this frequency but varied signifi-
cantly at#10 kHz and#3MHz. On the one hand, this difference
originates in the impedance being dominated by the electrode
impedance at LF, thus making the LF impedance magnitude less
sensitive to the presence of cells. On the other hand, the extra-
cellular resistance is shorted by the cell membrane capacitor
above 10 kHz as indicated by the phase angle. Hence, if one
wants to measure predominantly extracellular events, 10 kHz
appears to be the most sensitive frequency (phase angle is most
resistive before membrane relaxation). At #100 kHz phase
angles are constant during the cell culture due to the balance
between an increasing extracellular resistance and membrane
capacitance. Moreover, intracellular properties can be investi-
gated at HF as mentioned earlier. The impedance at HF increases
with the increasing number of cells because intracellular matter is
less conductive than the surrounding medium.29 Nevertheless,
the corresponding phase angle decreases due to the increasing
tissue capacitance that was observed up to 3 MHz (Fig. 6a).
Fig. 8 Perfusion of repeated AP doses. (a) Temporal evolution of |Z|10 kHz and |Z|3 MHz shows different decay profiles with time after AP exposure as
well as signal recovery once perfused with clean medium (b) |Z| is plotted vs. phase angle. A more capacitive response at both LF and HF is observed
during recovery.
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Thus, our experiments provide information about extracellular,
intracellular and cell membrane properties. Such cell specific
characteristics can only be distinguished with the interpretation
of the impedance spectra with corresponding phase angle profile,
thus making phase angle analysis an indispensable tool for
understanding cellular phenomena.
The phase-component of the impedance has a typical angle of
#%45" at 10 kHz and of #%15" at 3 MHz. This indicates
stronger capacitive behavior of the cell population at LF, origi-
nating from the electrode and the tissue capacitance. We intro-
duced a new correction method to eliminate the effect of the
electrode–electrolyte interface and to offer the possibility to
theoretically counteract the inherent drawback of bipolar
measurement. This technique assumes that electrode character-
istics do not change throughout the whole experiment time.
Practical alternatives to eliminate the electrode interface contri-
bution are multipolar measurements such as tetrapolar config-
uration.23 However, these techniques have a limited practical
bandwidth, at least when using microelectrodes, as described
previously.23 On the contrary, it is currently not possible to apply
such a correction method for tissue capacitance since it changes
with the tissue resistance.
4.3 Impedimetrical detection of AP-induced cellular changes
We observed that impedance changes after AP treatment were
time and dose-dependent. Significant changes on the impedance
spectra after 2 h at 10 kHz confirm that impedance screening is
a very sensitive method. Continuous monitoring up to 60 h
revealed the high potential to obtain real-time information.When
comparing low and high frequency measurements, we found that
|Z|3 MHz decreases later than |Z|10 kHz. This shows that different
information can be obtained when investigating different
frequency ranges as presented in Fig. 9. At LF, cellmembranes act
as capacitors and block the current flow through the cells. Protein
channels embedded in the cell membrane are negligible as their
resistance is in the MU range.45 This leads to a high extracellular
resistance, considering a densely packed insulating cell layer. If
cell–substrate and cell–cell contacts are loosened and cells start to
retract, current shunts through the intercellular space which
results in an abrupt resistance drop (due to the inverse quadratic
relationship between Rextra and intercellular distance). This
phenomenon explains the signal decrease at LF. Such rapid
impedance decrease is correlated with cytoskeletal actin and
subsequentmorphological changes afterAP exposure (Fig. 7b). In
cell culture on stiff substrates and dense cell–cell contacts, the
actin cytoskeleton tends to organize in stress fibers.46 AP treat-
ment disrupts such fiberlike organization by mechanisms
involving glutathione depletion, oxidative stress and mitochon-
drial dysfunction.47 This leads to cell–substrate and cell–cell
detachment as described in former studies where cytoplasmic
retraction and cell lifting have been observed.48 Previous studies
also indicated that AP mediated metabolism can cause the deac-
tivation of the Rho protein which in turn is responsible for the
formation of actin stress fibers.49 In long-termdrug exposure, cells
start dying either through apoptosis or necrosis50,51 which again
leads to signal decrease. This is consistent with the changes
observed in the cell morphology inside the microchip such as cell
retraction and increase in the intercellular space after 2 h and cell
death after 24 h AP exposure as seen in Fig. S5b and c in the ESI†.
On the other hand, at HF, the membrane capacitor is considered
shorted and both extracellular and intracellular matter contribute
to the measured impedance. Intercellular gaps formed after AP
exposure barely contribute to the decrease in HF impedance due
to their low volume fraction compared to the large intracellular
volume at high cell density. When cells start dying, ion pumps
embedded in the membrane cease functioning and small pores are
formed during cell death, leading to exchange of intra- and
extracellular matter. Considering continuous perfusion of the cell
sample, cell cytosol is replaced by freshmedium, which has two to
three times higher conductivity than the cytosol.29 Our results on
HF kinetics indicate that the conductivity change in such large
volume contributes to the impedance decrease. Indeed, the
measuredHF values in Fig. 7a follow the same trend as the profile
obtained in the MTT viability test (Fig. 7c) and other reported
conventional viability data on HepG2 cells.52,53 The present data
strongly suggest that, in combination with very high cell density
and continuous perfusion flow, HF measurements report serious
cell injury, while LFmeasurements inform about intercellular and
morphological phenomena.
Furthermore, we measured that |Z|10 kHz was higher at 20 h
and 60 h than initially when 5 mMAP was applied. This is due to
the continuously growing liver carcinoma cell line used in our
experiments. Cell growth is disrupted after AP exposure, and cell
Fig. 9 Hypothesized correlation between frequency-dependent imped-
ance changes and cell culture morphology. After short term drug expo-
sure, cell–cell contacts are loosened and the formation of intercellular
gaps causes current shunting at low frequency (LF), but no significant
impedance change at high frequency (HF) due to their low volume
fraction. Low conductivity cytosol (high volume fraction) is eliminated
through continuous perfusion following cell death after long term drug
exposure. This leads to decrease in the impedance at HF.
This journal is ª The Royal Society of Chemistry 2011 Lab Chip, 2011, 11, 2352–2361 | 2359
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cycle reentry occurred after a certain ‘adaptation time’. 5 mMAP
concentration was too low to cause serious HepG2 cell pop-
ulation damage within 60 h.
The perfusion of repeated AP doses revealed the ability of
HepG2 cells to recover from drug-induced cell injury. The signal
recovery was obtained within 5 h as seen in Fig. 8a after 3 h
exposure to 10 mM AP solution and flushing with medium
stimulated the reestablishment of cell–cell and cell–substrate
contacts. Longer AP treatment caused major cell injury, indi-
cated by the HF signal. During the following medium perfusion,
cells reattach to each other and to the substrate, characterized by
constant HF- and increasing LF signal. Subsequently, cell
proliferation starts and reestablishes an impedance value of 90%
after 40 h of medium perfusion, showing an increase in both high
and low frequency magnitudes. Even though, impedance values
were regained, we showed that the recovered cell population
showed a more capacitive behavior compared to non-treated
cells, which could be attributed to remaining cell membrane
blebbing, membrane asymmetry and cell debris from apoptotic
and necrotic events. These results indicate the advantage of
electrical characterization over standard end-point assays when
using doses that are sublethal but still cause toxic effects.
Conclusions
In conclusion, we have developed a microfluidic-based sensing
platform for hepatocyte culture using dielectric screening. It
enables direct, continuous, label-free and non-invasive
measurements of cell dependent parameters. We demonstrated
that phase angle analysis is an indispensable tool to understand
cellular phenomena when impedance spectroscopy is used. We
were able to distinguish between morphological changes and
severe cell injury within a cell population owing to the combi-
nation of high-density culture, perfusion flow and whole
impedance-frequency spectrum analysis. More importantly,
cellular changes can be sensed long before cellular death, offering
a very high sensitive technique over standard expensive and time
consuming viability assays. Future improvements of the tech-
nique will include on-chip controls, real-time normalization and
the use of multiple assays run in parallel to increase the statistical
strength. Therefore, the use of an electrode switch might be
considered for high-throughput cytotoxicity screening that can
meet the needs of pharmaceutical industry more closely.
Therefore, as a novel demonstration of drug induced cyto-
toxicity screening with impedance spectroscopy within a wide
frequency range, this study offers a highly sensitive detection
platform for cellular behavior during cell culture and drug
exposure. From this point of view, this cell-based impedimetric
sensing system inside microfluidic filters opens new avenues to
develop new classes of detection devices for cellular phenomena
upon toxicant intake. Real-time imaging and continuous moni-
toring of cell dependent changes using microfluidics combined
with the detection of cellular events using phase angle and
impedance analysis allow developing new designs of microscale
cytotoxicity-based sensing systems for different cell types under
various physiological conditions. Overall, this system exemplifies
the significance of microfluidics and cell dielectric properties to
create a miniaturized detection device for cell toxicology studies.
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ABSTRACT: This communication presents a novel experi-
mental model for Alzheimer studies, where connected pri-
mary neurons were set into subtend, co-pathological states.
Cortical neurons were cultured in two separated cell com-
partments in a microfluidic device. A neurite network was
generated in a main channel through the neurite outgrowth
from both cell compartments. A gradient of okadaic acid
(OA) is generated over this neurite network by perfusion.
OA is a phosphatase inhibitor that induces hyperphosphor-
ylation of Tau proteins, a major hallmark in Alzheimer
disease. The local OA treatment resulted in a connected
‘‘diseased’’ and ‘‘healthy’’ cell population. Anti-phosphory-
lated tau (Ser262) staining confirmed different states of
phosphorylated Tau proteins, and synapthophysin staining
the connection of ‘‘healthy’’ and ‘‘diseased’’ cells. Here, we
present a novel in vitro model that opens the possibility to
study cellular and molecular propagation mechanisms in
neurodegeneration, in Tauopathies (as e.g., in Alzheimer),
as well as simultaneous drug effects on connected healthy
and diseased cell populations.
Biotechnol. Bioeng. 2011;108: 2241–2245.
! 2011 Wiley Periodicals, Inc.
KEYWORDS: primary neural cell culture; co-pathology;
hyperphosphorylated Tau; microfluidic device; chemical
gradient; okadaic acid
Alzheimer’s disease (AD) is the most common cause of
dementia and affects more than 35.6 million people
worldwide representing over US $604 billion in 2010
(Wimo and Prince, 2010). The disease starts from a very
precise brain area, the limbic system, and spreads out in
distinct brain regions, indicating the contribution of neural
networks in disease propagation (Delacourte, 2008; Savioz
et al., 2009). While most Alzheimer studies are focused on
biochemical mechanisms (Brandt et al., 2005; Small, 2008),
interactions between neurons have been shown to be
important as well (Horn et al., 1996; Palop et al., 2006;
Pariente et al., 2005). In vivo, however, studies of
interactions between co-localized Alzheimer affected and
non-affected neurons are very difficult to reproduce, and
also, traditional in vitro techniques are limited so far.
Microfluidic devices have come up in the last 5 years to
enhance neuronal cultures, where cell placement can be
locally controlled and neurites guided along microchannels
(Millet et al., 2010; Pearce and Williams, 2006; Taylor and
Jeon, 2010; Wang et al., 2009). Also, perfusion of neurites
has been used to change transport mechanism in the axon to
the soma (Taylor et al., 2010). All these examples have in
common that they study cell effects on one homogeneous
cell population, only. But to study interactions between
healthy and diseased neuronal cells, two-cell populations
have to be connected to each other by generating an active
neurite network.
Here, we present a novel experimental model to generate
two distinct co-pathological states within two separated
primary cortical cell compartments that are connected
through a neurite network. A special chosen microfluidic
design (Fig. 1a), adapted from literature (Shamloo and
Heilshorn, 2010), guarantees the local pattern of primary
cortical neurons as well as their connectivity and commu-
nication through a neuronal network after cell culture. The
cell metabolism of one compartment can be changed locally.
Okadaic acid (OA), a protein phosphatase 2A (PP2A)
inhibitor (Fig. 1c), was perfused over one-cell culture
compartment, as shown in Figure 1b. The OA results in
protein hyperphosphorylation, namely Tau proteins,
which are known to be a major hallmark of AD (Arias
et al., 1993; Krinke et al., 2010; Wang et al., 2001; Zhang
and Simpkins, 2010). Local inhibition of dephosphor-
ylation generates an imbalance of the Tau phosphorylation
states between the two connected cell populations. We called
the controlled generation of two different phosphorylation
states between connected neuronal cell compartments a
co-pathological state. Furthermore, neural cells showing
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Tau-hyperphosporylation states after OA treatment are
defined as diseased neurons, while neurons with normal Tau
phosporylation states are called healthy neurons.
To achieve the co-pathological culture, a microfluidic-
based cell culture device in poly(dimethylsiloxane) (PDMS)
was fabricated. The microfluidic design has three compart-
ments: two lateral cell culture channels (3mm long, 200mm
wide, and 100mmhigh), 24 junction channels (150mm long,
10mm high, and 20mm wide) and a main channel (3mm
long" 640mm wide" 100mm high). The two different
heights of the microfluidic channels required a two-step
fabrication process of the silicon master used for PDMS
molding. We developed a two-step dry etching process to
fabricate the two different heights in silicon. We chose the
two-step dry etching process, because of the longer life span
of silicon structures compared to photoresist structures for
PDMSmolding. The detailed process flow for fabricating the
silicon master is described in Additional supporting
information (Fig. 1). After PDMS molding the microfluidic
device has 7mm high PDMS reservoirs on the top of the
PDMS body to generate perfusion flow through the cell
culture channels. When only one reservoir is filled up to
7mm, the pressure difference between the full and the empty
reservoir causes a perfusion flow for at least 75min.
Applying perfusion flow in the two-cell culture channels,
while one fluid is enriched with OA, will lead to linear
concentration gradients through the junction channels and
across the main channel. The special design of the main
channel favored the formation of complex neurite structures
between the two-cell compartments. The junction channels
function as neurite navigators and as injection channels
to generate a chemical gradient in the main channel.
Dissociated cortical neurons (E19) were obtained from
embryonic rats (Wistar; a detailed description of the cell
culture protocol can be found in the Materials and Methods
Section and in additional supporting information). The
surface of microfluidic channels was pre-treated with 0.01%
(v/v) poly(ethylenimine) in borate buffer to enhance neural
Figure 1. Generation of a co-pathological neural cell culture. a: Photograph image of the PDMS microfluidic device. b: Schematic of experimental procedure to achieve a co-
existence of diseased and healthy neurons after 8 days in vitro: Step 1: Neuronal cells cultured in two lateral channels; Step 2: Local injection of okadaic acid in the left culture
channel, generating a concentration gradient in the main channel. Cells are treated for 75min, leading to a local diseased neuronal cell culture due to Tau-hyperphosphorylation. c:
Disequilibrium of Tau-microtubule-binding induced by inhibition of dephosphorylation through okadaic acid.
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cell attachment and to avoid air bubble entrapment. All
channels were filled with Neurobasal/B27 prior cell
injection. Twenty microliters of cell suspension was loaded
in each of the two PDMS reservoirs of the cell culture
channels. The microfluidic devices were placed in Petri
dishes, surrounded by Neurobasal/PenStrep and incubated
for 8 days (95% air, 5% CO2, 65% R.H.).
After 2 days in vitro (DIV) we observed neurite outgrowth
through the junction channels and into the main channel.
From 5 DIV, neurite length saturated in the microfluidic
device (Fig. 2; in Additional supporting information).
Figure 2a shows the two neuronal cell compartments after 8
DIV with neurites grown into the main channel. We
observed that most cell bodies were located in the cell
culture channels. In addition we found that roughly one-
third of cells had migrated from the cell compartments
through the junction channels into the main channel (Fig. 3;
in Additional supporting information). Functional neurite
connectivity in the main channel was shown through
synapthophysin immunostaining (Fig. 4; in Additional
supporting information).
After 8 DIV, 600 nM OA in Neurobasal was injected in
one of the reservoirs for the left cell culture channel; only
Neurobasal was filled in the right reservoir. In this way, the
left neuronal cell population was exposed to OA for 75min.
During perfusion the OA diffused from the cell culture
channel through the junction channels across the main
channel. An experiment with fluoresceine showed the
Figure 2. Co-pathological cell compartments of primary cortical neurons after treatment. a: Differential interference contrast (DIC) image of the primary cell culture in the
microfluidic device before OA treatment. b: Immunocytochemical staining of Ser262-phosphorylated Tau proteins after OA treatment (600 nM) for 75min (green: CY-2, blue: DAPI). c:
Transient chemical gradients in the main channel, characterized with 20mmol fluoresceine, stabilized after 1 min (time in s). d: Mean fluorescence intensity across the main channel
corresponding to the presence of immunostained phospho-Tau-Ser262 gradient generated through OA treatment in three different devices. e: Fluorescence intensity ratio of left to
right cell compartment representing the phosphorylated Tau imbalance, n¼ 4. t-Test showed significant different phosphorylated Tau states, P< 0.001.
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generation of transient chemical gradients across the main
channel and the establishment of linear gradients after 1min
(Fig. 2c and Additional supporting information). For a
diffusion coefficient of 200mm2/s for OA, the linear gradient
can be assumed after approx. 30min.
After OA treatment, PP2A inhibition leads to hyperpho-
sphorylation of Tau proteins and dissociates microtubules,
as already shown in Figure 1c, a main indicator for AD
(Ballatore et al., 2007; Brandt et al., 2005; Wang et al., 2001).
Different phosphorylation states in neurites in the main
channel were visualized with Ser262-Tau immunostaining.
Figure 2b shows a confocal image from the microfluidic
device after OA perfusion and immunostaining. On the left,
hyperphosphorylated Tau proteins are present, while in the
main channel the effect decreases in correlation with the
chemical gradient of OA. The different phosphorylation
states are represented in Figure 2d by their fluorescence
intensity. In non-treated experiments, no significant
intensity differences can be observed between left and right
cell populations (Fig. 2e). On the other hand, there is a
striking 19:1 ratio between the left and right phosphorylated
Tau imbalance.
Now, we discuss the effect of local phosphorylated Tau
after OA treatment on primary cortical neurons in the two-
cell compartments. Diseased neurons in the left cell
compartment exhibit phosphorylated Tau aggregates in
neurites (Fig. 3a, arrow 1) and accumulation in the soma
(Fig. 3a, arrow 2). Both effects are in correlation with
previous studies, where phosphorylated Tau unbinds from
microtubules and forms aggregates causing axon swelling
(Yoon et al., 2006) and filament formation in somata (Togo
et al., 2004). In contrast to the diseased neuron, a
homogeneous Tau-distribution can be seen in
Figure 3b, a healthy neuron, as indicated by a non-textured,
lower fluorescence intensity, without aggregates and
accumulations. The counting of cell numbers and neurites
per cell in both cell populations (Fig. 3c and d) yields no
significant decrease of cells after the OA perfusion, while
neurites per cells reduced about 32% in the left perfusion
channel. Our results confirm that the cell response is
independent on sheer stress that can also be induced during
perfusion. The staining of synapses with synaptophysin after
the OA treatment (Fig. 3 in Supplementary data) confirms
the connection between the healthy and the diseased cell
population. In addition to Tau hyperphosphorylation, OA
treatment has previously been linked to oxidative stress
(Zhang and Simpkins, 2010) and increased intracellular
amyloid b (Sun et al., 2002), two further characteristics in
AD brains (Baig et al., 2009; Nunomura et al., 2006). All
these data indicate the relevance of OA treatment for AD.
In conclusion, we have developed a novel experimental
model to generate two distinct co-pathological states in
connected neural cell culture in vitro. In a PDMS
microfluidic device, neuronal cells have been cultured up
to 8 days in two separate cell compartments and formed
neurite connections to each other. A local perfusion of OA
caused a local hyperphosphorylation of Tau, a characteristic
feature of AD. By immunostaining, we confirmed in the
microfluidic device: (1) gradient controlled Tau phosphor-
ylation states and (2) diseased and healthy neuronal cell
population. The different phosphorylation states resulted in
a co-pathological state of equilibrated versus disequili-
briated phosphorylated Tau metabolism within the same
neural cell culture. Our novel microfluidic-based experi-
mental model generated co-pathological states of phos-
phorylated Tau proteins within a connected cell culture of
primary cortical neurons. This new model allows in future
the study of neurodegenerative propagation processes or the
performing of drug efficiency tests while evaluating side
effects between healthy and diseased cell compartments.
Materials and Methods
Microfluidic Device Fabrication
Microfluidic devices were fabricated by PDMS injection
molding over silicon masters at 808C for 1 h. The
microfluidic channels are cast in the bottom of a PDMS
body through two-step structured silicon masters. Silicon
masters were fabricated in the clean room (for more details
Figure 3. OA perfusion generates co-pathological states of phosphorylated Tau
without significant influence on neuronal integrity of healthy and diseased cells. a,b:
Fluorescent images of neuronal cells show staining of phosphorylated Tau in green
and DAPI in blue. (a) Diseased cell from left compartment and (b) healthy cell from
right compartment in the same microfluidic device. Diseased neurons demonstrated
accumulation of phosphorylated Tau clusters in neurites (1) and soma (2). Healthy
neurons showed homogeneous distribution of Tau within neurites. Bars¼ 10mm. c:
Cell number counted in cell culture channels, B¼ before treatment, A¼ after treat-
ment, n¼ 5. d: Neurites per cell before and after OA treatment, n¼ 5. In the left
perfusion channel a significant decrease of neurites was detected (t-test, P< 0.05),
whereas the number of cells did not differ significant.
2244 Biotechnology and Bioengineering, Vol. 108, No. 9, September, 2011
see Additional supporting information, Fig. 1). PDMS
microfluidic channels were sealed with 18mm" 18mm
glass slides using oxygen plasma bonding (50W, 0.5 sccr,
0.3mtorr, 45 s).
Primary Cortical Cell Culture in the Microfluidic Device
Dissociated cortical neurons (E19) were obtained from
embryonic rats (Wistar) in accordance to all state and
federal regulations. Cortical tissues were extracted from the
embryonic brain and digested for 15min in an enzyme
solution at 378C according to standard protocols previously
described (Kunze et al., 2010). For the 2D neural cell culture
until network formation, the microfluidic device was pre-
filled with culture medium. We added 20mL cell suspension
of 10" 106 neurons/mL into the PDMS reservoirs of the
perfusion channels. Neurobasal medium, 2% (v/v) B27, 1%
(v/v) PenStrep was filled to all other reservoirs. Neuronal
cells were cultured in microfluidic devices in an incubator at
378C (95% air, 5% CO2, 65% relative humidity). To prevent
evaporation, microfluidic devices were placed in petri dishes
and surrounded with Neurobasal medium. Medium change
has been conducted every 3 days.
Immunocytochemistry and Imaging
Neural cells in the microfluidic devices were incubated with
a 3% BSA solution (in 0.1% Triton/PBS) for 45min before
immunostaining. Phospho-Tau Ser262 primary antibody
(1:150 in PBST) was injected into all reservoirs and
incubated for 2 h at 48C. The samples were washed three
times with PBST and treated in dark with a CY-2 coupled
secondary antibody (1:150 in PBST) over night at 48C. The
microfluidic channels were again washed three times with
PBS followed by a cell nuclei staining with DAPI (1:7,000 in
PBS) for 20min at room temperature. A confocal
microscope was used to quantify Tau phosphorylation
states.
We kindly thank the LNMC for providing cell culture facilities, the
LMRP for the DIC microscope, and the Biop for advices in confocal
microscopy. R.M. acknowledges financial support from the NanoTera
Livesense Project No. 20NAN1-123593.
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We present a novel technology for the simultaneous and simple impedimetric screening of multiple
microfluidic channels with only one electrode pair. We have exploited the frequency dimension to
distinguish between up to three channels. Each ‘sub-sensor’ possesses its corresponding measurement
frequency where the sample-specific dielectric properties can be probed. We have shown the validity
of our frequency-multiplexing impedance sensor (FMIS) by comparison with conventional ‘single
sensors’. Our highly sensitive FMIS was proven suitable for life science applications through usage as
a cell-based toxicology platform. We are confident that our technology might find great utility in
parallelized cell-based analysis systems as well as in biomedical devices where size limitations and
spatially distributed probing are important parameters.
1 Introduction
Impedance spectroscopy is widely used in analytical chemistry
(e.g. in conductivity measurements) as well as in biosensing.
Many cell-based assays rely on the impedance as a cell status
indicator for drug response and toxicity.1–5 A great variety of
applications have also been demonstrated with small biological
components such as proteins,6,7 antibodies8,9 and nucleic
acids.10,11 In all these cases, one electrode pair is used to screen
one specific sample only. The automatized measurement of the
dielectric properties of various samples results in a multitude of
electrodes, each of them additionally connected to a common
multiplexing switch that is controlled by multiplexing software.
These setups are not only complex, but also add noise to the
recorded biological signals.
Similarly, impedance spectroscopy has been used for biome-
dical purposes where micro-probes are implanted in a tissue in
vivo to measure their resistivity at different sites.12–14 To access
these sites, the micro-probe had to be either displaced within the
tissue leading to cellular damage, or be equipped with an array of
separate micro-electrodes along the probe. Separate electrodes
require corresponding electrode traces that are placed in parallel
on the shaft. This increases the size of the entire micro probe and
potentially leads to tissue damage and inflammatory reaction.
Thus, there is a great need for very small devices that are,
nevertheless, equipped with a multitude of spatially dispersed
sensors.
In this study, we report the development of a frequency-
multiplexing impedance sensor (FMIS). Our novel technology
allows the screening of multiple sites or channels with one single
electrode pair only. We have developed a theoretical model for
designing a FMIS and fabricated devices with up to three sub-
sensors. Subsequently, we have demonstrated the functionality
of a FMIS system that records two signals simultaneously. Cell-
based toxicity screening is applied and demonstrates the great
impact that the FMIS technology might have in future
applications.
2 Theory
2.1 The concept of microfluidic-based frequency multiplexing
The purpose of this device is to screen the bulk resistance in
multiple microfluidic channels with a single electrode pair
(Fig. 1). Instead of using individual sensors that are accessed
through a switch, we are aiming at a ‘‘switch-free’’ simultaneous
Laboratoire de Microsyste`mes LMIS4, Ecole Polytechnique Fe´de´rale de
Lausanne, Station 17, CH-1015, Lausanne, Switzerland.
E-mail: robert.meissner@epfl.ch; Tel: +41 216936752
{ Electronic Supplementary Information (ESI) available: See DOI:
10.1039/c2lc40236j
{ These authors contributed equally to this work.
Fig. 1 Concept of microfluidic-based frequency multiplexing. Left:
standard measurements of three samples in different channels with three
electrode pairs and a switch system. Right: the same measurements using
one single frequency-multiplexing impedance sensor (FMIS).
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recording with one FMIS. This can be achieved by connecting a
single electrode pair to different parallelized channels. All
channels with their embedded electrode segment define one
‘‘sub-sensor’’ respectively. Due to different geometries of the
electrode segments, each sub-sensor has a specific peak resistance
frequency13 (PRF)§ where the sample resistance from the
corresponding micro channel can be probed.
Accordingly, the impedimetric information is obtained by
choosing the corresponding measurement frequency. In conclu-
sion, frequency-dependent current pathways are created where
the interface capacitors act as gates.
2.2 Modeling of a simple electrode–electrolyte sensor
Hereafter, the equivalent circuit model of a sub-sensor is
discussed in more detail. An electrical double layer is built up
at the electrode–electrolyte interface when an electrode is in
contact with a solution. This double layer can be modelled as a
capacitor (Cdl) and adds up in series to the solution resistance
(Rsol). The cross-section of the sensor that was used in this study
is illustrated in Fig. 2.
The electrical double layer capacitance can be calculated with
the simple mathematical Helmholtz–Perrin model (V, 50 mV)15:
CH~
1
2
e0er
A
dOHP
~
1
2
e0er
wel :lel
dOHP
(1)
where e0 = 8.85 6 10
212 Fm22 is the vacuum permittivity, er =
12.4" is the relative permittivity of water,16A is the surface area of
the electrode, wel is the width of the electrode, lel is the electrode
length (= channel width wch) and dOHP = 5 A˚ is the outer
Helmholtz plane distance.16 The capacitance is divided by 2 to
account for both measurement electrodes (in series).
It has been described earlier that the double layer capacitance
is potential dependant15 (Gouy–Chapman capacitance). For
simplicity, we did not consider the effect of voltage-dependant
space charge because its effect on the sensor design optimization
is negligible.
The solution resistance can be calculated as follows
Rsol = rk (2)
where r is the resistivity of the solution and k is the cell constant,
a geometrical factor. The cell constant depends on the shape of
the sample and the electrodes. Two cases have been employed
in this study. For the case where large electrodes are spaced
far from each other, the cell constant calculates as follows17
(a derivation is provided in the ESI{)
k~
1
wch
sel
h
z
4 ln 2ð Þ
p
! "
(3)
where sel is the interelectrode spacing, wch is the channel width
and h is the channel height. The first term can be interpreted as
the resistance through the channel and the second term as the
series resistance due to the curving of the field lines down
towards the metal electrode. For the case where small electrodes
are placed in proximity, the cell constant calculates as follows18
k~
1
lel
K kð Þ
K
ffiffiffiffiffiffiffiffiffiffiffiffi
1{k2
p$ % (4)
where K(k) is the complete elliptic integral of the first kind and
k = sel/(sel + 2wel).
2.3 Optimization of frequency-multiplexing
For the FMIS, several sub-sensors characterized by different
geometries are connected in parallel. In order to perform reliable
impedance measurements in the different channels, a number of
parameters need to be optimized. Two factors influencing the
measurement sensitivity have to be taken into account. First, the
PRF of the different sub-sensors needs to be well-defined and
well-separated for good identification of all sensor-specific
measurement frequencies. Second, the total resistance range
needs to be maximal in order to avoid cross-talk between the
sensors and to guarantee a large resistance measurement window
(DR). It is obvious, however, that these two conditions are
guaranteed by separating the different cut-off frequencies. We
call this process the frequency separation method (FSM). All
relevant frequencies for the FSM are illustrated in Fig. 3.
As a specific case, all the following considerations apply to a
triple-sensor (a similar reasoning is valid for any number of
sensors). A maximal separation of the PRFs requires the
differences of all cut-off frequencies (Df1–4) to be as large as
possible. This is guaranteed by maximizing the product of all the
Df. We further refer to this product as M:
§ The peak resistance frequency is the frequency of 1/Z = 1/X1 + 1/(R +
X2) where the impedance is most resistive, i.e. the phase angle is close to
0u. The corresponding impedance magnitude value indicates the value of
R. X1 and X2 are the reactances of two capacitances (in our case:
electrical double layer capacitances or the parasitic capacitance at high
frequency).
Fig. 2 Cross-section of the planar bipolar sensor with corresponding
equivalent circuit and dimension parameters.
" The relative permittivity at an outer Helmholtz distance of 5 A˚
corresponds to 24.8 (and er = 0 at dOHP = 0) according to Conway et al.
16
An average value of 12.4 for the entire electrical double layer was used
in this study. This is valid because of the linear relationship between d
and er.
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M~ Df1:Df3ð Þ|ﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄ}
P
: Df2:Df4ð Þ|ﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄ}
D
~ log
f2
f1
! "
: log
f4
f3
! "! "
: log
f3
2
! "
: log
f5
f4
! "! " (5)
where Dfn = log(fn + 1/fn) is defined as the cut-off frequency
difference, P as the plateau length parameter and D = DR1 6
DR2 as the total resistance range.
In Fig. 3 the different cut-off frequencies are given by
fc = 1/(2pRC), where R is the solution resistance Rsol (eqn (2))
and C is the Helmholtz double layer capacitance CH (eqn (1)).
Consequently, the maximization ofM has implications on all the
experimental parameters from eqn (1–4). It becomes nevertheless
apparent that only wel and sel are relevant for the optimization
process since lel is cancelled out (if kept the same for all channels)
and r cannot differ in cell culture applications. Finally,M can be
simplified as
M~ log
wel,1
wel,2
! "
| log
wel,2
wel,3
! "
| log
k1
k2
! "
| log
k2
k3
! "
(6)
where k is calculated according to the electrode size by using eqn
(3) and eqn (4).
We have simulated M for all three sensors as a function of wel
and sel as shown in Fig. 4. According to Fig. 4a, both electrode
spacing and width have to be as large as possible for sub-sensor
1. In this case, the main size limitations are given by the available
space on chip and by the lowest AC measurement frequency.
Similarly, according to Fig. 4c, the geometrical dimensions have
to be as small as possible for sub-sensor 3, the main limitation
being now given by the microfabrication process. Once the
dimensions of sub-sensors 1 and 3 are set, the electrode spacing
and width of sub-sensor 2 can be optimized by maximizing the
function M (Fig. 4b).
Note that the dimensions of sub-sensors 1 and 3 determine
respectively the lowest and highest cut-off frequencies of the
FMIS, and consequently its total frequency range (= f1/f5) and
total resistance range (= R3/R1). The optimization of the
dimensions of sub-sensor 2 determines the other cut-off
frequencies such that they are distributed as equally as possible
over the total frequency range, especially P1 = P2 (Df1 = Df3) and
D1 = D2 (Df2 = Df4).
Moreover, the total resistance range D can be further
increased by introducing interdigitated electrodes (IDE), simul-
taneously decreasing the plateau lengths (P). We have developed
a model that provides the number of interdigitated electrode
fingers for a desired resistance range (see Fig. S1 in the ESI{ for
detailed information).
3 Materials and methods
3.1 Electrode chip design and fabrication
The electrode dimensions were based on the simulations presented
in Fig. 4. We have chosen large sel,1 and wel,1 (8000 mm and
500 mm) as indicated by Fig. 4a. The parameters of the third
sensor, sel,3 and wel,3, were chosen small (both 5 mm). In the case of
the triple sensor, the additional parameters sel,2 and wel,2 were
chosen according to the resulting optimum as demonstrated in
Fig. 4b (wel,2 = 51 mm and sel,2 = 1150 mm). The FMIS is shown in
Fig. 5 (double sensor: only the upper and lower channel was used;
triple sensor: all channels).
For the electrode microfabrication, a 20 nm thick titanium
adhesion layer and a 200 nm thick platinum layer were
successively evaporated and structured on a 4-inch glass
substrate using the standard photolithographic lift-off technique.
3.2 Microfluidic chip design and fabrication
A microfluidic chip made of PDMS (polydimethylsiloxane) was
used to separate the sensing areas. Two (double sensor) or three
(triple sensor) microfluidic channels were embedded, all with
a channel width of wch(lel) = 500 mm and a channel height of
h = 120 mm. The channel height was defined by the fabrication
process. For this, a cutter plotter was used to cut and structure a
120 mm thick tape that was adhered onto a transparent foil. The
resulting structure was used to mold the PDMS microfluidic
chip. Holes punched through the PDMS served as injection
reservoirs.
3.3 Conductivity and cell culture experiments
The assembled PDMS and electrode chip were connected to a
printed circuit board (PCB) for electrical measurements. The
microfluidic channels were filled with different concentrations of
PBS (phosphate buffered saline) (0.1256, 0.256, 0.56, 16,
26). First, only one channel was filled with liquid while the
other ones contained air (mono sensor). Second, all channels
were filled with PBS and the concentration was varied crosswise
(double/triple sensor). The impedance was measured with an
impedance analyser (Agilent 4294, Agilent technologies, USA)
from 40 Hz to 30 MHz (10 mV amplitude, 0 mV bias) and
recorded using Matlab software. The solution resistances were
consequently obtained through equivalent circuit fitting. All
values are presented as mean ¡ standard error of the mean
(SEM). For sensitivity determination (rmeas/rreal), the measured
resistivity was obtained by dividing the mean resistance by the
average experimental cell constant. The resistivity of the different
Fig. 3 A simplified impedance magnitude-frequency spectrum accord-
ing to a triple sensor. All cut-off frequencies necessary for the
optimization process are shown. Cn is the double layer capacitance and
Rn is the bulk resistance of the n
th electrode-channel segment.
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solutions was measured with a conductivity meter (SevenEasy,
Mettler Toledo). We assume hereafter that these values are the
real resistivities of the solutions.
MCF-7 cells were cultured in a 75 cm2 flask before loading
them in the microfluidic chip. The cells were incubated in
Dulbecco’s Modified Eagle’s Medium (DMEM) (Invitrogen,
Switzerland), containing 10% fetal calf serum (Invitrogen,
Switzerland), at 37 uC and 5% CO2. The cells were loaded into
the microfluidic channels at a density of 10 Mio cells ml21. They
were cultured for 24 h before 100 mM doxorubicin treatment
was started. The drug treatment initiation was shifted by 45 min
for the two channels so that the functionality of the double
sensor could be demonstrated. All materials were autoclaved for
the cell culture experiments.
4 Results and discussion
4.1 Characterization of the double sensor
The goal of this study was to demonstrate the ability to measure
two or more signals with one single electrode pair. For this, we
have exploited the frequency dimension to separate the different
signals. The major challenge was to design the sensor such that a
maximal frequency separation of the PRFs (Fig. 1) and thus a
maximal M (eqn (5)) could be achieved.
In the first step, we have characterized our device experimen-
tally to verify the validity of our simulations and the consequential
chip design. All system specific parameters are presented in
Table 1 and the corresponding impedance spectra are depicted in
Fig. 6.
The small deviations in cell constant, resistance and capaci-
tance values were attributed to the flexible PDMS that cannot
guarantee very precise fabrication dimensions. In addition, the
dimensions of the electrode after fabrication were not exactly
5 mm each (sel2 = 3.4 mm and wel2 = 6.3 mm).
Fig. 4 Simulation ofM as a function of wel and sel. (a) Sub-sensor 1 indicates a largeM with larger values for wel,1 and sel,1, (b) sub-sensor 2 indicates
an optimum ofM at wel,2# 50 mm and sel,2# 1000 mm; (c) sub-sensor 3 maximizesM for small values of wel,3 and sel,3. All simulations were carried out
with the fabrication values (wel,1 = 500 mm, wel,2 = 51 mm, wel,3 = 5 mm, sel,1 = 800 mm, sel,2 = 1150 mm, sel,3 = 5 mm).
Fig. 5 Electrode (black) and channel (grey) design. The bipolar
electrode pair is characterized by three sub-regions that differ in
electrode width and spacing. Three microfluidic channels are implemen-
ted to create a sample separation aligned onto the three sub-sensors.
Four PCB connection pads are used since the shortening of the current
injection and the voltage pick-up electrodes are done on-chip (higher
sensitivity).
Table 1 Theoretical and experimental values for equivalent circuit
parameters for the double sensor. Calculated data was obtained by eqn
(1)–(4). Experimental data was extracted through equivalent circuit
fitting (mean, n = 5)
Parameters Calculated data Experimental data
R1 82 kV 104 kV
R2 1.2 kV 1.5 kV
C1 27.4 nF 28.4 nF
C2 0.35 nF 0.29 nF
f1 70 Hz 40 Hz
f2 5.6 kHz 5.6 kHz
f3 383 kHz 357 kHz
k1 139 6 10
3 m21 169 6 103 m21
k2 2026 m
21 2156 m21
Fig. 6 Simulated and experimental impedance spectra of the double
sensor.
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Concurrently, the experimental impedance magnitude and
phase curves are found to be more flattened than the simulated
one (Fig. 6). This is explained by the complex nature of the
electrode–electrolyte interface. Surface roughening and steric
effects lead to a multitude of different capacitor–resistor circuits
resulting in a descending slope that is inferior to 45u (which is the
slope angle of an ideal capacitor). This complex behaviour is
conventionally described by a constant phase element.19
However, for the sensor optimization we consider the interface
capacitance as a perfect capacitor since the goal here is to simply
separate cut-off frequencies. For this purpose, an approximate
value for the capacitance is sufficient.
We fabricated a double sensor that meets the initial require-
ment of well frequency-separated PRFs. Small deviations in the
cell constant of sensor 1 and the capacitance of sensor 2 were
attributed to setup and fabrication. Nevertheless, it has been
shown that the double sensor complies with the design
specifications.
4.2 Validation of the FMIS
In order to validate our FMIS, we checked the similarity of the
measurement results of both sub-sensors compared to their
corresponding mono sensors on the one hand, and their
measurement sensitivity on the other. We have measured channel
1 and 2 individually (mono sensing) and simultaneously (double
sensing). The mono sensor measurements were done by leaving
one channel filled with air. The double sensor measurements
were carried out by varying the PBS concentration in channel 1
and 2 crosswise. The results are shown in Table 2 and illustrated
in Fig. 7. The values for the mono and double sensors match well
for both channels with a maximum deviation of less than 4%
for sensor 1 at 0.56 PBS (196 kV vs. 205 kV). No significant
deviation difference from the mono to double sensor is observed
between channel 1 and 2 (3.4% vs. 1.5%). Thus, both sensors are
considered equally functional. Next, we have evaluated the
sensitivity of sub-sensor 1 and 2. Fig. 7b shows the ratio of the
measured resistivity against the real resistivity at different
dilutions of PBS. Both sensors show a very high sensitivity with
a maximal median deviation of 3.8% for sensor 2 at 16 PBS.
Nevertheless, sub-sensor 2 reveals a larger average deviation of
the means than sub-sensor 1 (2.2% vs. 0.7%). This is explained by
the inherent higher sensitivity of sub-sensor 2, due to its lower
resistance compared to sub-sensor 1. In conclusion, no significant
value differences between the mono sensors and the FMIS were
observed and a high sensitivity was demonstrated.
4.3 Cell toxicity application
The applicability of the FMIS to cell culture experiments was
verified. We seeded MCF-7 cells, a human breast cancer cell line,
in both microfluidic channels and cultured them for a period of
24 h. We then treated the cells with 100 mM doxorubicin in one
channel after another with a time delay of 45 min. Accordingly,
the sensor selectivity of the FMIS measurement method was
investigated for utility in cell toxicity platforms. Fig. 8 shows the
impedance magnitude spectra in the absence and presence of
cells (a) as well as the temporal evolution of the cellular
impedance for both channels after drug treatment (b). The
frequency where the impedance change is largest (following cell–
electrode attachment) depends on the sensor geometry.
Consequently, different geometrical constants among sensors 1
and 2 lead to two different screening frequencies (relative |Z|-
maxima in Fig. 8a). Furthermore, we observed that the relative
impedance change is larger for sensor 2 than for sensor 1. This
may be explained by the different electrode sizes. One cell is able
Table 2 Measured solution resistance values (in kV) in channel 1 and 2 in the mono- and double sensor mode as a function of PBS concentration
(mean ¡ SEM, n = 5)
PBS conc. (resistivity) 0.1256 (4.37 Vm) 0.256 (2.24 Vm) 0.56 (1.15 Vm) 16 (0.61 Vm) 26 (0.32 Vm)
Mono sensor 1 748.6 ¡ 13.3 380.7 ¡ 7.9 195.8 ¡ 4.5 103.5 ¡ 2.4 55.2 ¡ 1.6
Mono sensor 2 9.12 ¡ 0.19 4.79 ¡ 0.06 2.49 ¡ 0.03 1.32 ¡ 0.02 0.71 ¡ 0.01
Double sensor 1 768.3 ¡11.8 393.2 ¡ 5.5 204.6 ¡ 1.6 107.1 ¡ 0.7 57.4 ¡ 1.0
Double sensor 2 9.30 ¡ 0.07 4.80 ¡ 0.03 2.53 ¡ 0.04 1.37 ¡ 0.02 0.71 ¡ 0.01
Fig. 7 Double sensor validation. (a) Measured solution resistance values in channel 1 and 2 in the mono and double sensor mode are plotted against
the PBS concentration (mono sensor: mean + connecting line; double sensor: mean¡ SEM, n = 5). Error bars not shown are smaller than the symbol
size. The double sensor values correlate well with those from the mono mode. (b) Box plot of the ratio of the measured resistivity and the real resistivity
as a function of the PBS concentration (whiskers: min to max). The measured resistivities were calculated by dividing the solution resistance by the
average experimental cell constant (see Table 1). Both sensors show a high sensitivity with a maximal median deviation of 3.9% (sensor 2 at 16 PBS).
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to cover the entire electrode width of sensor 2, thus insulating
this one completely. The electrode of sensor 1, on the other hand,
is too large and the current can shunt in between the cells
resulting in a leaky insulation and a less strong relative
impedance increase.
Being treated first with doxorubicin, the resistance of channel
1 dropped by 40% within 30 min. The measured resistance in
channel 2, on the other hand, remained constant at 100%. Once
channel 2 was treated after 45 min, the corresponding resistance
decreased as well.
This experiment demonstrates the high selectivity of the FMIS
measurement method. Two distinct cell populations have been
screened separately with only one electrode pair. Although two
identical microfluidic channels have been used, the electrode
geometry differed. This might be a problem in cell culture
applications where identical conditions are required, e.g. current
penetration depth or cell–substrate contact. For those cases, we
suggest implementing an additional electrode–electrolyte capa-
citor using a simple liquid-filled channel in order to modify the
sub-sensor capacitance value (‘capacitive bridge’) (an example is
provided in Fig. S2 in the ESI{). In such a case, the final
electrode–cell contact region can be identical.
4.4 Multi-channel sensing and sensor limitations
We have demonstrated the functionality of the double sensor by
validation with a cell-based application. We will now discuss the
implementation of more than two sub-sensors. Instead of using
multiple separated electrodes, such a FMIS would not only open
the door to very simple multi-channel screening, but also allow
the minimization of the total sensor size.
A triple sensor has been designed, as illustrated in Fig. 5,
according to the simulations presented in Fig. 4. This optimiza-
tion process aims at both a maximum PRF separation and
maximum resistance range. The corresponding impedance
spectrum of the fabricated triple sensor is depicted in Fig. 9a.
The experimental and the theoretical curve match well, although
there are some deviations. These deviations are explained, as
already mentioned for the double sensor, by the complex nature
of the electrode–electrolyte interface and by the sensor fabrica-
tion (see section 4.1). However, our fabricated triple sensor fulfils
the most important requirements, i.e. the distinct separation of
the PRFs and equally distributed sub-resistance ranges (D1#D2),
within the total resistance range (D). This total resistance
range is predefined by the parameters indexed 1 and 3 and
equals the one of the double sensor. As a logical consequence,
a common total sensor resistance range for the double and
triple sensor results in halved sub-sensor resistance ranges for
the triple sensor. This effect is illustrated in Fig. 9b. Hence,
the resistance range linearly decreases with an increasing
number of sub-sensors. Such a decrease can be opposed by
introducing interdigitated electrodes (IDEs) as sub-sensor 3.
IDEs decrease the cell constant and thus increase the total
resistance range. This effect is shown in Fig. 9b where D is
increased by the expense of a decreased P and also a decreased
frequency range. In this context, the number of electrode
fingers of the IDE can be determined for a desired resistance
range (detailed information about this optimization is provided
in Fig. S1 in the ESI{). Despite a decreased frequency range,
an increased resistance range can be particularly useful when
large resistance changes are measured.
In conclusion, we have been able to fabricate a triple sensor
using the optimization function M. A higher number of sub-
sensors at a constant total resistance range is accompanied by a
lower measurement resistance range for the individual sub-
sensors. This effect may be avoided by selectively increasing D,
e.g. by introducing IDEs.
5 Conclusions
We have introduced the concept of a FMIS that is capable of
screening more than one channel at the same time. The
simultaneous measurement of these channels was achieved
through frequency multiplexing. The frequency division (FSM)
for all sub-sensors required the optimization of the chip design.
For this purpose, we have developed a simulation model for
simple rectangular electrode pairs as well as for interdigitated
electrodes. Our fabricated chips corresponded well to the model
and allowed very precise conductivity measurements in all
channels in parallel. The applicability for biological experiments
was demonstrated with a cell-based toxicity experiment. It has
been shown that two distinct cell populations are monitored
separately and simultaneously with only one electrode pair.
Our technology may find applications in impedance measure-
ments that are carried out in vivo. Microprobes implanted in
tissues to measure the resistivity at different sites can be
simplified by reducing the total probe width since parallel
electrode traces become unnecessary. Therefore, the invasiveness
of a probe using our technology would be decreased.
The measurements, as they were done in this study, comprised
of sub-sensors that differed in shape and positioning. When
identical experimental conditions are required, e.g. in biological
applications, we recommend the introduction of ‘‘capacitive
bridges’’. We refer to capacitive bridges as capacitors that are
placed between the individual sub-sensors, that do not contribute
to the resistance measurement, but that modify the capacitance
of this sensor. An additional liquid-filled channel, for example,
that adds an electrode–electrolyte interface capacitor, is cur-
rently being developed. On the other hand, the geometry
differences may be considered as an advantage since different
sensor sizes and geometries lead to different measurement
Fig. 8 Cell toxicity experiment. (a) Impedance magnitude spectra and
relative |Z| change (rel. |Z| = (|Z|cell?|Z|cell-free)/|Z|cell-free) due to cell
attachment in channel 1 and 2 are shown. Each channel has its specific
rel. |Z| maxima. (b) The cell impedance Zcell is shown for both sub-
sensors at the rel. |Z|-maxima-frequencies. MCF-7 cells cultured in both
channels were exposed to 100 mM doxorubicin with a time delay of
45 min. ‘1’ and ‘2’ indicate the drug application in channel 1 and 2.
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depths. As an application, one FMIS may be used to probe the
thickness of a tissue as it has been shown previously with a
complex switch system.20
Altogether, we have introduced an easy technique to screen
multiple channels at the same time with a simple measurement
setup. We see a high demand for such devices in in vivo
applications where the size of the implanting probes is limited,
but multiple sensors are required; as well as in in vitro
applications where different measurement depths are needed.
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Fig. 9 Multi-channel sensing. (a) Simulated and experimental impedance spectra of the fabricated triple sensor with 16 PBS. Three PRFs are
identified indicating three well frequency-separated sub-sensors. The resistance ranges are similar for all sensors (D1# D2). (b) The calculated values of
P1,2, D1,2 and the frequency range are shown for the double, triple and triple-interdigitated sensor. All values correspond to optimized sensors (Mmax)
where P1 = P2 and D1 = D2. The resistance ranges of the triple sub-sensors are halved compared to the double sub-sensors while the total frequency
range remains constant. In contrary, the resistance ranges of the triple-IDE sub-sensors are increased by the expense of a decreased total frequency
range.
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Label-free recognition of drug resistance via impedimetric screening of breast cancer
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Abstract
We present a novel study on label-free recognition and distinction of drug resistant breast cancer cells (MCF-7 DOX) from
their parental cells (MCF-7 WT) via impedimetric measurements. Drug resistant cells exhibited significant differences in their
dielectric properties compared to wild-type cells, exerting much higher extracellular resistance (Rextra). Immunostaining
revealed that MCF-7 DOX cells gained a much denser F-actin network upon acquiring drug resistance indicating that
remodeling of actin cytoskeleton is probably the reason behind higher Rextra, providing stronger cell architecture. Moreover,
having exposed both cell types to doxorubicin, we were able to distinguish these two phenotypes based on their
substantially different drug response. Interestingly, impedimetric measurements identified a concentration-dependent and
reversible increase in cell stiffness in the presence of low non-lethal drug doses. Combined with a profound frequency
analysis, these findings enabled distinguishing distinct cellular responses during drug exposure within four concentration
ranges without using any labeling. Overall, this study highlights the possibility to differentiate drug resistant phenotypes
from their parental cells and to assess their drug response by using microelectrodes, offering direct, real-time and
noninvasive measurements of cell dependent parameters under drug exposure, hence providing a promising step for
personalized medicine applications such as evaluation of the disease progress and optimization of the drug treatment of a
patient during chemotherapy.
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Introduction
Breast cancer is the most common cancer type in women and
one of the leading causes of female mortality worldwide [1].
Chemotherapy is still one of the main treatment methods in clinic,
causing cell death in breast tumors treated with various anti-
cancer drugs. Despite the fact that many tumors initially respond
to chemotherapy, cells can gain resistance and they can adapt to
survive. Drug resistance often involves the transition of cancer cells
from an anti-estrogen-sensitive, non-metastatic, hormone depen-
dent phenotype to an anti-estrogen-insensitive, metastatic and
hormone independent phenotype [2]. Despite the fact that there
have been a plethora of studies addressing the mechanism behind
drug resistance [3–11], a comprehensive answer to such a complex
problem still remains elusive. Hence, a pressing demand has
directed researchers towards the development of rapid and simple
techniques for the investigation of interactions of cancer cells with
drugs [12] at different stages of the disease.
Cell-based impedance spectroscopy has attracted significant
attention as a label-free and non-invasive tool to study cellular
properties such as cell adhesion and cell growth [13–15], cell
migration [16,17], stem cell differentiation [18] and the effect of
anti-cancer drugs on cancer cells [19–21]. Although, there have
been some efforts on dielectric characterization of drug resistant
cells with impedance spectroscopy [22,23] and also with dielec-
trophoresis technique [24], there has been no detailed study that
distinguishes cell models of acquired drug resistance without
genetic manipulation from their parental cells, nor investigation of
drug interaction with such cells. Still substantial work needs to be
done to demonstrate a comprehensive explanation why dielectric
properties of cancer cells change when they gain drug resistance
and how drug resistant cells interact with drugs compared to their
parental wild type cells.
In addition, most of the toxicity studies demonstrated only the
temporal evolution of cellular changes at one frequency where the
contribution of cells to the measurement is at its maximum (cell
index). As was pointed out previously [25,26], it is possible to
distinguish cellular events by measuring the impedance spectra at
distinct frequencies assuming that a single cell can be described as
a shell-covered sphere [27,28]. At low frequencies (LF), the cell
membrane capacitor functions as an insulator and extracellular
events can be probed with impedance. At high frequencies (HF),
the cell membrane capacitor is short-circuited, and the impedance
changes correlate with intracellular events. Thus, impedance
measurements within a wide frequency range (from Hz to MHz)
allow the differentiation between the extracellular environment
and the cell interior, and their changes can be probed
simultaneously.
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Herein, we performed real-time monitoring of drug induced
cellular changes for MCF-7 breast cancer cells using impedance
spectroscopy. We were able to distinguish drug resistant breast
cancer cells (MCF-7 DOX) from their parental cells (MCF-7 WT)
by studying their inherent dielectric properties. The effect of
doxorubicin, one of the most widely used anti-tumor antibiotics,
was investigated over a wide frequency range and revealed sharp
differences in the temporal evolution of cellular changes between
the two phenotypes. To our knowledge, this is the first study that
differentiates drug resistant breast cancer cells from their parental
cells based on their dielectric properties and investigates their drug
response at different stages of the disease using impedance
screening at different frequencies.
Materials and Methods
Electrode Design and Fabrication
Interdigitated (IDEs) electrodes as shown in Figure S1 were
implemented in a well-based device for impedance measurements
of MCF-7 cell populations. IDEs offer highly sensitive measure-
ment owing to having large total electrode surface area. Platinum
was used for electrode material since it is biocompatible [29], and
highly polarizable offering mild conditions such as minimum
faradaic currents and lower risk of generation of cytotoxic
compounds [30]. Following evaporation of 20 nm thick titanium
adhesion layer, 200 nm thick platinum layer was evaporated and
patterned on a 4-inch glass substrate using standard photolitho-
graphic lift-off technique.
Cell Lines and Cell Culture on Microelectrodes
MCF-7 cells; wild-type (MCF-7 WT) and doxorubicin resistant
(MCF-7 DOX) cells (resistant to 1 mg/ml doxorubicin) were kindly
provided by Prof. Kapil Mehta (Department of Bioimmunother-
apy, The University of Texas M. D. Anderson Cancer Center,
Houston) [31]. MCF-7 DOX are a subclone of MCF-7 WT cells
that was selected by continuous exposure to doxorubicin and they
are functionally and phenotypically distinct from the parental
MCF-7 cells [32]. Both cell lines were maintained at 37uC and 5%
CO2/95% air in RPMI 1640 culture medium (Sigma-Aldrich,
Switzerland) supplemented with 10% heat-inactivated fetal calf
serum (Invitrogen, Switzerland), 2 mM glutamine and antibiotics
(100 U/ml penicillin and 100 mg/ml streptomycin) (Invitrogen,
Switzerland). MCF-7 DOX cells were cultured in the presence of
1 mg/ml doxorubicin (LC Laboratories, USA) in order to maintain
the drug-resistance phenotype. When cells are confluent inside 75
cm2 cell culture flasks, cells were detached with 0.25% trypsin/
EDTA (Invitrogen, Switzerland), counted with hemacytometer
(Sigma-Aldrich, Switzerland), and loaded inside the wells.
Glass chips (electrodes) were autoclaved and poly(methylmetha-
crylate) (PMMA) wells (inner diameter = 10 mm and
height = 8 mm) were disinfected with 70% ethanol before use.
For each electrode chip, one PMMA well was attached on it with
polydimethylsiloxane (PDMS) (Figure 1). 400 ml of cell suspension
with 1 million.ml21 cell density were seeded inside the well.
400000 cells on each electrode chip were sufficient enough to
cover the inside part of the wells (5095 cells/mm2). The device was
placed into the CO2 incubator and connected to an impedance
analyzer (Agilent 4294A, Agilent technologies, USA) via coaxial
cables, which pass through a small hole at the back of the
incubator, connecting the inside of the incubator to the outside
equipment.
After seeding the cells, both cell lines attached on the electrodes
within 10 h as was monitored by impedance spectroscopy (Figure
S2). Cells reached confluency resulting in a constant impedance
signal. Potential cell proliferation in z-direction (multilayer) did not
lead to further impedance increase since the current density of the
electric field is not strong enough to impact the impedance signal
(larger distance from electrodes). Then, doxorubicin was dissolved
in cell medium and added to the wells at different concentrations
(from 0.005 mM to 40 mM for MCF-7 WT and from 2 mM to
100 mM for MCF-7 DOX). The drug treatment for both cell lines
was performed for 48 h. Impedance spectra were recorded from
100 Hz to 30 MHz (10 mV amplitude, 0 mV bias) using Matlab
software [33]. The impedance measurements were performed at
10 mV since it corresponds to an electric field of 5 V cm21 close
to the electrode surface, which is three orders of magnitude lower
than the membrane permeation limit of 1–4 kV cm21 [34] and
can be considered as safe.
Equivalent Electrical Circuit Modeling for Cell Type
Characterization
The electrical properties of a cell can be described with an
electrical circuit, which has a membrane capacitor Cm with a series
intracellular resistance Rintra and a parallel extracellular resistance
Rextra [35]. Cm is replaced by a constant phase element (equation
(1)) since a cell population might have variations in their properties
and those of their microenvironments exerting heterogeneity
Figure 1. Cell culture well platform and electrical interface
(top). Schematic of cell culture on microelectrodes (bottom).
doi:10.1371/journal.pone.0057423.g001
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within the same cell population and might result in a number of
equivalent circuits with different time constants [36–38].
CPEcells~
1
bcells jvð Þacells
ð1Þ
where bcells is the magnitude and acells is the exponent component
of CPEcells, v is the circular frequency and j the imaginary number.
The electrode–electrolyte interface is represented by an electrode
constant phase element CPEel, which describes the non-ideal
capacitive behavior of the electrode due to surface roughness [39]
and protein adsorption [40] on the metal surface. Cpar is the
parasitic capacitance between the electrodes. This equivalent
circuit model (Figure 2a) was shown to have a good correlation
with measured impedance spectrum (Figure 2b). The weighted
sum of squares (WSS) was calculated as 0.2247 based on the
following equation (2).
WSS~
X Re,Imð Þmodel{ Re,Imð Þobservation! "2
DZDobservation
ð2Þ
Cell-dependent circuit components such as Rextra, Rintra, CPEcells
(acells and bcells) were obtained based on the fitting of the impedance
data to the equivalent circuit model. First, the impedance spectra
of the medium without cells were fitted and CPEel and Cpar were
obtained as 5.560.961028 Va21Fa and (9.760.9)610212 F
respectively. Then, the impedance spectra of both cell lines were
fitted and their specific circuit components were compared.
Equivalent circuit fitting is convenient since it allows attributing
values to all elements of a specific circuit model and comparing
these between different cells. However, for cultures exerting low
impedances (such as after drug exposure or low cell density), the
fitting process becomes less reliable since more than one solution
with low error becomes possible considering the number of free
parameters and the less characteristic impedance curves. There-
fore, we have chosen to follow-up the raw data at specific
frequencies for drug effect analysis as will be described in the next
section.
Choice of Measurement Frequencies for Drug Response
Studies
For drug response studies, we have recorded impedance data
both at low frequency (LF) and high frequency (HF). LF is defined
as the frequency before the membrane capacitor is shorted and
gives information about the cell exterior. Once the membrane
capacitor is short-circuited, the cell membrane is not a barrier to
current anymore, the current can pass through the cell interior
and information regarding the intracellular resistance can be
obtained. Based on this information, the drug response studies for
both cell lines were performed to extract both extra- and
intracellular properties of cells.
The choice of the two frequencies is based on a whole spectrum
analysis as follows. LF is ideally chosen at f = 0 Hz in order to
avoid the impedance drop caused by the shortening of the
membrane capacitor at higher frequencies. However, this is not
possible at least for bipolar measurements since the impedance
owing to the capacitive double layer at the electrode/electrolyte
interface decreases the sensitivity for extracellular effects. There-
fore, an intermediate frequency compromising both effects
(interface and cell membrane capacitances) needs to be chosen.
For this, we have defined LF as the frequency where the difference
between the phase angle in the presence and that in the absence of
cells is maximal (wLF) (equation 3).
wLF~ max
i~1,:::,n
wcells fið Þ{w0 fið Þ
w0 fið Þ
# $
ð3Þ
where wcells(fi) is the frequency-dependent impedance phase in the
presence of cells and w0(fi) is the one in the absence of cells. n is the
total number of frequency points at which the impedance was
measured. The impedance magnitude at this maximum phase
difference frequency was found to be most sensitive to extracellular
resistance changes. In our case, LF was determined as 10 kHz
(Figure 2b).
HF, on the other hand, needs to be chosen high enough to avoid
the impact of the membrane capacitor. HF was chosen as 2 MHz
since at this frequency the phase angle was closest to 0u before
being impacted by the parasitic capacitance (Figure 2b).
Half Maximal Inhibitory Concentration (IC50) Calculation
In order to calculate the half maximal inhibitory concentrations
(IC50) of MCF-7 WT and MCF-7 DOX cell lines, the normalized
|Z|cells at 2 MHz were plotted vs. logarithm of different
concentrations of doxorubicin. These inhibitory concentration-
response curves were fitted with nonlinear regression by using
equation (4) (GraphPad Software, USA) and IC50 values were
extracted.
Y~Ybottomz
Ytop{Ybottom
1z10 log (IC50){Xð Þ:m
ð4Þ
where Ybottom and Ytop are the values of the y-axis that correspond to
the bottom and the top part of fitting curve repsectively, IC50 is
half maximal inhibitory concentration, and m is the steepness of
the curve (a m of 21 is standard).
Fluorescence Microscopy
For immunohistochemistry staining cells were fixed with 4%
paraformaldehyde in phosphate buffer saline (PBS) (Invitrogen,
Switzerland) for 20 min. After fixation, cells were treated with 3%
BSA/0.1% Triton X-100 (Sigma-Aldrich, Switzerland) for
50 min. For tight junction staining, cells were first incubated with
the primary antibody monoclonal rabbit-anti-occludin (1:200,
Invitrogen, Switzerland) for 2 h and subsequently with the Cy-2
coupled secondary antibody (1:150, Dianova GmbH, Germany)
for 2 h. For E-cadherin staining cells were incubated with the
primary antibody monoclonal mouse-anti-E-cadherin (1:150,
Invitrogen, Switzerland) for 2 h and followed by the incubation
of rhodamine coupled secondary antibody (1:200, Dianova
GmbH, Germany) for 2 h. For actin staining, cells were incubated
with FITC coupled phalloidin (Sigma- Aldrich, Switzerland) for
2 h. Thereafter; all samples were incubated with 0.1 mg ml21
DAPI in PBS (Sigma-Aldrich, Switzerland) for 30 min. After
repeated washing, cells were observed with a confocal laser-
scanning microscope (LSM 700 inverted, Zeiss, Germany).
Time-Lapse Microscopy
Both cell lines were cultured in glass bottom culture dishes
(MatTek Corporation, USA). After all the cells adhered on the
glass bottom, the effect of doxorubicin at different concentrations
(from 0.02 to 20 mM) on cells were monitored with time-lapse
microscopy (Olympus CellR inverted, Japan) at 37uC and 5%
CO2 during 2 days, taking measurements every 30 min. The cell
morphology during drug exposure was investigated with 606
objective and phase contrast mode.
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Figure 2. Equivalent circuit modeling. a) The cell population is represented by the Cole-Cole model with an extracellular resistance (Rextra) in
parallel to the tissue constant phase element (CPEcells) and a high frequency intracellular current pathway (Rintra). The electrode/electrolyte interface is
modeled by a constant phase element (CPEelectrode). A parallel capacitance (Cpar) characterizes parasitic current shunts at high frequency. b)
Impedance plot of MCF-7 cell culture. LF and HF refer to the low and high frequency respectively that were followed-up in this study. The equivalent
circuit was used to fit the impedance and phase angle plots. (Weighted Sum of squares = 0.2247).
doi:10.1371/journal.pone.0057423.g002
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Statistical Analysis
Dielectric components of cells such as Rextra obtained for MCF-7
WT cells in 35 different chips and MCF-7 DOX cells in 20
different chips were expressed as means with 95% confidence
interval. Statistical analysis of Rextra was compared between MCF-7
WT and MCF-7 DOX cell populations using unpaired t-test. The
observed importance level (p-value) of the difference between two
means was considered significant when p,0.001.
Results
MCF-7 DOX and MCF-7 WT Cells Possessed Different
Extracellular Properties
We investigated whether doxorubicin resistant MCF-7 cells
(MCF-7 DOX) can be singled out from their parental cells (MCF-
7 WT) or not based on their dielectric properties. In order to reach
this goal, the impedance spectra of MCF-7 WT and MCF-7 DOX
cells with equal cell density were fitted in the absence of drug.
Figure 3 shows the values of the fitted circuit components (Rextra,
Rintra, magnitude b of CPEcells) for both wild type and drug resistant
cells. Although Rintra, and b showed negligible change when the
cells gained resistance to doxorubicin, we observed a significant
difference in Rextra between these two. MCF-7 DOX cells exhibited
50% increase in Rextra compared to MCF-7 WT cells when both
were cultured at confluency on platinum electrodes.
In order to find out the reason behind the increase of Rextra when
the MCF-7 WT cells gain drug resistance, we investigated the
nature of MCF-7 cellular tight junctions, adhesive junctions and
cytoskeleton structure by occludin staining, E-cadherin staining
and actin labeling respectively (Figure 4). The presence of tight
and adhesive junctions was confirmed for MCF-7 WT cells.
Occludin and E-Cadherin labeling was intense and formed a
continuous line at the cell contacts. No E-Cadherin could be
identified for MCF-7 DOX cells and tight-junctions were very
rare. Immunocytochemical staining of actin cytoskeleton revealed
significant structural changes between MCF-7 WT and MCF-7
DOX cells. Drug resistant cells exhibited a highly dense fiber-like
network of actin filaments while MCF-7 WT cells showed much
less labeling for F-actin protein.
MCF-7 DOX and MCF-7 WT Cells Displayed Different
Impedance Response to Doxorubicin at Low and High
Frequency
The effect of doxorubicin on MCF-7 WT and MCF-7 DOX
was studied separately at LF and HF. First, MCF-7 WT and
MCF-7 DOX cells were exposed to a 20 mM concentration of
doxorubicin during one day of continuous exposure. Figure 5
shows time dependent impedance magnitude changes at 10 kHz.
The impedance response to doxorubicin of both cell lines is
substantially different. While MCF-7 WT cells were severely
affected by the drug at this concentration, MCF-7 DOX cells
showed increasing impedance magnitudes under drug exposure
within 24 h. Control experiments showed that both MCF-7 DOX
and MCF-7 WT cells were healthy in the absence of drug and
displayed relatively unchanged impedance profiles within 24 h. In
order to make sure the impedance magnitude changes originate
from doxorubicin-induced cellular changes, not from the presence
of doxorubicin in the cell medium itself, the spectra of cell medium
with and without drug were recorded as a control experiment.
Only a 5% increase was observed in the impedance when 20 mM
doxorubicin was introduced to the cell medium (Figure S3). This is
negligible compared to the observed increase of the impedance in
the presence of cells. In addition, the temporal evolution of |Z| of
20 mM doxorubicin in cell medium also did not show any change
when there are no cells inside the wells (Figure S3).
Doxorubicin treatment with different concentrations was
performed with MCF-7 WT cells but one-day drug exposure
was enough to obtain significant cellular changes for highly
sensitive MCF-7 WT cells. Doxorubicin was dissolved in cell
medium and added to the cells at different concentrations (from
0.005 mM to 40 mM for MCF-7 WT and from 2 mM to 100 mM
for MCF-7 DOX). As seen in Figure 6a, The LF signal exhibited
an increase in the presence of low drug concentrations when HF
signal was unaltered. When cells were exposed to higher drug
concentrations, the LF signal reversed its direction and started
decreasing after 0.02 mM drug intake, while HF signal did not
change significantly up to 2 mM drug exposure and decreased
much later than LF signal. Figure S4 also supports the correlation
between LF and HF signals and the drug induced morphological
changes of MCF-7 WT as a function of drug concentrations.
On the other hand, since MCF-7 DOX cells are highly
resistant; their temporal evolution was monitored during drug
Figure 3. Comparison of the dielectric components of MCF-7 WT and MCF-7 DOX cells (mean ± SEM). a) The resistant cells display a
significant increase in Rextra compared to the wild type cells (p,0.0001). b) and c) The magnitude b of CPEcells and Rintra do not show significant
alterations when the cells gain drug resistance. (n = 35 for MCF-7 WT and n= 21 for MCF-7 DOX cells, cell constant = 3660650 m21 and
smedium = 361 mS.cm
21, substrate: platinum).
doi:10.1371/journal.pone.0057423.g003
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Figure 4. Immunocytochemical staining of cellular tight junctions (bar=50 mm, green: occludin-Cy-2, blue: DAPI), adhesive
junctions (bar=20 mm Red: E-cadherin - Rhodamine, blue: DAPI) and actin (bar =10 mm, green: Phalloidin-FITC, blue: DAPI) for
MCF-7 WT and MCF-7 DOX cells. Loss of tight junctions and adhesive junctions is observed upon gaining drug resistance. No E-cadherin was
identified for MCF-7 DOX cells. Drug resistant cells displayed a highly dense fiber-like network of actin filaments and more cell-to-cell contact
compared to MCF-7 WT cells.
doi:10.1371/journal.pone.0057423.g004
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exposure for a longer period of time (48 h). LF signal showed
considerable increase up to 20 mM drug exposures while HF signal
displayed a slight increase up to the same drug concentration
(Figure 6b). Figure S5 also confirms that MCF-7 DOX cells were
healthy and dense, all adhered on the platinum electrodes after
24 h of 20 mM drug exposure. High concentrations of doxorubicin
(from 40 mM to 100 mM) lead to an impedance drop at both LF
and HF, revealing similar kinetics and decreasing sharply at both
frequencies.
In addition, concentration-response curves were obtained by
plotting |Z| at 2 MHz after 48 h of drug exposure vs. different
drug concentrations. The half maximal inhibitory concentrations
(IC50) for both MCF-7 WT and MCF-7 DOX cells were extracted
from the fit to sigmoid concentration-response curves as shown in
Figure 7. IC50 values were obtained as 0.4 mM and 70 mM for
wild-type cells and drug resistant cells respectively.
MCF-7 DOX and MCF-7 WT Cells Showed Remarkable LF
Impedance Increase at Nontoxic Drug Doses
MCF-7 DOX cells showed a concentration-dependent imped-
ance increase when they were exposed to drug concentrations
between 2 mM and 20 mM and such impedance increase with
respect to the control was more pronounced at LF with very little
difference obtained at HF (Figure 6b and 8a). When the drug was
replaced with medium after MCF-7 DOX cells were exposed to
such concentrations of doxorubicin for 48 h, the impedance
signals retrieved back to their initial magnitudes (Figure 8b). In
addition, a step-wise increase of the drug concentration also leads
to a sequential increase of |Z| (Figure 8c). The subsequent
exposure of the resistant cells to first 5 mM and then 20 mM
doxorubicin concentrations (each for 24 h) resulted in a step-wise
increase of |Z|; finally the signal dropped back to its initial value
after incubating the cells in medium for 1 h.
Such an impedance increase at nontoxic drug concentrations
was also observed for MCF-7 WT cells (Figure 6a). MCF-7 WT
cells displayed higher impedance when they were exposed to the
nonlethal drug concentrations such as 2 and 5 nM compared to
the same cells in the absence of drug (control). Such an increase
was observed only at LF while HF signal showed negligible change
in the presence of non-lethal drug concentrations.
Discussion
In the present study, we have demonstrated that impedance
spectroscopy is a simple and useful technique that distinguishes
drug resistant cells from their parental cells based on their
dielectric properties. Drug resistant variants were shown to exert
higher extracellular resistance. It was found that actin cytoskeletal
remodeling might play an important part in higher extracellular
resistant behavior of MCF-7 DOX cells, providing stronger
cellular architecture. Moreover, we have screened concentration
and time dependent effects of doxorubicin on cell interior and
exterior of breast cancer cells at earlier and later stages of the
disease. Our experiments indicate four distinct drug concentration
Figure 5. Drug response of MCF-7 WT cells and MCF-7 DOX
cells to 20 mM doxorubicin during 24 h at LF (10 kHz). Data
points (mean 6 SEM, n = 5) were normalized to the magnitude value at
t = 0 h. The impedance drops sharply at LF for MCF-7 WT cells,
indicating that 20 mM doxorubicin is strong enough to induce toxic
effects, while cells in the absence of drug (control) were healthy and LF
signal was relatively unchanged. On the other hand, MCF-7 DOX cells
displayed increasing impedance compared to their control indicating
resistance to this drug concentration and demonstrating the substantial
differences in the drug response of MCF-7 WT cells and their drug
resistant phenotypes.
doi:10.1371/journal.pone.0057423.g005
Figure 6. Normalized |Z| vs. different concentrations of
doxorubicin at LF (10 kHz) and HF (2 MHz) for a) MCF-7 WT:
the LF and HF signals exhibit different profiles with respect to
different drug concentrations. At low drug concentrations, the LF
signal increased when HF signal was unaltered. At mild drug
concentrations such as 0.2 mM doxorubicin, the LF signal decreased
with no change in HF signal. At high drug concentrations such as 20 mM
and 40 mM doxorubicin both LF and HF signal decreased sharply,
showing similar kinetics. b) MCF-7 DOX: the LF signal increases at non-
lethal drug concentrations when HF signal exhibited a slight increase.
At high drug concentrations such as 40 mM and higher, the LF and HF
signal displayed similar impedance profiles and dropped sharply. The
plots were fitted by nonlinear regression based on the equation for bell-
shaped concentration response only for visual presentation. Data points
(mean 6 SEM, n = 5) were normalized to the magnitude value at t = 0 h.
doi:10.1371/journal.pone.0057423.g006
Label-Free Recognition of Drug Resistance
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e57423
ranges that display particular dielectric responses of the cells under
drug exposure.
Distinction of Drug Resistant Cells with their Cell
Dielectric Properties
We investigated the dielectric properties of MCF-7 DOX cells
and MCF-7 WT cells. Based on fitting their impedance profiles
with the equivalent circuit model, both cell lines exhibited similar
Rintra and b indicating that there were no measurable alterations in
the electrical properties of the cell membrane and cytosol when
MCF-7 cells gain drug resistance. However, drug resistant cells
displayed 50% increase in Rextra, implying significant changes in
the cell morphology and structure upon drug resistance. The
finding with Rextra is a novel result, however quite unexpected. Rextra
for drug resistant cells was expected to be lower since loss of tight
junctions and absence of E-cadherin in MCF-7 DOX cells
(Figure 4) should have resulted in shunting of the current flow
through the intercellular space and thereby lowering the Rextra. On
the other hand, actin staining shows that MCF-7 DOX cells
possessed highly dense F-actin network and had elongated form of
actin fibers in cytoplasm up to cell peripheral region, while MCF-7
WT cells had peripheral actin, which is much less dense in their
cellular structure. These results suggest that remodeling of the
actin cytoskeleton might probably be the reason behind the higher
extracellular resistance when MCF-7 cells become resistant to
doxorubicin and when seeded at confluence on platinum
electrodes. In fact, in cell culture on stiff substrates, the actin
cytoskeleton tends to organize in stress fibers [41]. Doxorubicin
treatment disrupts such fiber-like organization [42,43] leading to
cell–substrate detachment [44].
Hence, the actin network is a crucial and complex system that
provides base and support to retain cell morphology and
mechanical structure [45]. The extracellular and phenotypical
events of a metastatic carcinoma are mainly governed by
structural reorganization of actin [46,47]. If the MCF-7 cells use
the reorganization of the actin cytoskeleton to become resistant to
doxorubicin, then a question may arise about the role of dynamic
actin remodeling on transformation of a cancer cell to a drug
resistant phenotype. Some studies showed that actin remodeling
may play a part in inactivation of some actin binding proteins such
as E-cadherins [48,49] and gelsolin [50] that have tumor-
suppressor functions, and activation of actin signaling pathways
that leads to malignant phenotypes such as pathways involving
Ras [51] and Src [52] proteins. A recent study showed lower cell
stiffness upon disrupting the actin cytoskeleton with an inhibitor of
actin polymerization, implying the importance of actin remodeling
in drug-mediated cell stiffness modulation and drug resistance
[53]. However, it is still unclear if such highly dense F-actin
network participates in drug efflux by limiting the drug intake by
drug resistant cells or if such organization of F-actin filaments
participates in drug efficacy through influencing the cell
membrane physical properties. In addition, such actin reorgani-
zation might be a consequence of drug-induced phenotypic events
of a signaling pathway that leads to drug resistance. The exact
effect of actin remodeling on the drug resistance remain to be
elucidated and was not our focus here, thereby was not conducted
in the framework of this study.
Overall, the drug resistant cells were distinguished from their
parental cells based on their higher extracellular resistance. Such
detection of drug resistant cells based on their dielectric properties
might allow assessing the stage of the disease by selective
recognition of certain phenotypes and designing the optimum
personalized treatment based on the disease progress.
Figure 7. Concentration-response curves are obtained by
plotting |Z| at 2 MHz after exposing the cells to various
concentrations of doxorubicin. The data was fitted to a sigmoid
model. Based on the resulting fit, IC50 values were obtained as 0.4 mM
and 70 mM for MCF-7 WT and MCF-7 DOX respectively. Data points
(mean 6 SEM, n = 5) were normalized to the magnitude value at t = 0 h.
doi:10.1371/journal.pone.0057423.g007
Figure 8. Effect of stimulatory non-toxic drug concentrations on MCF-7 DOX. a) MCF-7 DOX exhibits a concentration-dependent increase
in impedance magnitudes during drug treatment with nontoxic concentrations. The plot was fitted by nonlinear regression using exponential decay
equation only for visual presentation. b) Impedance magnitudes vs. time plots of MCF-7 DOX cells when 20 mM doxorubicin was applied for 48 h and
followed by medium washing for 24 h. This shows that the impedance increase is reversible when the drug is removed. c) Temporal evolution of |Z|
when resistant cells were exposed to 5 mM doxorubicin for 24 h, followed by 20 mM drug concentration for 24 h, then medium washing as a last step
for 1 h. This shows that the impedance increase can be sequentially added up; once the stress on cells is removed, the initial state of extracellular
environment is reobtained. Data points (mean 6 SEM, n = 5) were normalized to the magnitude value at t = 0 h.
doi:10.1371/journal.pone.0057423.g008
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MCF-7 DOX Displayed a 175 Times Higher Drug
Resistance
The drug response of MCF-7 DOX cells was compared with
the one of MCF-7 WT cells. It was observed that only strong
doxorubicin concentrations such as 40 mM and higher could
decrease the LF and HF impedance signal of MCF-7 DOX within
48 h (Figure 6b). MCF-7 WT cells, on the other hand, already
displayed an impedance decrease at much lower concentration
such as 0.2 mM after 24 h (Figure 6a), showing that MCF-7 DOX
cells are more resistant to doxorubicin.
Based on the concentration response curves of these two cell
lines (Figure 7), MCF-7 DOX cells exhibited a 175 times higher
IC50 value than that of MCF-7 WT cells, which is consistent with
the findings of Mehta et al. who obtained more than 150 times
more resistance with MCF-7 DOX cells compared to their
parental cells by applying conventional viability assay to the same
cell lines [11]. This shows that impedance screening offers a highly
sensitive label-free technique that can assess the effect of a drug on
the different phenotypes of the same cell type with high accuracy.
Impedance Profiles Revealed Four Distinct Drug
Responses within Specific Ranges of Drug
Concentrations
We already showed in our previous study that LF and HF
impedance signals exhibited different kinetics when cells were
exposed to drug, revealing different information about cell
properties [25]. In this study, we also observed different temporal
evolutions at LF and HF when MCF-7 WT cells were exposed to
0.2 mM and higher doses of doxorubicin (Figure 6a). At LF cell
membranes block the current from flowing inside the cells, acting
as capacitors. Such densely packed insulating cell layer exerts a
high extracellular resistance and this resistance is prone to change
when stress is applied on cells. The extracellular resistance drops
when cell-substrate and cell-cell contacts are weaker due to the
contraction of cells in the presence of drug and current flows
through the intercellular space more easily. This phenomenon is
the reason why the LF signal decreases upon interaction with drug
[25] and renders this method much more sensitive to toxic effects
compared to traditional viability assays since drug toxicity can be
sensed long before cell death takes place (see Figure 4 in [10]). On
the other hand, the cell membrane capacitor shortcuts at HF and
cell interior contribute to the measured impedance more
significantly. As we already discussed in our earlier study [25]
when cells are dying, the intra- and extracellular matters exchange
due to the pore formation during cell death, resulting in more
conductive cytosol with the influx of more conductive cell medium
[28], and thus lower HF impedance signal.
In addition to the difference between LF and HF profiles, we
have observed two more distinct responses at LF within specific
concentration ranges (Figure 9). First, the drug has no effect,
resulting in unaltered LF and HF signal. Second, at higher
nontoxic drug concentrations, an increase in impedance at LF is
observed. The cell morphology might adapt itself in a way that
cells show stimulatory response upon drug interaction and impede
the current more with enhanced cell-substrate contact, resulting in
higher impedance at LF while HF signal remains the same. When
the drug is toxic at higher concentrations, there are two
circumstances that need to be taken into account. At mild
inhibitory drug doses, there might be an intermediate phase where
drug induced morphological changes might result in lower LF
while cell interior is unaffected with no change in HF signal. At
higher toxic concentrations, drug might induce substantial changes
in the extracellular and intracellular environment, reflecting in
sharp and simultaneous decrease in both LF and HF signal. These
findings indicate that impedance spectroscopy not only distin-
guishes minor morphological changes from major cellular damage
based on different kinetics of LF and HF signal, but also provides
useful information when applying non-toxic drug concentrations,
i.e. distinguishing concentrations that induce a stimulatory
response from the concentrations that result in no measurable
effect.
Impedimetric Measurements Revealed Enhanced Cell
Stiffness at Non-toxic Drug Concentrations
When low concentrations of doxorubicin (2–5 nM for MCF-7
WT and 2–20 mM for MCF-7 DOX) were added to the cell
medium, |Z| showed remarkable increase, especially at LF,
compared to that of cells in the absence of drug (Figure 6). The HF
signal was relatively unchanged. In addition, there was no
impedance change when such drug concentrations were added
to the cell medium itself in the absence of cells. These results imply
that drug at low and non-toxic concentrations might influence the
biophysical and biomechanical properties of cells as hypothesized
in Figure 9 and the cellular structure might adapt its organization
in a way to fight against the drug by gaining cell stiffness. In fact,
while a disease state causes biological and functional changes in
cells, it also leads to the significant changes in the morphological
properties of cells [54]. Cytoskeletal actin has a crucial role in
governing mechanical properties of cells [55,56] and it is prone to
dynamic changes during progression of cancer in all forms [54].
Some studies showed increased cell stiffness when normal cells
evolve to be cancerous cells [57] and some showed reduced cell
stiffness upon metastasis using different biomechanical assays
[58,59]. Moreover, it was revealed that chemotherapy drugs such
as taxol and cisplatin resulted in the increase in cell stiffness of
metastatic cancer cells [60] and increased cell stiffness of drug
Figure 9. Hypothesized impedimetric concentration response
map. (1) At low nontoxic drug concentrations, the drug has no effect
on cells, which results in unchanged LF and HF signal. (2) There is a
drug concentration range where stimulatory effect takes place and
reflects in higher impedance owing to the changes in the cellular
structure and cell-cell interaction. (3) At toxic drug concentrations, there
are two different circumstances that need to be taken into account. (3)
At mild drug concentrations, the drug induces minor morphological
changes while cell interior is intact, reflecting in lower LF with HF
remaining the same. (4) At high inhibitory concentrations, the LF and
HF signal drop sharply due to the substantial morphological changes
and major cell damage.
doi:10.1371/journal.pone.0057423.g009
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sensitive ovarian cancer cells upon sublethal concentrations of
cisplatin was shown by using atomic force microscopy (AFM) [53].
Here, we also observed pronounced and intense changes in the
actin cytoskeleton structure and organization when cells gain drug
resistance. This indicates that cell stiffness might play an important
part behind the 50% increase of |Z| in the presence of non-toxic
concentrations of doxorubicin, but possibly other factors regarding
drug-induced extracellular events might also contribute to such an
impedance increase at LF.
In addition, it was shown that the drug-induced impedance
increase is concentration-dependent (Figure 8a) and reversible
(Figure 8b and 8c). This implies that the drug itself might induce a
direct effect on cellular structure, and/or cells might temporarily
adopt a protection mechanism against the drug effects by their
structural reorganization via actin remodeling. Overall, potential
stimulatory drug effects such as cell stiffness were measured during
the continuous exposure of cells to the nontoxic drug concentra-
tions. These findings suggest that impedance spectroscopy is
suitable for detecting and quantifying the increasing cell stiffness of
drug sensitive cancer cells upon drug exposure and sensing the
alterations of biomechanical properties of cancer cells on the onset
of drug resistance.
Conclusions
In conclusion, we demonstrated that drug resistant breast
cancer cells could be distinguished from their parental cell
population based on the differences in their dielectric properties
such as Rextra. It was also shown that these two cell lines
demonstrate a sharply different impedance response to doxorubi-
cin. Moreover, a reversible increase in the cell stiffness in the
presence of nontoxic drug concentrations could be measured using
impedimetric measurements, indicating that structural reorgani-
zation of F-actin due to the drug could play a significant role on
the onset of gaining drug resistance. Such stimulatory response
with simultaneous LF and HF analysis enabled the creation of an
impedimetric cellular drug response map. Future investigations
might include testing heterogeneous tissue samples from patients
and the use of multiple assays running in parallel within an
automatic system in order to develop a high-throughput platform
that meets the needs of laboratory diagnostics and pharmaceutical
industry more comprehensively.
Overall, impedance screening is a trendsetting technique owing
to a number of striking advantages including label-free, non-
destructive, cost-effective and continuous cell characterization.
From this point of view, cell-based impedimetric sensing opens
new avenues in personalized medicine to create new classes of
detection devices for drug induced cellular events. Such sensing of
cellular phenomena using impedance analysis combined with real-
time imaging might represent a useful technique for identification
of cancer cells at different stages and their interaction with drug
during the disease. Thus, such miniaturized devices could be useful
for personalized medicine applications to identify the disease
progress and optimize the drug treatment of a patient during
chemotherapy.
Supporting Information
Figure S1 Electrode design; a bipolar interdigitated
electrode (IDE) pair were adapted to six-filter configu-
ration to maximize electrode surface coverage for high-
sensitivity impedance measurement of the cell culture
area. Total of 54 electrode fingers are provided for each electrode
(w= 10 mm, l = 100 mm) separated by a gap of 15 mm.
(TIF)
Figure S2 Cell adherence on microelectrodes moni-
tored as a function of time by impedance spectroscopy
at 10 kHz for a) MCF-7 WT b) MCF-7 DOX. Imaging of cell
culture on microelectrodes before drug treatment for c) MCF-7
WT and d) MCF-7 DOX.
(TIF)
Figure S3 a) The impedance profile of cell medium with and
without doxorubicin in the absence of cells at 10 kHz as a control
experiment. 5% increase in the impedance magnitude was
observed when 20 mM drug was introduced to the cell medium;
b) The temporal evolution of |Z| of 20 mM doxorubicin in cell
medium in the absence of cells, no change was observed in the
impedance as a function of time at 10 kHz.
(TIF)
Figure S4 Imaging of MCF-7 WT cells on microelec-
trodes before and after drug treatment of a) 0.2 mM
doxorubicin b) 2 mM doxorubicin c) 20 mM doxorubicin.
(a) 8 h and 24 h of 0.2 mM drug treatment caused morphological
changes such as cell retraction (blue arrow) but no cell death was
observed (b) Cell retraction (blue arrow) and formation of wider
intercellular gaps (red arrow) were observed after 8 drug treatment
and some cell death occurred (black arrow) after 24 h of 2 mM
drug treatment. (c) Severe morphological changes (red arrow) and
cell death (black arrow) took place both after 8 h and 24 h
treatment of 20 mM doxorubicin.
(TIF)
Figure S5 Imaging of MCF-7 DOX cells on microelec-
trodes before and after drug treatment of a) 20 mM
doxorubicin; no cell death was observed after 24 h and
cells were healthy and highly densely packed on the
microelectrodes. b) No doxorubicin (control); cells were healthy
and densely packed after 24 h.
(TIF)
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On the relationship between tissue structure and 
dielectric β-dispersion 
We present a method that enables estimating parameters linked to the cellular structure of 
biological tissues using impedance spectroscopy. We defined a parameter that allows drawing 
conclusions about the distribution of cell membrane capacitances as well as extra- and 
intracellular resistances within tissues.  This method is based on an accurate description of the 
fundamental difference in dielectric dispersion properties between tissues and single cells, a 
phenomenon that has remained incompletely explained since its observation by K. Cole in 1932 
(K. Cole, J Gen Physiol. 15, 6 (1932)). 
Introduction - Biological tissues are heterogeneous compositions of cells, each of them being 
described by specific properties (e.g. cell-cell distance, cell size, amount of intracellular organelles). 
Those properties differ from one cell to another resulting in a natural distribution within the tissue. 
Information about these distributions has not been exploited until now. In fact, optical microscopy 
does not allow the analysis of a large number of cells with their microenvironments due to low 
throughput and the inability to image large 3D environments of biological tissues. Moreover, when 
primary cells are biopsied and isolated from their tissue either for single cell flow cytometry analysis 
[1], [2] or for in vitro cell culture, their natural microenvironment is dramatically changed regarding 
intercellular distances, cell shape and cellular metabolism. However, the knowledge of cellular 
distributions may be a highly valuable asset in characterizing tissues and diagnosing their pathological 
states. For example, intercellular communication distances are an important parameter for cell-to-cell 
signaling [3] which in turn is sensitive to cancerous alterations [4], [5]. Distribution changes of such 
distances may therefore indicate early, localized pathological changes within a tissue.  
A biological cell behaves like an equivalent electrical circuit as shown in figure 1a where the cell 
membrane is represented by a capacitor, the intra- and extracellular matter by resistors. Information 
about the nature of this circuit and the value of each element can be obtained by measuring the 
impedance over a wide frequency range (impedance spectroscopy) as illustrated in figure 1b. 
However, it has been shown by K. Cole in 1932 that when measuring tissues, the impedance spectrum 
deviates from the one that is hypothesized for a single cell (figure 1b, Nyquist plot) [6]. Although an 
element named constant phase element (CPE) was suggested by Cole in 1940 [7] and used instead of a 
capacitance for almost a century to describe this particular β-dispersion1 behavior of cells in tissues 
[8], [9], [10], the physical meaning of its parameters (CPE exponent α and magnitude β) has been 
unclear and for this reason the parameters themselves have been rarely used [11], [12], [13]. Several 
studies interpreted the α as an indicator of tissue heterogeneity in cell sizes and shapes [14], [15] as 
well as of heterogeneity in the extracellular space [16], but no precise explanation has been provided. 
H.P. Schwan rightly stated in 1957 that a distribution of such microenvironments, each with a specific 
time constant, leads to such CPE-like behavior [17] but again no more detail about the dispersion 
mechanism of tissues was given. An intrinsic electrical property of biological tissues has been 
incompletely explained for more than 80 years now. 
In this article we provide new insight into how the β-dispersion of tissues is related to the electrical 
circuit of a single cell in medium. We show that the CPE exponent α does not directly correlate with 
tissue heterogeneity as was claimed before. Based on our findings, we demonstrate how impedance 
                                                          
1 β-dispersion describes the ability of cell membranes to act like a capacitance which filters out currents at low 
frequency and allows high frequency currents to pass through. This phenomenon is centered between 0.1 and 10 
MHz. 
spectroscopy allows obtaining qualitative data about distributions of cell membrane capacitances as 
well as of extra- and intracellular resistances and accordingly how distribution information about 
cellular parameters such as extracellular spacing, cell sizes and shapes can be extracted. 
 
Figure 1: Single cell impedance. a) Equivalent electrical circuit of a single cell with a cell membrane 
capacitance Cm, a series intracellular resistance Rint and a parallel extracellular resistance Rext; b) 
Impedance spectrum corresponding to the equivalent circuit of a single cell (big: Bode plot, small: Nyquist 
plot) 
Equivalent electrical circuit of biological tissues - In order to better understand the effect of tissue 
structures on impedance measurements, an overall equivalent electrical circuit model was built. A 
tissue is generally composed of a large number of cells. One single cell in a tissue is modeled by a 
capacitance Cm representing the lipid bilayer membrane, a resistance Rint representing the inner media 
of the cell and a resistance Rext representing the extracellular microenvironment (figure 1a). By 
connecting a large number of these single cell elementary circuits, a complex three-dimensional model 
of a tissue is obtained as illustrated in figure 2. Although this model is simplified, e.g. neglecting ion 
channels embedded in the cell membrane [18] and intracellular organelles [19], it is complex enough 
to provide insight in the main characteristics of tissue-specific impedance spectra in the β-dispersion 
frequency range. Within a tissue, different cell sizes, shapes and distances result in different resistance 
and capacitance values for each single elementary circuit. For each of the three elements (Rext, Rint and 
Cm) these values give rise to a distribution providing the probability for every element in a random 
single cell circuit to take a certain value. We assumed a homogeneous tissue, i.e. the distribution is the 
same for the whole circuit and we simulated impedance spectra by first determining the mean and the 
width of the distribution for the three single cell circuit elements. The values for every element were 
then allocated randomly. We used lognormal distribution as a distribution function for the different 
elements since it is a good description of size distributions in nature [20] (see supplemental material 
for distribution and simulation details).  
 
Figure 2: Complex tissue circuit with distributed single elements. The tissue model is made of a 3D-matrix 
of connected single cell equivalent circuits. Carrot cell picture is adapted from Gibson et al. [21] (image: 
Don Galler), with kind permission from Cambridge University Press. 
Influences of distribution width on impedance spectra - The different elements of a single cell circuit 
have an effect on distinct parts of the impedance spectrum. To study the effect of their distribution 
within the complex tissue circuit from figure 2, we simulated tissues with only one of the three 
elements being distributed, the two others being uniform and we compared the obtained graphs with 
the one of a circuit with no distribution at all (figure 3). It is noted that each cell in the circuit has two 
cut-off frequencies 1 01/ (2 )c mf R Cπ=  and 2 01/ (2 )c mf R Cπ=  where the part of the spectrum at 
which the impedance is dominated by the membrane capacitance is separated from the parts at which 
the impedance is dominated by the resistance at zero frequency R0 (fc1) and by the resistance at infinite 
frequency R∞ (fc2) (see figure 1b, these frequencies are precisely defined by the phase being equal to 
45°). When all three elements are the same in every cell of the whole tissue circuit, they also have the 
same cut-off frequencies resulting in an impedance behavior that is equivalent to the one of a single 
cell circuit (clear dots in figures 3a, b and c). On the contrary, when Rext, Rint and Cm are distributed, 
this also affects the distribution of fc1 and fc2, albeit to a different extent: a deviation from the single 
cell spectrum occurs around fc1 when Rext is distributed (figure 3a), around fc2 when Rint is distributed 
(figure 3b) and around both cut-off frequencies when Cm is distributed (figure 3c). In all cases, the 
transition from resistive to capacitive regime and vice versa is shifted between the single cell circuits. 
As a consequence, the slope of the impedance modulus |Z| is becoming smaller at these frequencies. 
When Rext is distributed, fc2 should also be slightly distributed since R∞ also depends on the external 
resistances. Nevertheless this effect can be neglected in a first approximation; especially if the ratio 
between R0 and R∞ is large and thus the dependency of R∞ on Rext is negligible. Regarding a 
distribution of Cm, both cut-off frequency distributions overlap if they are wide enough and almost no 
part of the impedance modulus has a slope of one anymore (figure 3c). 
By examining the effect of the distribution of every element individually, we discovered that each of 
them acts on a specific part of the spectrum. More importantly, if only one element is distributed, the 
resulting impedance is not showing a constant slope during the dispersion (see FigS1 in the 
supplemental material), unlike generally assumed in past bio-impedance spectroscopy studies. A very 
specific combination of element distributions might lead to such a constant phase but this is not the 
general case as will be shown later in this study. For this reason, we introduce hereafter a dispersion 
element. This new element will allow us to acquire a better understanding of the dispersion curve and 
to gather more information about tissue specific distributions from the impedance measurements. 
 
Figure 3: Impedance modulus with a distribution of  = .  for a) Rext, b) Rint and c) Cm. The resulting 
curves are compared with the non-distributed curves (clear dots). The distribution curves on the x-axis 
represent the distribution of cut-off frequencies. 
Distribution element - The method presented here to extract information about the distribution of the 
different elements from the tissue impedance spectrum is based on a new circuit element called 
dispersion element (DE) with an impedance 
( )
( ) ( )
1
( ) 2DE f
Z f
f i f αβ π
=
⋅
 
This element is simply a capacitance if 1α =  for all f and β is frequency-independent; it is a constant 
phase element (CPE) if both α and β are frequency-independent. Owing to the frequency dependence 
of the parameters α and β, the resulting general tissue circuit (figure 4b) allows describing every β-
dispersion behavior of any tissue model of figure 2. In fact, the DE, in contrary to the commonly used 
capacitance or CPE, accounts exactly for the distribution effect of the three single cell circuit elements 
in the tissue. Thus the DE-based circuit is not a fitting model of the measured data but its impedance is 
set equal to the data thanks to the freedom given by α(f) and β(f). Since β(f) depends only on α(f) and 
on a constant parameter β0 (see the supplemental material for detailed information on how to extract 
α(f) and β(f)), most of the relevant information concerning the distribution of the different elements is 
stored in α(f). 
As depicted in figure 4, the value of α(f) is 1 at very high and very low frequencies since none or all of 
the membrane capacitances are shorted. In the frequency range of the β-dispersion, α(f) is 
characterized by two troughs corresponding to the distribution of the cut-off frequencies (fc1 for Rext 
and Cm, fc2 for Rint and Cm, see supplemental information for a more detailed explanation). 
Consequently, the commonly used model of the CPE with a constant α over the dispersion frequency 
range is an imprecise description of the general β-dispersion and contains less information than the 
complete curve of a(f). 
 
Figure 4: a) The parameter α(f) for a lognormal distribution of the elements Rext ( = . ), Rint (  . ) 
and Cm (  . ) is shown. The real tissue α(f) (calculated) cannot be known for experimental data (due 
to imprecise values for R0 and R∞) and is therefore approximated by a capacitance (α=1), a constant phase 
element (CPE) or a logarithmic phase element (LPE). In contrast to capacitance and CPE, LPE carries 
additional information about the distribution of the circuit elements. The corresponding αmean is extracted 
at the frequency where 
0Z R R∞=  b) General equivalent tissue circuit that models the complex tissue 
circuit from figure 2. 
Logarithmic phase element - The curve of α(f) is directly related to the distributions of the different 
elements and therefore offers useful information about the tissue structure. However the computation 
of α(f) is only possible as long as R0 and R∞ are precisely known. Experimental measurements do not 
allow obtaining such precise values due to the limited frequency measurement range (defined by the 
apparatus) and more importantly due to other system-related circuit elements (electrode capacitance at 
low frequency and the parasitic effects at high frequency). We circumvent this problem by fitting the 
impedance curve using a tissue circuit with a specific case of the DE that we refer to as logarithmic 
phase element (LPE), whose frequency exponent α(f) is growing or decreasing logarithmically with 
the frequency: 
( ) meanLPE
mean
ff m log fα α
 
= ⋅ + 
 
 
where αmean is the value of α(f)LPE at the frequency fmean and m is the slope of α(f)LPE on a logarithmic 
scale of the frequencies. The frequency fmean is defined as the frequency where the impedance modulus 
is the geometric mean 0R R∞  of R0 and R∞ (figure 4a). By fitting the impedance data to the LPE-based 
tissue circuit, we obtain R0, R∞, slope, αmean and β0 as fit results where slope and αmean carry tissue-
related distribution information that has been unavailable until now. Note that ( )LPEfα  is not a fit to 
the calculated α(f), but it results from the fit of the measurement data to the LPE-based tissue circuit 
(figure 4b where the DE is replaced by a LPE). 
In conclusion, the DE is a general element that, placed into the tissue circuit, completely describes the 
β−dispersion behavior of every tissue as shown in figure 2, owing to the frequency-dependence of its 
parameters. Different approximations of the DE have been considered in the past (Table 1). Both the 
capacitance and the CPE are dispersion elements that possess a constant α and thus a constant phase 
over frequency. The LPE is a more sophisticated element that takes into account the distribution 
weighting of the elements of a single cell circuit. More advanced elements are imaginable in order to 
describe the real tissue dispersion behavior; however, such models would be prone to overfitting due 
to their increased number of free parameters. 
Table 1: The dispersion element describes a tissue’s dispersion behavior completely. The corresponding 
α(f) and β(f) can be found only as long as R0 and R∞ are precisely known. Since this is not possible in 
practice, approximations can be made and these are subdivided into two groups. A simple capacitance 
and a CPE both have constant phases. More sophisticated models have variable phases with a frequency-
dependence closer to the real one. The LPE represents a good compromise between frequency-dependence 
and few model parameters, but in theory any more complex equation is possible. Derivation of the 
formulas for β(f) is available in the supplemental information. 
Correlation between LPE and distribution width - In order to correlate tissue structure with the results 
of the LPE fit, the lognormal distribution width σ of the different elements was varied by keeping the 
mean value of each element constant. We extracted the values of αmean and slope, which determine 
uniquely α(f)LPE (figure 5). 
Simulations were carried out with a cubic circuit where x, y, z = 12 cells (1728 cells). The value of 
0 ) (logR log R R∞Δ = ⁄  was kept at 1.5. αmean decreases for an increasing σ of any of the three elements, 
this effect being stronger for the membrane capacitances. The slope is dependent on which element is 
distributed: positive for the external resistance, slightly negative for the membrane capacitance and 
strongly negative for the internal resistance. 
In a tissue, all three elements are distributed, which leads to a combination of their effects on αmean and 
on the slope. Based on our simulations, we created a distribution map that distinguishes different cases 
according to specific pairs of alpha and slope as illustrated in figure 5b. The slope gives insight into 
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which of the distributions is stronger (external resistance if the slope is within the dark gray area, 
internal resistance if the slope is within the light gray area). In addition, the lower the value of αmean is, 
the higher is the probability that Cm is distributed (patterned gradient). Moreover, we are able to detect 
relative differences between tissues based on the directional influences of each element's distribution 
(arrows). Although the knowledge of  αmean and slope does not provide enough information to 
uniquely determine the distribution width values of the different elements, it does enable determining 
the range in which they are included. 
 
Figure 5: The parameters αmean versus slope of the dispersion corresponding to different distributions of 
the elements Rext, Rint and Cm a) Simulations of a selection of different distribution combinations with ∆ = . . σ=0 when not mentioned b) Simplified distribution map where specific combinations of 
αmean and slope provide information about distribution weighting among the three elements. This map is 
based on simulations run for all combinations of distribution widths between 0 and 1 with a mesh of 0.1. 
Validation with plant tissue - For validation of our method, we chose carrots (Docus carota) as tissue 
samples because of their availability and ease of handling. αmean and slope were extracted from 
impedance measurements on the three different parts of the carrot as depicted in figure 6a and 
compared to the tissue structures as observed under the microscope (figures 6b-d). 
The parameter αmean alone (≈αCPE) does not allow differentiating all tissue samples but thanks to the 
additional slope value, the different parts of the carrot can be distinguished unequivocally and their 
cellular structures estimated as follows : the lower αmean (wider distribution of membrane 
capacitances) and the lower slope (wider distribution of internal resistances with respect to external 
resistances) of part 2 correlate with the cell sizes being visibly more distributed in part 2 than in parts 
1 and 3. According to the difference in slope between part 1 and part 3, the external resistances are 
more distributed in part 1. 
Finally, it is noted that although cell sizes can be estimated using optical microscopy, this is hardly 
possible for intercellular spaces, which are in the micro to nanometer range. Therefore, our technique 
enables qualifying a tissue characteristic that has been inaccessible until now. 
 
Figure 6: (a) αmean and slope from LPE-based tissue circuit best fits of measurements on carrots 
(mean±SEM, n=8) (b-d) Bright field images of three different parts of a carrot slice as depicted in (a). (b) 
Center part (1), (c) Intermediate part (2), (d) external part (3). The scale bar corresponds to 200 μm on 
the right side and 50μm on the left side. 
Conclusion - This article explains the deviation of tissue dispersions from hypothesized single cell 
circuits. Although K. Cole introduced a so called constant phase element which more closely 
described the observed curves; the physical meaning of its parameters was unclear and therefore 
mostly unexploited. Tissue-specific information that is related to cellular distributions was missed.  
The study of tissue dispersion effects revealed that the distribution of each of the three basic elements 
of a single cell circuit (intra- and extracellular resistance as well as cell membrane capacitance) 
throughout the whole tissue circuit has a distinct impact on the impedance curves. We introduced a 
new element named logarithmic phase element that allows drawing conclusions about distributions 
within a tissue. Our distribution results on plant tissues correlated with cellular structures that were 
observed under the microscope, pointing out the potential this method might have on human disease 
diagnostics where fast, label-free and above all objective analysis methods are of high interest. 
The variations of different tissue-specific parameters such as cell sizes, intracellular properties and 
above all intercellular distances may be compared and such gained knowledge might help understand 
fundamental disease-related phenomena within tissues. Considering the wide use of electrical 
impedance spectroscopy, our new technique may have strong implications on tissue characterization, 
in particular in the field of cancer diagnostics, but also in the study and characterization of in vitro cell 
populations for tissue engineering. 
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